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Abstract 
 
The enzyme 3-deoxy-D-manno-octulosonate 8-phosphate (KDO8P) synthase catalyses the 
aldol condensation of the five-carbon sugar phosphate, arabinose 5-phosphate (A5P), and 
phosphoenol pyruvate (PEP) to give the eight-carbon phosphorylated sugar, KDO8P.  It is the 
second committed step in the synthesis of KDO, a necessary component of the cell wall of 
Gram-negative bacteria. 
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This thesis describes the design, synthesis and evaluation of a number of inhibitors of 
KDO8P synthase that utilise the functionality of one or both substrates. 
The KDO8P synthase family can be divided based on the requirement of a divalent metal ion.  
Chapter 2 describes the growth, purification and characterisation of an example from both the 
metal-independent KDO8P synthases (Neisseria meningitidis, Nme) and metal-dependent 
KDO8P synthases (Acidithiobacillus ferrooxidans, Afe) in order to utilise these enzymes for 
the inhibition studies described in this thesis. 
In Chapter 3, a number of small molecule PEP analogues were selected as mimics of KDO8P 
synthase reaction intermediates and tested as inhibitors of KDO8P synthase from N. 
meningitidis and A. ferrooxidans.  Glyphosate, (E)-vinyl phosphonate and the fluorinated 
analogue of (E)-vinyl phosphonate were selected as mimics of the high-energy oxocarbenium 
intermediate through which the KDO8P synthase reaction is thought to occur.  The two 
enantiomers of phospholactate were selected in order to investigate the chirality of the 
tetrahedral intermediate and determine the importance of this chirality for inhibition of 
KDO8P synthase.  All five inhibitors were found to be moderate to poor inhibitors of both the 
KDO8P synthase from N. meningitidis and A. ferrooxidans. 
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Chapter 4 describes the design and synthesis of inhibitors that incorporated structural features 
of the second substrate, A5P, in order to improve inhibition from that observed for the PEP 
analogues investigated in Chapter 3.  A bisphosphate inhibitor was designed that incorporated 
a terminal phosphate moiety, representative of the phosphate of A5P.  A large increase in 
inhibition was found, compared to the phospholactates from which it was derived.  A 
structure-activity-relationship study was undertaken on this compound by design of 
compounds that lacked one of the two phosphate moieties of the bisphosphate inhibitor, in 
order to determine their relative importance.  The inhibition results indicate that the primary 
terminal phosphate, thought to bind in the A5P phosphate binding site, is more important for 
inhibition of KDO8P synthase than the secondary phosphate. 
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In Chapter 5 these investigations into the inhibition of KDO8P synthase are discussed in 
detail, and interpreted using the aid of computational studies.  In addition several approaches 
are described for the completion and advancement of the studies presented here in this thesis. 
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1.1. Lipopolysaccharide biosynthesis as a target for anti-microbial drugs 
Gram-negative bacteria have both an inner and outer membrane, the former being the site of 
the electron transport chain, and the latter being a unique, asymmetric layer used in the 
protection of a fragile peptidoglycan layer.  The outer membrane is asymmetric as the inner 
face is mainly phospholipids, whereas the outer face contains lipid A bound to a 
lipopolysaccharide (LPS) which extends out from the surface (Figure 1.1).1 
 
 
Figure 1.1: Model of the inner and outer membranes of Escherichia coli K-12.  Taken from Raetz et al.1 
This LPS is composed of four main regions;1 
1. Lipid A is the hydrophobic component, composed of six fatty acids that anchor LPS 
to the outer surface of the bacterial cell. 
2. The inner core region is composed of two to three molecules of 3-deoxy-D-manno-
octulosonate (KDO) and two to three heptose residues.  This region is usually 
conserved within bacterial families. 
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3. The outer core region is a pentasaccharide whose covalent structure is more variable 
than that of the inner core and is usually made up of sugars such as glucose, galactose 
and heptose.  It provides an attachment site for the O-antigen polysaccharide. 
4. The O-antigen repeat extends into the extracellular environment and can differ in the 
monomer glycoses, the position and stereochemistry of the O-glycosidic linkages, and 
the presence or absence of non-carbohydrate substituents.  It provides the antigenic 
specificity of the bacterial species. 
 
KDO has been shown to be the only conserved saccharide in nearly all LPS structures 
investigated thus far2 and is synthesised from the five-carbon sugar ribulose 5-phosphate 
(Rib5P) (Figure 1.2).  This pathway is only found in Gram-negative bacteria and certain plant 
species,3 and is considered a potential target for the generation of anti-microbial drugs.  Thus 
far work targeting this pathway has focussed on inhibition of the 3-deoxy-D-manno-2-
octulosonic acid (KDO) pathway enzymes; arabinose 5-phosphate (A5P) isomerase, cytidine 
monophosphate (CMP)-KDO synthetase and 3-deoxy-D-manno-octulosonate 8-phosphate 
(KDO8P) synthase.4 
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Figure 1.2: Biosynthesis of Lipid A from ribulose 5-phosphate 
Investigation of A5P isomerase as an anti-microbial target is problematic as the enzyme has 
not been well characterised and the catalytic residues are still relatively unknown.4  The pKa 
values of these catalytically important amino acids in E. coli have been estimated at 6.55 ± 
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0.04 and 10.34 ± 0.07 however,5 and data suggests the presence of a histidine or possible 
carboxylate side chain, with an lysine or arginine in the active site.6  These same amino acids 
are present in the active site and common to two other known isomerases, glucose 6-
phosphate isomerase7 and triose phosphate isomerase,8,9 and this may reflect a common 
mechanism.  The inhibition of A5P isomerase has thus far focussed on analogues of Rib5P 
and A5P and the most potent inhibitors have been found to have IC50 values ranging from 
0.53–1.6 mM (Figure 1.3).10 
The work to inhibit CMP-KDO synthetase has been far more successful, with initial studies 
into KDO analogues resulting in 2-deoxy-β-KDO (Figure 1.3) with a Ki of 3.9 µM in vitro.9  
This compound was found not to be active against Gram-negative bacteria in vivo however, 
and so a series of amino groups were derivitised at the C8 position, resulting in a series of 
dipeptide attached inhibitors that were found to have in vivo activity,11-13 presumably due to 
their increased uptake via the oligopeptide permease system.  Of these dipeptide prodrugs, 
the alanylalanyl, norvalylalanyl and arginylnorvalyl derivatives were also found to have good 
in vitro activity against CMP-KDO synthetase from E. coli14 and Salmonella typhimurium15 
with IC50 values in the µM range. 
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Figure 1.3: Known inhibitors of LPS pathway enzymes A5P isomerise and KDO-CMP synthetase 
KDO8P synthase is the other enzyme in the KDO synthetic pathway that has been 
investigated in detail, and is the focus of this project. 
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1.2. KDO8P synthase 
The second step in the synthesis of the sugar KDO from ribose 5-phosphate (R5P) is 
catalysed by KDO8P synthase, a key enzyme in the carbon flow of the LPS synthetic 
pathway.  It catalyses the irreversible aldol-like condensation reaction between arabinose 5-
phosphate (A5P) and phosphoenol pyruvate (PEP) to give the eight-carbon sugar KDO8P 
(Figure 1.4). 
O
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Figure 1.4: The reaction catalysed by KDO8P synthase 
KDO8P synthase, when first characterised in 1959 from Pseudomonas aeruginosa was found 
to exclusively utilise A5P as a substrate, not accepting D-ribose 5-phosphate, D-xylose 6-
phosphate,16 D-glucose 6-phosphate, D-erythrose 4-phosphate and a number of other sugars 
and sugar phosphates.17  A mutant of S. typhimurium that had a temperature sensitive KDO8P 
synthase was isolated by Rick and co-workers.18  This mutant was shown to have a much 
decreased affinity to A5P at higher temperatures, with the Km of A5P increasing 25-fold 
between 29 °C and 42 °C.  Below 30 °C bacterial growth and synthesis of LPS was relatively 
normal, but as the temperature of incubation was increased to 37 °C the bacteria became 
increasingly dependent on exogenous A5P.  At 42 °C exogenous A5P failed to halt the 
synthesis of protein, DNA, RNA and peptidoglycan, and the ultimate result was cell death.  
This lead to the conclusion that KDO8P synthase catalytic activity is required for cell growth, 
and as such is an attractive target for inhibitors acting as anti-bacterial compounds.  Recently 
it has been shown that E. coli can survive without the KDO core in the LPS, but that 
depletion of KDO causes permeability of the cell wall to many large molecules not 
previously able to travel across the cell membrane, such as detergents and large hydrophobic 
antibiotics usually only effective against Gram-positive bacteria.19  This permeability is 
responsible for cell death, at least in this bacterial species. 
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1.2.1. Mechanism of KDO8P synthase 
The mechanism of KDO8P synthase has been the subject of in depth study and a number of 
observations have been made.  In contrast with many other PEP utilising enzymes, the 
chemical mechanism of the reaction KDO8P synthase catalyses involves the cleavage of the 
C-O bond of PEP rather than the more common cleavage of the high energy P-O bond 
(ΔG0 = -62.0 kJ/mol).20 This was determined by studies using PEP labelled with 18O in the 
bridging oxygen position, showing that the 18O was recovered as inorganic phosphate.21  The 
same study that determined the C-O bond cleavage also showed the reaction was irreversible 
by incubating KDO8P synthase and 32P labelled inorganic phosphate with just PEP, PEP and 
R5P, and PEP and A5P.  No exchange of 32P into PEP was observed under any of these 
conditions.21 
Analysis of the product formed from the KDO8P synthase catalysed reaction using 
stereospecifically deuterated PEP has shown the condensation proceeds in a stereospecific 
manner via the attack of the si face of PEP onto the re face of A5P22 as shown in Figure 1.5. 
OPO32-HO
O
HO
OPO3-2
CO2-
OH
si
re
H
 
Figure 1.5: Stereospecificity of the KDO8P synthase reaction 
This condensation was thought to occur via one of two mechanisms, involving either attack 
of the 3-hydroxy group or a water molecule on C2 of PEP to give cyclic (path b)23 or acyclic 
(path a)21 intermediates respectively (Figure 1.6). 
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Figure 1.6: Two proposed mechanisms of KDO8P synthase and the isosteric cyclic phosphonate analogue 
1.2. 
The reaction through a cyclic intermediate (path b, Figure 1.6) has been largely discounted in 
a number of different studies.  The proposed cyclic intermediate 1.1 has been synthesised and 
tested both as a substrate for, and inhibitor of KDO8P synthase.24,25  It was found not to be a 
substrate for KDO8P synthase, broke down to KDO8P and inorganic phosphate at the same 
rate regardless of the presence of the enzyme, and was a competitive inhibitor with a 
moderate Ki value of 35 µM for E. coli KDO8P synthase (EcoKDO8PS).  The best cyclic 
inhibitor to date, the isosteric phosphonate analogue 1.2, in which the bridged oxygen is 
replaced by a methylene group, had a Ki of only 4.9 µM for EcoKDO8PS,23 which should be 
considered high for an inhibitor containing the topological and electrostatic properties of the 
reaction intermediate.  Reaction via an acyclic intermediate (path a, Figure 1.6) was then 
thought to be the most likely reaction mechanism, with a linear transition state mimic 
showing the most potent inhibition to date with a Ki value of 0.42 µM against 
EcoKDO8PS.26,27 
Shortly thereafter, the linear intermediate was identified by time-resolved ESI-TOF mass 
spectrophotometry, a technique that allows for the detection of enzyme-intermediate 
complexes with lifetimes of less than 10 ms.  The technique can be considered a stopped-flow 
spectrophotometry equivalent of mass-spectrometry.28  Using this technique the hemiketal 
phosphate intermediate bound to the enzyme was identified (Figure 1.7).  This was the first 
direct evidence for the KDO8P synthase mechanism. 
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Figure 1.7: Time-resolved ESI-TOF mass spectra for the KDO8P synthase reaction showing the partial 
enzyme mechanism through analysis of the mass peaks.  Taken from Li et al.28 
Using the same technique, rate data were collected for the enzymic reaction (Figure 1.8).29  
The formation of the intermediate was found to be rate limiting (k = 95 s-1) and the 
breakdown of this intermediate to KDO8P much faster (k = 500 s-1).  These values agree with 
the overall kinetic constant first determined for the KDO8P synthase reaction (k = 100 s-1). 
                E•A5P•PEP                                              E•I                                           E•KDO8P•Pi 
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HO
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Figure 1.8: Rate constants for formation and breakdown of the tetrahedral intermediate in the KDO8P 
synthase reaction. 
Two mechanisms have been proposed for the enzymic reaction through the known linear 
intermediate, and differ in how the water attacks the C2 carbon of PEP (Figure 1.9). 
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Figure 1.9: Two competing roles of the water molecule in the KDO8P synthase reaction. 
The first (path a, Figure 1.9) involves deprotonation of a water molecule as the carbonyl 
moiety of A5P approaches.  This hydroxide ion then attacks the C2 carbon of PEP either 
producing a transient carbanion molecule30 producing a negatively charged C3 of PEP which 
reacts with the C1 atom of A5P, or through a concerted mechanism.  The carbanion 
mechanism has many flaws associated with it.  It requires that the C2 carbon of PEP have 
unprecedented electrophilic character in order for the hydroxide ion attack to occur, as well 
as requiring the existence of an unstabilised carbanion, with a pKa likely to be > 30, inside the 
enzyme active site surrounded by protons of far greater acidity.  It is highly likely that any 
carbanion, even one that only need exist for a short period of time, would immediately be 
quenched by one of these active site protons and therefore be unable to react to form the 
linear intermediate. 
The second proposed mechanism (path b, Figure 1.9) is more plausible and involves the 
formation of an oxocarbenium ion, either a transition state with oxocarbenium character or a 
high energy intermediate via attack of the C3 atom of PEP with the C1 atom of A5P, and 
reaction of this ion with a water molecule on the C2 atom of this intermediate.31  It has been 
proposed that both the related enolpyruvyl transferases, enolpyruvylshikimate-3-phosphate 
(EPSP) synthase and UDP-GlcNAc enolpyruvyl transferase (MurZ), catalyse a reaction that 
proceeds via a similar oxocarbenium ion, either as a reaction intermediate or highly unstable 
transition state molecule.32,33  In the similar aldolase DAH7P synthase this is thought to be 
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aided by activation of the carbonyl via the divalent metal ion in the active site using Lewis 
acid catalysis.  Not all KDO8P synthase enzymes require a metal ion however (vide infra), 
and in all crystal structures of the wild-type metal-dependent KDO8P synthase from Aquifex 
aeolicus (AaeKDO8PS) with A5P bound, the aldehyde moiety of the A5P is not close enough 
to the metal ion to interact with it.34  Instead, it has been proposed that the bound PEP is in 
the monoanionic state, and the second weaker phosphate ionisation of PEP may be used to 
protonate the A5P carbonyl oxygen (Figure 1.10).30  This theory is supported by the presence 
of a conserved phenylalanine residue in KDO8P synthases near the phosphate moiety of PEP 
that may promote this monoanionic binding. It should be noted that the opposite 
conformation, with the A5P aldehyde moiety within bonding distance of an asparagine 
residue, representative of the metal ion in metal-independent KDO8P synthase enzymes, has 
been observed in a mutant enzyme,35 and will be discussed in more detail in Section 1.3.2. 
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Figure 1.10: Proposed partial mechanism showing protonation of the aldehyde moiety by the 
monoanionic phosphate of PEP. 
A 2009 study36 used a crystal structure of a metal-independent C11N mutant of 
AaeKDO8PS35 as the basis for computational studies in order to probe the two reaction 
pathways.  They found that the most energetically favourable pathway to the formation of the 
intermediate (Figure 1.9) was a concerted mechanism between PEP, A5P and a water 
molecule in the enzyme active site.36 
1.3. Two classes of KDO8P synthase 
KDO8P synthases have been divided into two classes; those which require a divalent metal 
ion for catalytic activity (KDO8P synthases from A. aeolicus,37 Aquifex pyrophilus,38 
Helicobacter pylori,39 Chlamydia psittaci,39 and those that do not (E. coli,17 Neisseria 
meningitidis40).  The similarity in sequence and structure between these two classes is high, 
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and a sequence alignment of annotated KDO8P synthase genes from different species reveals 
a number of conserved residues, as well as distinct differences between the two classes that 
can be putatively assigned as either a metal-dependent or metal-independent KDO8P 
synthase by the presence of either a conserved cysteine or arginine residue respectively in the 
metal binding site, or equivalent area of the metal-independent enzyme (Figure 1.13). 
1.3.1. Evolutionary relationship to DAH7P synthases 
The 3-deoxy-D-arabino-heptulosonate 7-phosphate (DAH7P) synthases, a related aldolase 
enzyme, that catalyses the condensation reaction between the four carbon aldehyde erythrose 
4-phosphate and PEP (Figure 1.11), has been divided into two types based on sequence 
similarity, the type I and type II DAH7P synthases (Figure 1.12).41  The sequence similarity 
between these two types is ∼10 %, below the level of statistical significance for such a 
measurement.  The type II enzymes are around 50 kDa.  Until recently it was thought that 
type II DAH7P synthases were only found in plants, though they have now been found in 
some bacterial species such as Mycobacterium tuberculosis, H. pylori and Campylobacter 
jejuni.  The type I DAH7P synthases are smaller at around 40 kDa, and can be further split 
into two classes, the Iα and Iβ DAH7P synthases (Figure 1.12).  The Iα are considered the 
most ancestral of the aldolases, and contains species of comparatively ancient lineages such 
as Pyrococcus furiosus and Thermotoga maritima.42  The Iβ class are thought to be related to 
the KDO8P synthases through divergent evolution, by sequence similarity and morphological 
studies and it is thought that the metal-independent KDO8P synthase enzymes diverged from 
the metal dependent enzymes.39  All DAH7P synthase enzymes characterised thus far require 
a divalent metal ion for catalysis43-48 and this is used as further evidence that the metal-
independent KDO8P synthases are the newest branch of the aldolase evolutionary tree.39 
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Figure 1.11: The reaction catalysed by DAH7P synthase. 
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Figure 1.12: The types of DAH7P synthase and relationship to KDO8P synthase. 
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Eco             MKQKVVSIGDINVANDLPFVLFGGMNVLESRDLAMRICEHYVTVTQKL-GIPYVFKASFD 
Nme             MDI---KINDITLGNNSPFVLFGGINVLESLDSTLQTCAHYVEVTRKL-GIPYIFKASFD 
Hin             MQNKIVKIGNIDVANDKPFVLFGGMNVLESRDMAMQVCESYVKVTEKL-GVPYVFKASFD 
Aae             ME---------------KFLVIAGPCAIESEELLLKVGEEIKRLSEKFKEVEFVFKSSFD 
Afe             MRL-----CGFEAGLQHPFFLMAGPCAIESESLALRTAEDLRDICARL-GIPFIYKSSYD 
Hpy             MKTS--------KTKPPKSVLIAGPCVIESLENLRSIAIKLQPLANNE-RLDFYFKASFD 
Cps             MQKF--SVGTVSLPGPKGLFLIAGPCLIENRRMAMDVAAELDRIRKKE-DVRVIFKGSYR 
                *                  .: :.*   :* .             :   .   :   :* .*:  
 
Eco             KANRSSIHSYRGPGLEEGMKIFQELKQTFGVKIITDVHEPSQAQPVADVVDVIQLPAFLA 
Nme             KANRSSIHSYRGVGLEEGLKIFEKVKAEFGIPVITDVHEPHQCQPVAEVCDVIQLPAFLA 
Hin             KANRSSIHSYRGPGMEEGLKIFQELKDTFGVKIITDVHEIYQCQPVADVVDIIQLPAFLA 
Aae             KANRSSIHSFRGHGLEYGVKALRKVKEEFGLKITTDIHESWQAEPVAEVADIIQIPAFLC 
Afe             KANRSSGQSFRGPGMDEGLRILEKVRREVGVPVVTDVHEKEDVSAVAEVVDVLQTPAFLC 
Hpy             KANRTSLESYRGPGLEKGLEMLQIIKEEFGYKILTDVHESYQASVAAKVADILQIPAFLC 
Cps             KANRSSASSYTGIGDRQALEILREIRDYFGMPVLTDVHETSEVELAASYVDVLQIPAFLC 
                ****:*  *: * *   .:. :. ::  .*  : **:**  : . .*.  *::* ****. 
 
Eco             RQTDLVEAMAKTGAVINVKKPQFVSPGQMGNIVDKFKEGG-------------NEKVILC 
Nme             RQTDLVVAMAKTGNVVNIKKPQFLSPSQMKNIVEKFHEAG-------------NGKLILC 
Hin             RQTDLVEAMAKTGAVINVKKPQFLSPSQMGNIVEKIEECG-------------NDKIILC 
Aae             RQTDLLLAAAKTGRAVNVKKGQFLAPWDTKNVVEKLKFGG-------------AKEIYLT 
Afe             RQTDFIQAVAAAGKPVNIKKGQFLAPWDMLHVASKAKATG-------------NEQIMVC 
Hpy             RQTDLIVEVSQTNAIINIKKGQFMNPKDMQYSVLKALKTRDSSIQSPTYETALKNGVWLC 
Cps             RQTDLIVAAASTGLAVNIKKGQFLAPEDMALAAAKAAATG-------------NKKIMLT 
                ****::   : :.  :*:** **: * :    . *                     : :  
 
Eco             DRGANFGYDNLVVDMLGFSIMKKVSGNSPVIFDVTHALQCRDPFGAASGGRRAQVAELAR 
Nme             ERGSSFGYDNLVVDMLGFGVMKQTCGNLPVIFDVTHSLQTRDAGSAASGGRRAQALDLAL 
Hin             DRGTNFGYDNLIVDMLGFSVMKKASKGSPVIFDVTHSLQCRDPFGAASSGRRAQVTELAR 
Aae             ERGTTFGYNNLVVDFRSLPIMKQW---AKVIYDATHSVQLPGGLGDKSGGMREFIFPLIR 
Afe             ERGASFGYNNLVSDMRSLAVMRQT--GCPVVFDATHSVQLPGGQGDRSGGQREFIPVLAR 
Hpy             ERGSSFGYGNLVVDMRSLTIMREF---APVIFDATHSVQMPGGANGKSSGDSSFAPILAR 
Cps             ERGTTFGYHNLVVDYRGLPIMAES--GWPVILDVTHSVQLPGAGAGVSGGDRRFLMPLAR 
                :**:.*** **: *  .: :* :      *: *.**: :*   .     * .*       *   
 
Eco             AGMAVGLAGLFIEAHPDPEHAKCDGPSALPLAKLEPFLKQMKAIDDLVKG--FEEL--DT 
Nme             AGMATRLAGLFLESHPDPKLAKCDGPSALPLHLLEDFLIRIKALDDLIKS--QP-I--LT 
Hin             SGLAVGIAGLFLEAHPNPNQAKCDGPSALPLSALEGFVFQMKAIDDLVKS--FPEL--DT 
Aae             AAVAVGCDGVFMETHPEPEKALSDASTQLPLSQLEGIIEAILEIREVASK--YYET--IP 
Afe             AAVAAGVSGLFMETHPNPADALSDGPNAWPLGRMEDLLRILQHIDHVVKNQDFPENYPEE 
Hpy             AAAAVGIDGLFAETHVDPKNALSDGANMLKPDELERLVTDMLKIQNL------------- 
Cps             AAVAAGVDGLFFEVHPDPATAMSDASTQAPLAGFGEMVRELMQLQRCMQS--IREE--FH 
                :. *.   *:* * * :*  * .*...      :  : :  :  :                 
 
Key: Metal  a5p  pep  re-face H2O  *:. Well/moderately/partially conserved residues 
 
Figure 1.13: Sequence alignment of KDO8P synthases from both classes.  Including in the alignment are 
the sequences from the metal-independent class; E. coli (Eco), N. meningitidis (Nme), Haemophilus 
influenza (Hin), and the metal-dependent class; A. aeolicus (Aae), Acidithiobacillus ferrooxidans (Afe), H. 
Pylori (Hpy) and C. psittaci (Cps).  Roles of key residues are indicated.  Alignment generated with 
Expressio, www.tcoffee.org. 
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As shown in Figure 1.13, the active site residues are the same between the two classes of 
KDO8P synthase, except for those that contribute to the metal binding site (Figure 1.15). 
In the metal-dependent KDO8P synthases, the metal binding site is in a distorted octahedral 
geometry, with the metal bound to four residues, C11, D233, E222 and H185 in 
AaeKDO8PS, and a conserved water molecule (Figure 1.14).  In some crystal structures this 
water molecule is displaced when A5P is bound, with the C2 hydroxyl of A5P replacing it as 
a metal ligand.34 
 
Figure 1.14: Metal coordination site of AaeKDO8PS (drawn from 1FWW34).  The metal ion (cadmium, 
gold) is bound to absolutely conserved residues C11, D233, E222 and H185 with the fifth ligand normally 
being a conserved water molecule, shown to be bridging C2 of PEP (bonding between the cadmium ion 
and ligands is shown in black, bonding between the water molecule and C2 of PEP is shown in yellow).  
Substrates and amino acid side chains are shown in red/blue/yellow/grey/orange (O/N/S/C/P respectively).  
Distances are measured in angstroms. 
In the metal-independent class of KDO8P synthase the cysteine residue that acts as a metal 
ligand is replaced with a conserved asparagine residue that probes further into the active 
site,49 and displaces the aspartate residue that acts as a metal binding ligand in 
AaeKDO8PS.34 
H185 
E222 
D233 
C11 
 
PEP 
3.43
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Chapter 1:Introduction 
15 
 
 
Figure 1.15: Overlay of the metal (cadmium, shown in gold) binding residues and active site bound PEP 
in AaeKDO8PS (shown in green, drawn from 1FWW34) and equivalent residues in the metal-independent 
EcoKDO8PS (shown in magenta, drawn from 1Q3N50).  D250 from EcoKDO8PS (top right) is equivalent 
to D233 from AaeKDO8PS (middle left). 
1.3.2. Conversion of metal-dependency by site-directed mutagenesis 
Many of the conserved residues that differ between the two classes of KDO8P synthase have 
been mutated to determine whether it is possible to convert a KDO8P synthase from one class 
into the other.  Conversion of the two classes by mutation of conserved residues may give 
insight into the evolutionary path the KDO8P synthase enzyme took from an ancestral 
DAH7P synthase-like enzyme, and show how it evolved to become metal-independent in 
some bacterial species. 
As previously discussed, the most obvious difference in the active site between the two 
classes of enzyme is the replacement of a conserved, metal binding cysteine residue in the 
metal-dependent class of KDO8P synthase with a conserved asparagine residue in the metal-
independent class.  Initially this was attempted with AaeKDO8PS to remove metal-
dependency and the C11 residue in AaeKDO8PS was mutated to an asparagine residue.51  
The result of this single C11N mutation was an enzyme that was no longer activated by the 
addition of divalent metal ions, and whose catalytic activity was unaffected by the presence 
of the metal chelating agent ethylenediaminetetraacetic acid (EDTA), which has been shown 
C11 Aae 
N26 Eco 
H185 Aae 
H202 Eco 
E222 Aae 
E239 Eco 
D233 Aae 
D250 Eco 
PEP 
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to significantly reduce the wild-type AaeKDO8PS activity to 0.4 % of the maximum activity 
in the presence of divalent metal ions.37  The specific activity of the C11N mutant was 75 % 
that of wild-type, but was catalytically more efficient; the kcat/Km for PEP increased from 
0.0027 to 0.053 s-1 µM-1, and PEP bound more tightly; Km of PEP decreased from 155 µM for 
wild-type to 12 µM for the C11N mutant, at 60 °C.  The Km for A5P was largely unaffected, 
which is expected as the mutation is found in the PEP binding site, and not the A5P binding 
site.  The crystal structure of the C11N mutant of AaeKDO8PS34 shows that the N11 residue 
overlays with the equivalent residue (N26) in EcoKDO8PS.50 
 
Figure 1.16: Overlay of the previously metal binding residues and active site bound PEP in the C11N 
mutant of AaeKDO8PS (shown in green, drawn from 2NWS34) and equivalent residues in the metal-
independent EcoKDO8PS (shown in cyan, drawn from 1Q3N50).  Important residues have been identified 
and distances are measured in angstroms. 
The reverse mutation (N26C) was also attempted in EcoKDO8PS to determine whether a 
single mutation could convert a metal-independent enzyme into a metal-dependent enzyme.  
This was not as successful however, and produced mixed results over a number of different 
studies.51,52  The same 2004 study that produced the metal-independent C11N mutant of 
AaeKDO8PS reported a virtually inactive enzyme when the N26C mutation was performed in 
EcoKDO8PS.51,52  A second 2004 study by Shulami et al. produced an N26C mutant of 
EcoKDO8PS that had a specific activity of 0.14 U mg-1 that increased to 0.73 U mg-1 in the 
C11N Aae 
N26     Eco 
7.77
D233 Aae 
D250 Eco 
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presence of EDTA, but that had a more than five-fold increase in kcat when assayed in the 
presence of Mn2+ or Cd2+ metal ions.52  In the presence of Cd2+ the Km of PEP for the N26C 
mutant was comparable to the value for wild-type EcoKDO8PS (5.8 and 6.0 µM 
respectively).  The increase in specific activity may have been due to the presence of 
inhibitory metal ions such as Pb2+ that were removed upon addition of EDTA.  The results 
from the study of EcoKDO8PS N26C demonstrated that the conversion of metal-dependency 
may not be achieved solely by single point mutations, and changes to other correlated 
residues may be required. 
It had been shown that a single point mutation was not sufficient in creating a bonafide metal-
dependent KDO8P synthase from a metal-independent KDO8P synthase, and so a study was 
undertaken in 2004 that implemented a double mutation in EcoKDO8PS adjacent to the N26 
residue.53  Metal-dependent KDO8P synthases have a conserved proline before the conserved 
cysteine that contributes to the metal binding site.  In EcoKDO8PS and some other metal-
independent KDO8P synthases this residue is instead a methionine.  Thus a double 
M25P/N26C mutation was created in EcoKDO8PS.  The kcat for the M25P/N26C mutant 
enzyme doubled when Mn2+ was added, from 1.65 to 3.2 s-1 which is a small increase but one 
that is greater than for the single N26C mutation (0.8 to 1.23 s-1).  The M25P/N26C mutant 
enzyme can still not be considered a bonafide obligate metal-dependent enzyme however, as 
in the absence of divalent metal ions 52 % of wild-type activity was retained. 
As shown in Figure 1.15 and Figure 1.16, a conserved aspartate (D233) that is a metal 
binding ligand in metal-dependent KDO8P synthases such as that from A. aeolicus (Figure 
1.14) is not found in the same position for the metal-independent EcoKDO8PS.  Instead the 
aspartate (D250 in EcoKDO8PS) adopts an opposing orientation close to 7.7 Å away from 
the position it adopts in the AaeKDO8PS active site and has its side chain projected away 
from the metal binding site in AaeKDO8PS.50  However in some crystal structures of the 
metal-independent KDO8P synthase from E. coli54  and N. meningitidis55 this area of the 
protein is poorly defined, indicating increased mobility.  Two separate studies mutated amino 
acids around this conserved aspartate in order to probe their importance in the orientation of 
this residue. 
A 2009 study by Cochrane et al. attempted to create a metal-dependent KDO8P synthase 
from the metal-independent N. meningitidis KDO8P synthase (NmeKDO8PS) by a 
combination of four mutations.55  The N23C mutation is identical to that which was created 
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in EcoKDO8PS in order to re-establish the metal binding scaffold.51,52  The other three 
residues targeted, C246, D247 and P249 are part of a conserved CDGP sequence in metal-
independent KDO8P synthase enzymes, that is only sometimes present amongst metal-
dependent KDO8P synthases.56  Instead, the cysteine residue is usually replaced with a serine 
residue, glycine is sometimes substituted for an alanine, and less commonly a serine, and the 
proline is often substituted for an alanine, serine or threonine.  C246 was mutated to a serine, 
which is present in most putative metal-dependent KDO8P synthase sequences.  P249 was 
mutated to a conformationally less restrictive alanine residue, as it was thought that in metal-
independent KDO8P synthases, this residue may be involved in the orientation of the 
conserved aspartate residue.  Finally, the conserved aspartate, D249, was mutated to 
glutamate, as the extended side chain would provide additional flexibility and potentially give 
improved metal binding.  All of the combinations of mutated residues that were created 
showed an increase in specific activity when treated with Mn2+ instead of the metal chelating 
agent EDTA, with three of the mutants showing activity only in the presence divalent metal 
ions; N23C/C246S/D247E, showing an increase in specific activity from 0.01 to 8.4 U mg-1 
and kcat of 3.9 s-1; N23C/C246S/P249A showing an increase in specific activity from 0.06 to 
9.8 U mg-1 and kcat of 4.79 s-1; N23C/C246S/D247E/P249A showing an increase in specific 
activity from 0.01 to 5.64 U mg-1 and kcat of 4.4 s-1.  The N23C/D247E/P249A triple mutant 
still showed some activity (0.35 U mg-1) in the presence of EDTA, which demonstrates the 
importance of the C246S mutation in the creation of the metal-dependent enzyme.  In crystal 
structures of mutant NmeKDO8PSs C246 forms a disulphide bond with N23C when the 
C246S mutation is not present (Figure 1.17), and this may negatively affect metal binding.  
The crystal structure of the quadruple mutant (3FYP)55 has a poorly defined L8 loop, on 
which the C246S/D247E/P249A mutations are found, and this may indicate a large amount of 
disorder in this region.  It has been proposed that the conserved cysteine in the CDGP 
sequence found in metal-independent KDO8P synthases plays a role in positioning the L8 
loop by hydrogen bonding to an asparagine residue found on the L2 loop.55  The difference in 
this sequence for metal-dependent KDO8P synthases may be be due to the conserved 
aspartate on the L8 loop acting as a metal ligand, thereby locking the L8 loop in place, 
making the cysteine-asparagine interaction unnecessary. 
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Figure 1.17: Overlay of the metal binding site of NmeKDO8PS N23C/D247E/P249A triple mutant (3FYO, 
green),55 and wild-type NmeKDO8PS residues (2QKF, cyan).55  Manganese ion in the triple mutant 
structure is coloured purple.  The new disulphide linkage between C246 and the new C26 residue in the 
triple mutant is shown.  Residues distinct to the NmeKDO8PS N23C/D247E/P249A triple mutant are 
labelled in red.  Distance from the bound manganese ion to E247 is measured in angstroms. 
Similar mutations have been created in the metal-dependent AaeKDO8PS, with a series of 
multiple point mutations; C11N, P10M/C11N, C11N/S235P/Q237A and  
P10M/C11N/S235P/Q237A.35  S235 and Q237 are found on the L8 loop and S235 is 
analogous to the proline in the CDGP sequence of metal-independent KDO8P synthases.  The 
importance of the proline to methionine mutation between the two classes of KDO8P 
synthases has previously been discussed with regard to the 2004 mutagenesis study on 
EcoKDO8PS.  The single and double mutations produced enzyme active sites that did not 
differ significantly from crystal structures of previous C11N mutants of AaeKDO8PS but 
crystals of the quadruple mutant diffracted very poorly.  However, in the crystal structure of 
the C11N/S235P/Q237A mutant (2NX3) co-crystallised with A5P and PEP, the A5P bound 
in such a way that the C2 hydroxyl was not positioned towards the N11 residue (or metal ion 
in metal-dependent KDO8P synthase enzymes) as seen in all previous crystal structures of 
AaeKDO8PS.  Instead the aldehyde moiety occupied this position, being within hydrogen 
4.21
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C23 
C246 
E247 
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bonding distance of not only the N11 residue but also H185 and D233 that normally 
contribute to the metal binding site in AaeKDO8PS (Figure 1.18).  Interestingly, a second 
crystal structure of the same mutant (2NXG) had the A5P bound in a configuration that 
resembled the A5P bound in the wild-type AaeKDO8PS.  Thus, it cannot be concluded that 
either binding mode in the crystal structures is representative of the native binding mode in 
solution. 
              
Figure 1.18: Comparison of A5P binding sites of wild-type AaeKDO8PS (left, 1FWW34) and the 
C11N/S235P/Q237A triple mutant (right, 2NX335).  A5P, PEP and surrounding residues are coloured 
orange/red/grey and blue (P, O, C and N respectively) and in the wild-type structure, the metal ion 
(cadmium) is coloured gold.  Distances to neighbouring atoms are measured in angstroms. 
1.3.3. Reactive water molecule 
As previously discussed, the KDO8P synthase reaction occurs through the attack of a water 
molecule onto the C2 atom of PEP.  Two possible candidates exist, conserved water 
molecules on the re and si face of PEP.34  The si face water molecule, in metal-dependent 
KDO8P synthases, is a metal ligand,30,34 though has shown to be displaced by the C2 
hydroxyl of A5P in some crystal structures,34 including the C11N mutant of A. aeolicus.35  
The re face water molecule may hydrogen bond with an aspartate and glutamate residue, and 
is also within bonding distance of the phosphate moiety of PEP (Figure 1.19). 
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Figure 1.19: Conserved water molecules in the active site of AaeKDO8PS (1FWW34), found on the re and 
si faces of PEP that may be involved in enzyme catalysis.  Also indicated are cadmium ion (gold) and 
surrounding residues D81 and Q99 (grey/red/blue) that may be involved in their activation and 
deprotonation.  Distances to neighbouring atoms are measured in angstroms. 
1.3.4. Observation of tetrahedral reaction intermediate 
The asymmetric unit in the two crystal structures of the C11N/S235P/Q237A AaeKDO8PS 
triple mutant in the aforementioned 2007 paper by Kona et al. contain 12 (2NX3) and 2 
(2NXG) subunits.  In one of the subunits from each crystal structure a hemiketal tetrahedral 
intermediate of the KDO8P synthase reaction was modelled into the active site.35 The authors 
claim that the modelled intermediate has the (R) configuration at the ketal carbon, implying 
PEP has reacted with the si face water molecule, via a carbanion mechanism or quenching of 
the oxocarbenium ion. 
                 
-2O3PO
HO
OH
HO
OH
-2O3PO
CO2-
OH
 
Figure 1.20: Hemiketal phosphate intermediate as reported by Kona et al. for the C11N/S235P/Q237A 
triple mutant of AaeKDO8PS; crystallographic and skeletal representations.35 
The conclusion that the tetrahedral intermediate can be modelled over the electron density 
found in the KDO8P synthase active site is disputed.  It has previously been reported that the 
hemiketal tetrahedral intermediate is highly unstable and the rate constants for formation and 
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breakdown of it were determined to be 95 s-1 and 500 s-1 respectively, for EcoKDO8PS,29 so 
it seems unlikely it would be observable by crystallographic methods  As already mentioned, 
the proposed intermediate is observed in only one active site of a large unit cell of twelve 
distinct monomers of the 2NX3 crystal structure, and only one of the two subunits in the 
2NXG structure.  In the other subunits for both crystal structures, a ternary enzyme-PEP-A5P 
complex is modelled and the trigonal planarity of the PEP molecule is still evident in most 
active sites.  The PEP molecules have some bent character at C2, which has been assigned as 
degradation of PEP due to Michael addition of water at C3.  This bent character is also seen 
in other KDO8P synthase crystal structures34 and in some DAH7P synthase 
structures.{Shumilin, 2003 #130;Shumilin I., 2004 #131;Konig, 2004 #62}  Additionally, as 
previously discussed in Section 1.3.2, the A5P orientation is rotated 180° between the two 
crystal structures of the C11N/S235P/Q237A AaeKDO8PS triple mutant, being in an 
orientation similar to that of the wild-type AaeKDO8PS structures with A5P bound for the 
2NXG structures, where as in the 11 subunits not containing the intermediate from the 2NX3 
structure it is bound with the aldehyde moiety orientated towards the N11 residue as 
discussed. 
The authors show in their paper a |Fo-Fc| σA map of the modelled enzyme without the 
intermediate included, overlaid with the proposed model of said intermediate (Figure 1.21).  
The amplitudes of the experimentally observed factors (Fo) are compared after subtraction of 
the structure factors that would be observed for the proposed model (Fc); the mean structure 
factor amplitude is denoted as σ.  Usually, in such a diagram, one would expect to see a large 
unexplained area of electron density due to the difference between the observed data Fo 
(containing the ligand) and the calculated data Fc (not containing the ligand).  The heavy 
atoms of the ligand (atomic weights > 12) should all appear inside this area.  This should 
occur at a level of high electron density, that is much greater than σ.  This is a simple method 
for assessing the viability of a ligand inside the enzyme active site.  As seen in Figure 1.21, 
the new oxygen atom, being the only heavy atom to distinguish the proposed intermediate 
from the substrates, lies outside the density map contoured at 3σ, casting doubt onto the 
existence of the ligand in the crystal structure at all.  As seen in both A and B of Figure 1.21, 
the C4 and C5 atoms of the intermediate are also deformed away from the electron density, 
giving additional weight to the theory that the intermediate may be incorrectly modelled 
inside the active site.  C4 and C5 of the intermediate correspond to C1 and C2 of A5P and 
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this kind of deformation in the model could occur if the intermediate had been modelled over 
the electron density derived from two separate molecules. 
These lines of evidence lead to the conclusion that the partial tetrahedral character could arise 
from the breakdown of PEP by Michael addition.  It is possible that the proposed 
intermediate is simply an artefact, and more work is required in order to substantiate the 
observation of the proposed intermediate and its stereochemistry, bound in the KDO8P 
synthase active site. 
 
Figure 1.21: |Fo – Fc| σA (omit) map of the C11N/S235P/Q237A KDO8P synthase from A. aeolicus 
contoured at 3σ, with the tetrahedral intermediate overlaid. A and B are in different orientations 
designed to show that the C2 centre is no longer planar, the C2 hydroxyl residue protrudes outside the 
modelled electron density (pink *) and the C4 and C5 hydroxyls are deformed away from electron density 
(pink arrows).  Diagram is taken from Kona et al.35 and pink elements have been added. 
 
** 
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As previously discussed, a 2009 study36 used the crystal structure of the engineered metal-
independent C11N mutant of AaeKDO8PS (which has both PEP and A5P bound)35 as a basis 
for modelling potential energy surfaces for possible reaction pathways.  This study showed 
that the lowest energy pathway was syn addition of the water molecule, that is, attack of the si 
face water molecule, and subsequent attack of the C3 of PEP onto the C1 of A5P, with an 
energy barrier of 19 kcal mol-1 for the formation of the tetrahedral intermediate.  The anti 
addition involving attack of the re face water onto the C2 of PEP had a much higher energy 
barrier of 44 kcal mol-1, and the authors concluded that the syn addition was much more 
likely.  However, this study did not take into account the entire effect of the surrounding 
residues, and it is likely that these would have a large effect on the energy barrier of the 
KDO8P synthase reaction, nor did it test all possible and relevant reaction pathways, such as 
water attacking the re side of C2 of PEP and C3 of PEP attacking the re side of C1A5P; with 
the PEP phosphate partially protonated.  At this stage it is unclear which water molecule is 
involved in the reaction mechanism of KDO8P synthase, and additional work will have to be 
undertaken in order to resolve this, some of which will be discussed further in chapters three 
and four. 
1.4. KDO8P synthase structure 
1.4.1. Tertiary and quaternary structure 
A metal-dependent (A. aeolicus34) and two metal-independent (E. coli,54 N. meningitidis55) 
KDO8P synthase have been thoroughly investigated by X-ray crystallography.  Comparison 
of the structures indicates nearly identical tertiary structure.  Each monomer is folded into a 
(β/α)8 TIM barrel (Figure 1.22), with the active site located near the C-terminus end, which is 
typical for proteins of this fold.60  Each monomer contains a β-hairpin which seals off the N-
terminus end of the TIM barrel. 
The first crystal structures of EcoKDO8PS showed the enzyme to be a homotetramer with a 
mass of around 120 kDa, calculated from the MR of the monomeric product containing 284 
amino acids (30833 Da).54  Crystal structures of AaeKDO8PS show homodimers, but in 
solution it had a similar elution profile in size exclusion chromatography to KDO8P 
synthases from E. coli and S. typhimurium, suggesting in vivo it is tetrameric.34  Additionally 
three other KDO8P synthases have been shown to be tetrameric; The metal-dependent H. 
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pylori KDO8P synthase61 was shown to exist as both a dimer and tetramer in solution, with 
the tetramer breaking down to the dimer in the gas phase; KDO8P synthase from A. 
ferrooxidans (AfeKDO8PS) was shown to be a tetramer of 123 kDa by size exclusion 
chromatography;62 the metal-independent NmeKDO8PS was shown to be a tetramer of 130 
kDa in solution by gel filtration chromatography.55 
The KDO8P synthase contact surface between subunits A and B (or C and D) are 
characterised by hydrophobic and polar interactions between the H6, H7 and H8 helices of 
one subunit and the same helices on the other subunit with two loops (L2 and L6) completing 
the tetrameric arrangement.54  L2 on subunit A binds to the H4 and H5 helices on the C 
subunit, and the L6 loop of subunit A binds to the same loop of subunit C in the centre of the 
tetramer (Figure 1.23). 
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Figure 1.22: Side (top) and top (bottom) views of a monomeric enzyme unit from AaeKDO8PS (1FWW34, 
chain A) with α-helix (red), β-sheet (yellow) and loop (green) regions indicated.  A5P and PEP 
(orange/red/grey) and the cadmium ion (brown) are also shown. 
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Figure 1.23: EcoKDO8PS tetramer (drawn from 1D9E54) showing the arrangement of the four subunit 
monomers (A-D).  Regions involved in intersubunit contacts are highlighted in blue and labelled on 
subunit A.  Secondary structures are also indicated as α-helices (red), β-sheets (yellow) and loops (green). 
KDO8P synthase is able to control access to the active site via the L7, L8 and L2 loops 
(Figure 1.24), with the L7 loop becoming ordered and hence observable crystallographically 
only upon binding of both substrates.  This was first observed in crystal structures of 
AaeKDO8PS, where the L7 loop which was disordered in previous structures of 
EcoKDO8PS (where only one or neither of the substrates were bound), was fully ordered, but 
only in subunits with both A5P and PEP bound in the active site.30,34 
L6 
L2 
H6 H8 
H7 
H4 
H5 
Subunit A Subunit C 
Subunit B Subunit D 
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Figure 1.24: Interaction of active site loops L2 (green), L7 (blue) and L8 (yellow) to close off the active site 
in AaeKDO8PS.  A5P, PEP and a conserved water molecule are coloured orange/red/grey (P/O/C 
respectively) and a metal ion (cadmium) is coloured brown.  Taken from Gatti et al.,63 drawn from 
1FWW.34 
The importance of these loops in closing off the active site was demonstrated in mutagenesis 
studies of a conserved arginine which is present on the L4 loop, R106 in AaeKDO8PS.63  
This residue is interesting because it reaches across from one enzyme subunit to interact with 
a serine (S50) and asparagine (N48) on the L2 loop of the adjacent subunit (all residues are 
numbered from AaeKDO8PS unless specified), allowing the L2 loop to act as a “latch” to the 
“lid” that is the L7 loop, as well as R106 binding the phosphate moiety of A5P, which will be 
discussed later.  With the L7 loop disordered, the active site of the enzyme is open to the bulk 
solvent and a number of changes can occur; the A5P and PEP phosphate distance increases 
from 10.32–11.14 Å; C2-OH and C3-OH positions of A5P change from those found in 
crystal structures of the wild-type enzyme; PEP binds more tightly, but A5P is less effective 
as a substrate and both products of the enzymic reaction, KDO8P and Pi, bind more tightly, 
and are more effective as inhibitors.  The end result of this mutation was that higher substrate 
concentrations were needed for the enzyme reaction and lower product concentrations were 
required to ensure the reaction occurred with normal catalytic efficiency.  Without the 
mutation it appears as though the active site upon catalysis undergoes a conformational 
change that leads to expulsion of the Pi molecule, but this conformational change is removed 
with the mutation of the R106 residue. 
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Figure 1.25: R106 residue from L2 loop on subunit A (magenta) interacting with S50, N48 on L2 loop of 
subunit A (green) and conserved water molecules (red) from subunit C.  Distances to neighbouring atoms 
are measured in angstroms.  Drawn from 1FWW.34 
Sequence alignment identified this R106 residue as a conserved residue across all identified 
or annotated KDO8P synthases.  As shown in Figure 1.13, a number of other conserved 
residues make up the PEP and A5P binding sites, which is the focus of the next section. 
1.4.2. Substrate binding sites 
PEP is bound at the bottom of the active site funnel (Figure 1.24) and forms non-covalent 
bonds with a number of conserved residues (Figure 1.26).  In AaeKDO8PS the phosphate 
moiety of PEP interacts with the positively charged side chains of a lysine and arginine 
(K124 and R154) and the nitrogen atom of an alanine main chain amide (A102).  The amine 
side chain of K124 also interacts with the bridging oxygen of the PEP phosphate.  This lysine 
is also within bonding distance of one of the carboxylate oxygen atoms.  A number of other 
conserved residues bind the other oxygen atom, namely K41, K46 and S43 in the 
AaeKDO8PS structure (1FWW).34  It should be noted here that the effect of these residues 
binding the carboxylate moiety of PEP is to pull it slightly out of planarity with the PEP 
alkene, increasing the carboxylate/alkene dihedral angle.  This has been observed in a number 
of other KDO8P synthase structures as well as in PEP-bound structures of the related aldolase 
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DAH7P synthase.  It has been calculated that this bent character lowers the delocalisation 
across the α-β carboxylate system, localising the electrons in the alkene bond and increasing 
the nucleophilicity of the C3 carbon of PEP.64  As previously discussed in Section 1.2, the 
conserved hydrophobic residue F103 is found not far from the phosphate moiety of PEP, and 
is thought to promote monoanionic binding of PEP, in order to protonate the A5P aldehyde 
residue during the reaction (Figure 1.10).30 
 
Figure 1.26: PEP (orange/red/grey) bound in the active site of AaeKDO8PS (1FWW34) showing hydrogen 
and electrostatic bonding with surrounding conserved active site residues (distances measured in 
angstroms).  A conserved phenylalanine side chain (F103) is shown close to the phosphate moiety of PEP. 
A conserved active site histidine residue (H185, a metal binding ligand in AaeKDO8PS) has 
been shown to be important in the orientation of the PEP substrate65 and a mutation of this 
residue to glycine in AaeKDO8PS causes activity of the mutant to drop to 8 % that of wild-
type.  The mutation also causes PEP to be orientated incorrectly, binding the metal ion via its 
carboxylate moiety and the si face water molecule to be displaced.  This gives more weight to 
the theory that this water molecule is not involved in catalysis, due to the remaining 8 % 
activity even when PEP is orientated in such an unusual fashion.  It was originally thought 
that this histidine residue may be involved in signal transduction to the L7 loop but the 
mutation does not interfere with L7 ordering upon substrate binding.65  It has been shown that 
this residue has conformational flexibility in the metal-independent EcoKDO8PS and it has 
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been proposed that this gives the residue the ability to block the bottom of the active site off 
from non-PEP substrates, as seen in its ability to change orientation from the major 
conformation seen in the ligand-free enzyme and stop KDO8P rebinding to the bottom of the 
active site.66 
As previously discussed, the C2 hydroxyl of A5P binds the active site metal ion either 
directly or through the conserved re face water molecule.  The A5P substrate also forms 
contacts with a number of absolutely conserved residues (Figure 1.27).  Of note is the 
conserved asparagine (R106), found on the L6 loop of the adjacent subunit, interacting with 
the phosphate moiety along with the conserved serine S197 found on the now ordered L7 
loop.  A conserved glutamate, Q188, also found on the L7 loop, interacts with the C4 
hydroxyl of A5P along with an aspartate residue, D233.  Of additional importance are three 
residues, N48, R49 and S50 which interact with the C3 and C4 hydroxyl groups as well as the 
phosphate moiety of A5P.  These residues make up part of a conserved KANRS(T) sequence 
motif found only in KDO8P synthases and not the related aldolase DAH7P synthase, which 
instead possesses an equivalent KPRT(S) motif. 
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Figure 1.27: Binding of A5P in AaeKDO8PS (drawn from 1FWW34).  Residues within 4 Å of A5P are 
shown, as are PEP (orange/grey/red) and a cadmium ion (brown).  Of note is part of the conserved 
KANRS(T) motif (N48/R49/S50) that binds the aldehyde and phosphate moieties.  Distances to 
neighbouring atoms are measured in angstroms. 
1.4.3. Alternative aldolase substrates 
The importance of the C2 and C3 hydroxyl active site contacts is reinforced by alternative 
substrate studies with KDO8P synthase from N. meningitidis that show that D-ribose 5-
phosphate (R5P),17,67 D-lyxose 5-phosphate (L5P), D-xylose 5-phosphate (X5P),40 all 
containing an inversion of stereochemistry at the C2 or C3 position, are not substrates for the 
enzyme but L-xylose 5-phosphate which has a stereochemical inversion at C4 is a substrate 
with a moderate Km of 57 µM for the monosaccharide, around 5-fold greater than A5P, and a 
slightly reduced kcat of 1.1 s-1, around two-fold lower than the natural substrate (Figure 
1.28).40  D-Ribose 5-phosphate has also been tested as a substrate with AfeKDO8PS where it 
was not a substrate,62 and EcoKDO8PS where it was a poor substrate with a Km 
approximately 40-fold greater than A5P.68  Interestingly, removal of the C2 hydroxyl in 2-
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deoxy ribose 5-phosphate does not destroy its ability to act as a substrate in NmeKDO8PS but 
does result in it being processed far less efficiently by the enzyme, with an almost 400-fold 
reduction in kcat/Km,67 and a 1500-fold reduction in kcat/Km for AfeKDO8PS.62  It may be that 
these active site contacts are vital in orientating the aldehyde moiety into a reactive 
conformation. 
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Figure 1.28: Five carbon monosaccharides that have been tested as substrates for NmeKDO8PS40,67 and 
AfeKDO8PS62.  
DAH7P synthase differs in that it contains an absolutely conserved KPRT(S) sequence for 
binding the shorter four-carbon sugar E4P67 instead of the KANRS(T) sequence found in 
KDO8P synthase that binds to A5P.  It should be noted whilst the conserved alanine and 
asparagine in the KDO8P synthase KANRS(T) sequence is a proline in DAH7P synthases, 
the hydrophobic recognition of the C3 carbon of PEP and hydrogen bonding to the 
monosaccharide’s main chain hydroxyl groups has been preserved.  Also, the side chain 
hydroxyl groups of E4P do not seem to be as important to the overall enzymic reaction as 
they are in A5P, as shown by the ability to change their position or remove them completely 
and still obtain relatively normal catalytic activity (Figure 1.29).67,69  This is not entirely 
surprising given the C2 hydroxyl of E4P in DAH7P synthase is thought to not bind to the 
metal ion as the C2 hydroxyl of A5P is shown to in most crystal structures of KDO8P 
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synthase, and therefore may not be as important in orientating the aldehyde moiety for 
enzyme catalysis. 
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Figure 1.29: Four carbon monosaccharides that have been tested against DAH7P synthase from E. coli as 
alternative substrates.67,69,70 
1.5. Related Enzymes 
There are four other identified enzymes that share the unusual C-O bond cleavage of the PEP 
phosphate moiety; DAH7P synthase,71 N-acetylneuraminic acid (NeuNAc) synthase,72 5-
enolpyruvoylshikimate 3-phosphate (EPSP) synthase73 and UDP-GlcNAc enolpyruvyl 
transferase (MurZ).74  These can be divided into two subclasses of enzymes, the enolpyruvyl 
transferases which include EPSP synthase and MurZ, catalysing the transfer of an 
enolpyruvyl moiety from PEP to an acceptor alcohol, and the aldolases, including KDO8P 
synthase, DAH7P synthase and NeuNAc(P) synthase, which catalyse the aldol-like addition 
of PEP to an aldehyde (Figure 1.30). 
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Figure 1.30: Enzymes that catalyse the C-O bond cleavage of PEP.  The enolpyruvyl transferases (EPSP 
synthase, MurZ) are highlighted in red and the PEP aldolases (NeuNAc synthase, KDO8P synthase and 
DAH7P synthase) are highlighted in blue. 
These aldolases, originally thought to be unrelated due to low overall sequence similarity, are 
now thought to be closely related, and are believed to share both a common mechanism and 
ancestor.  DAH7P synthase has the four-carbon sugar E4P as a substrate and catalyses the 
reaction with PEP to give the seven-carbon sugar DAH7P.  NeuNAc(P) synthase reacts either 
N-acetyl mannosamine or N-acetyl mannosamine-6-phosphate with PEP to give N-acetyl 
neuraminic acid and N-acetyl neuraminic acid-9-phosphate respectively.  The relationship 
between these three enzymes is summarised in the phylogenetic tree in Figure 1.31.75  The 
tree shows the differences in sequence similarity between the three enzymes from a variety of 
bacterial organisms with line junctions indicating a common ancestor sequence, and the 
length of lines from branch points being indicative of the degree of similarity between the 
sequences. 
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Figure 1.31: Phylogenetic tree showing genetic relationship between the aldolases, DAH7P synthase, 
KDO8P synthase and NeuNAc synthase.  Taken from Bravo et al.75 
1.5.1. NeuNAc(P) synthase 
The NeuNAc(P) synthases are involved in the synthesis of the most common sialic acid in 
nature, N-acetyl neuraminic acid.  Though sialic acids are mainly found in mammalian 
systems, where they are involved in cellular recognition and cell adhesion processes,76,77 
many neuroinvasive bacterial species also incorporate the nine-carbon sugars into their own 
cell walls in order to conceal them from the host’s immune system.78  Thus far only 
NeuNAc(P) synthases that take N-acetyl mannosamine 6-phosphate have been found in 
mammalian systems, and thus in order to synthesise N-acetyl neuraminic acid they must also 
utilise N-acetyl mannosamine kinase and N-acetyl mannosamine 9-phosphate phosphatase in 
a three step reaction scheme.  Many bacterial species are able to bypass this step, and take N-
acetyl mannosamine directly as a substrate (Figure 1.32).79 
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NeuNAc(P) synthase shows a requirement for a divalent metal ion, with most having 
maximum catalytic activity in the presence of Mn2+.  Crystal structures have shown that the 
aldehyde moiety is a metal ligand, and the metal ion may be involved in activation of the 
aldehyde in catalysis.72  The active site is quite different from KDO8P synthases however, 
with two histidines and a glutamate residue composing the metal binding site, and a number 
of different residues involved in binding the substrate (Figure 1.33).  It also appears that an 
antifreeze domain is present at the C terminus (Figure 1.34), and this is involved in sealing 
off the active site by forming non-covalent bonds with the substrate and surrounding residues 
in order to orientate the N-acetyl mannosamine substrate effectively.80  Studies utilising 
stereospecifically deuterated PEP with NeuNAc synthase from Campylobacter jejuni 
isozyme 1 have shown that the stereochemistry of the reaction involves attack of the si face 
of the aldehyde by the si face of PEP.81  This differs from KDO8P and DAH7P synthases as 
previously described, which involve attack of the re face of the aldehyde. 
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Figure 1.32: Biosynthesis of N-acetyl neuraminic acid (NeuNAc) in mammalian and bacterial systems. 
 
Chapter 1:Introduction 
38 
 
 
Figure 1.33: Active site of N. meningitidis NeuNAc synthase from 1XUZ72 showing binding of PEP (cyan), 
N-acetyl mannosaminitol (magenta) and a manganese ion (purple).  Residues (grey) within 4 Å of 
substrates and the metal ion are shown and potential bonding indicated with dashed lines. 
 
Figure 1.34: Top view of a monomeric enzyme unit from NeuNAc synthase from N. meningitidis (1XUZ)72  
showing the TIM barrel structure and C-terminal antifreeze domain, with α-helices (red), β-sheets 
(yellow) and loop (green) regions indicated.  N-acetyl mannosaminitol and PEP (orange/red/grey/blue) 
and the manganese ion (purple) are also shown. 
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1.5.2. DAH7P synthase 
The DAH7P synthases, as previously discussed in Section 1.3, catalyse the same aldol-like 
condensation but between E4P and PEP to give the seven-carbon phosphorylated sugar 
DAH7P (Figure 1.11). 
DAH7P synthases have the same stereospecificity as KDO8P synthases in that the si face of 
PEP attacks the re face of the aldehyde moiety.82  Unlike KDO8P synthases however, all 
DAH7P synthases are metal-dependent43-48 and mutations to change this dependency such as 
those performed on KDO8P synthase have been unsuccessful,67 leading to the assumption 
that the divalent metal ion is involved in the reaction mechanism. 
The metal binding site is similar to that found in metal-dependent KDO8P synthases as seen 
in Figure 1.35, and is conserved with the metal ion binding four ligands; a histidine, cysteine, 
aspartate and glutamate residue. 
 
Figure 1.35: Overlay of the metal binding site of AaeKDO8PS (1FWW34, magenta, residues labelled in 
black) and EcoDAH7PS (1N8F{Shumilin, 2003 #130}, green, residues labelled in red) with PEP bound 
(orange/red and green or magenta).  The cadmium ion in the AaeKDO8PS structure is coloured brown 
and the manganese ion from E. coli structure is coloured purple. 
As in KDO8P synthase, the PEP and E4P binding sites also contain residues that are 
conserved across the greater DAH7P synthase family. 
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Three residues, two arginines and a lysine, bind the phosphate moiety of PEP.  In type I 
DAH7P synthases the phosphate moiety also makes close contact with a main chain amide 
between a conserved glycine and alanine residue, while in type II M. tuberculosis and H. 
pylori DAH7P synthases the alanine is replaced by a glutamate residue.43,44  The conserved 
phenylalanine found in KDO8P synthase is replaced with a conserved arginine residue.  This 
may be because DAH7P synthase may not require a monoprotonated phosphate moiety in 
order to activate the aldehyde moiety of E4P, as modelling of E4P into the active site shows 
the aldehyde moiety likely binds as a metal ligand,67 and can subsequently be activated 
through Lewis-acid catalysis (Figure 1.36). 
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Figure 1.36: Proposed partial mechanism of DAH7P synthase utilising Lewis-acid catalysis. 
The carboxyl moiety of PEP is also within bonding distance of two conserved residues, an 
arginine and lysine, the latter being part of the absolutely conserved KPRT(S) sequence in 
DAH7P synthases that binds the E4P substrate, as previously discussed.67  In addition, a 
conserved aspartate D342 (numbering from Saccharomyces cerevisiae DAH7PS) is thought 
to bind the C3 hydroxyl moiety, as seen in crystal structures with D-glycerol 3-phosphate 
(GO3P) bound.59  In this same crystal structure a number of water molecules are found that 
are thought to mediate the binding of residues to E4P. 
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Figure 1.37: The binding of GO3P in the S. cerevisiae DAH7P synthase active site (1OF8)59 with PEP and 
GO3P (green/red/orange), surrounding residues, including the conserved KPRT sequence and conserved 
aspartate D342 (grey/red/blue), water molecules thought to mediate binding (red) and cobalt ion (brown).  
Potential bonding (residues and water molecules within 4 Å) is shown by dashed lines. 
1.6. The project 
This project involves the synthesis and testing of a number of mono- and bi-substrate 
inhibitors of KDO8P synthase.  It is hoped that the results from this study will help to 
determine the importance of certain substrate moieties as well as provide an understanding of 
the enzyme mechanism for future inhibitor design. 
Four previously designed bi-substrate inhibitors of KDO8P synthase have been characterised 
kinetically and are shown below (Figure 1.38). 
P98 T100 
R99 
D342 
K97 
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Figure 1.38: Previous bi-substrate inhibitors of KDO8P synthase.27,83-85 
The first inhibitor 1.2, a pyran molecule (Figure 1.38, left) was designed to resemble the 
proposed cyclic intermediate of the KDO8P synthase reaction (1.1,  
Figure 1.6).83  The Ki is surprising when consideration is given to the fact that the reaction 
through the cyclic intermediate has been largely discounted, as discussed in Section 1.2. 
The enol phosphate inhibitor 1.3 (Figure 1.38) was designed to mimic the planar nature of the 
PEP molecule.  Even though it has the gluco configuration of hydroxyl groups and lacks a 
terminal phosphate group, it inhibited the KDO8P synthase enzyme from H. pylori with a 
modest Ki of 132 µM, though could not be incorporated into the active site of A. aeolicus 
KDO8P synthase in crystallographic studies, even at concentrations up to 4.4 mM.84  The 
crystallisation was only achieved at pH 5.0, and this inability of the inhibitor to be found in 
the enzyme active site may be a result of this. 
The two amino phosphonate inhibitors were designed in order to mimic the proposed high 
energy oxocarbenium intermediate, with the phosphonate 1.5 (Figure 1.38)85 being created in 
an attempt to improve the anti-bacterial properties due to a possible dephosphorylation of the 
original inhibitor (1.4).27  However, this led to a 100-fold increase in Ki which gives evidence 
of the importance of the phosphate enol oxygen in binding to the active site residues. 
The structures of the most potent of these two inhibitors in complex with KDO8P synthase 
from E. coli31 and A. aeolicus30 have been determined by X-ray crystallography.  The 
AaeKDO8PS crystal structures show that the inhibitor binds to the enzymes in a similar 
fashion to the two substrates, using the same carboxylate and phosphate binding pockets 
(Figure 1.39). 
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The main difference seems to be the position of the main chain hydroxyl groups that are 
bound differently between A5P and the inhibitor.  The inhibitor hydroxyl, representative of 
the aldehyde moiety of A5P, acts as a metal ligand, and thus the other hydroxyl groups are 
also bound in different positions within the active site.  These hydroxyls are well defined in 
the crystal structure.  A σA omit map of the inhibitor bound however has shown that the 
carboxyl group is not well defined, leading to the conclusion that it may not be as tightly 
bound as the phosphate and phosphonate moieties.  Further evidence of this was observed 
when the carboxyl group was removed from the bi-substrate inhibitor without much loss of 
inhibitory activity, but removal of the phosphonate group led to a complete loss of inhibition 
(Figure 1.40).84 
 
Figure 1.39: Overlay of aminophosphonate inhibitor 1.4 (1JCX30 magenta/red/orange) and enzyme 
substrates A5P and PEP (1FWW34, green/red/orange) bound in the AaeKDO8PS active site showing 
differences in hydroxyl binding.  Phosphate and carboxylate binding residues are shown in 
magenta/blue/red (1FWW) and green/blue/red (1JCX).  Cadmium ions for 1FWW and 1JCX are shown 
in cyan and yellow respectively. 
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Figure 1.40: Limited structure-activity relationships of amino phosphonate bi-substrate inhibitors 
towards EcoKDO8PS.84 
The most potent amino phosphonate inhibitor was made using a one pot synthesis, involving 
the reaction of mannose 6-phosphate with glyphosate (1.6) (Figure 1.41),27 a previously 
identified inhibitor of EPSP synthase. 
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Figure 1.41: Retrosynthetic analysis of the amino bi-substrate inhibitor (1.1).27 
This is an example of an inhibitor whereby a known PEP mimic (glyphosate, 1.6) was 
extended to resemble the bi-substrate complex, and in this case, the high energy transition 
state, in order to more strongly bind to the enzyme active site through increased active site 
interactions.  Studies such as these, investigating the inhibitory changes when small molecule 
PEP mimics are extended have been investigated in our laboratory for the related enzyme 
DAH7P synthase with some promising results.86 
As such, a number of small molecule PEP mimics have been synthesised and tested against 
DAH7P synthase, but not KDO8P synthase, or only against a member of the metal-
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independent class of KDO8P synthase.  Given the success of these compounds in inhibiting 
DAH7P synthase, we decided to test a number of small molecules on a metal-dependent 
(AfeKDO8PS) and metal-independent (NmeKDO8PS) enzyme, and then subsequently extend 
some of these molecules to incorporate an A5P-like binding motif in order to determine the 
effect on inhibition these additional motifs will have. 
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2.1. Introduction 
As part of the proposed studies into the inhibition of KDO8P synthase, enzyme examples of 
both the metal-independent and metal-dependent type were required.  In our laboratory, the 
two examples available were the metal-independent KDO8P synthase from N. meningitidis 
and the metal-dependent KDO8P synthase from A. ferrooxidans.  Both these enzymes have 
been previously purified but enzyme samples was not available for the current work.  A 
known procedure for the purification of each enzyme40,62 was modified in order to obtain 
pure protein for inhibition studies. 
N. meningitidis is a mesophilic Gram-negative bacterium, first isolated in 1887.87 It is most 
well known as the causative pathogen in meningococcal disease and septicaemia.  The 
disease usually develops rapidly, and can cause brain damage, hearing loss and in 4-10 % of 
cases, death.88-90  Those people that survive the effects of meningococcal disease often suffer 
from permanent tissue damage, and neurological sequelae.88  N. meningitidis, being a Gram-
negative bacterium, contains LPS as part of the cell wall that is important for the structural 
integrity of the cell.  As KDO8P synthase is one of the first committed steps in the synthesis 
of LPS, it is a novel target for drug design. 
A. ferrooxidans is not pathogenic, but is a mesophilic Gram-negative bacterium that lives in 
pyrite deposits and metabolises iron and sulfur producing sulfuric acid.91,92  The KDO8P 
synthase enzyme from A. ferrooxidans has recently been identified as a putative metal-
dependent enzyme by sequence analysis.62 
2.2. Purification of KDO8P synthase from N. meningitidis 
Previously, the KDO8P synthase gene from N. meningitidis (kdsA) was successfully cloned 
into the pT7-7 plasmid.40  This plasmid also contained a gene for ampicillin resistance to 
enable selection for competent cells, and also allowed for overexpression of the 
NmeKDO8PS gene by induction with isopropyl-1-thio-β-D-galactopyranoside (IPTG).  The 
pT7-7 NmeKDO8PS plasmid was then transformed into E. coli BL21(DE3) cells for 
expression, which were subsequently stored in glycerol stock at -80 °C until use. 
The glycerol stock was used to inoculate a preculture of NmeKDO8PS wild-type containing 
ampicillin, and was grown overnight and used to inoculate a large culture.  The large culture 
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was grown and cells harvested by centrifugation four hours after IPTG induction.  The cell 
pellet was not used immediately but instead stored at -80 °C.  The cell pellet was resuspended 
in lysis buffer and sonicated in order to lyse the cells to obtain access to the soluble protein.  
The cellular material suspended in lysis buffer was then subjected to centrifugation to remove 
the insoluble cell debris. 
2.2.1. Purification by anion exchange chromatography 
The first purification step in the established protocol for the purification of KDO8P synthase 
from N. meningitidis utilised Anion Exchange Chromatography (AEC).40  AEC involves 
passing a mixture of proteins down a column of positively charged resin, and separating the 
proteins based on their overall ionic charge at a given pH.  KDO8PS from N. meningitidis has 
a theoretical pI of 6.2593 and so at pH 7.5 has an overall negative charge.  The overall 
negative charge means the KDO8P synthase enzyme binds to the AEC resin, and by 
increasing the concentration of an ionic solution the protein can be eluted by countering the 
charges on the surface amino acids. 
The supernatant at pH 7.5 was loaded onto the anion exchange (SOURCE™ 15Q) column 
with protein eluted from the column using a gradient between 0.1 and 0.2 M sodium chloride 
at 4 °C (Figure 2.1).  These fractions were analysed by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) (Figure 2.2) and those fractions containing 
the KDO8P synthase protein, shown as a protein with an approximate molecular weight of 31 
kDa, were pooled.  Both the overall shape of the traces in Figure 2.1 (showing a variety of 
peaks within the shaded region) and the SDS-PAGE analysis shown in Figure 2.2 indicates 
that a number of impurities remained in the protein sample.  The protocol for the purification 
of the KDO8P synthase enzyme called for further purification steps to remove these 
impurities. 
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Figure 2.1: Chromatogram trace of AEC purification of NmeKDO8PS.  Fractions containing KDO8P 
synthase that were pool for further purification are highlighted in magenta.  Purple and green traces are 
280 nm and 260 nm detectors respectively.  Black trace shows the sodium chloride gradient (0-1 M). Red 
trace is conductivity detector. 
 
 
Figure 2.2: SDS-PAGE analysis of AEC purification of NmeKDO8PS. SDSPAGE analysis was performed 
on a 12 % polyacrylamide gel and visualised with Coomassie Brilliant Blue R 250.  Lane 1-6: fractions as 
they were eluted from the AEC column (0.11-0.2 M NaCl, fractions from lanes 1-5 were pooled); Lane 7: 
Molecular markers. 
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2.2.2. Purification by hydrophobic interaction chromatography (HIC) 
As discussed, a number of contaminants remained in the NmeKDO8PS protein sample after 
AEC, and so further purification by another method was necessary.  Proteins differ with 
regards to their overall surface hydrophobicity, and Hydrophobic Interaction 
Chromatography (HIC) separates proteins based on their interactions with hydrophobic 
ligands attached to an uncharged matrix.  HIC requires a large surface area on the protein, 
and therefore can be affected by temperature.  It has previously been found for the established 
purification protocol that the elution profile gave sharper signals when the chromatography is 
performed at room temperature rather than at 4 °C.94 
The pooled fractions from AEC purification were exchanged into buffer containing 1 M 
ammonium sulfate and loaded onto a hydrophobic interaction (SOURCE™ 15Phe) column.  
Bound protein was eluted from the column with a decreasing concentration gradient of 
ammonium sulfate.  Fractions that contained NmeKDO8PS, as determined by SDS-PAGE 
analysis (Figure 2.3), were subsequently pooled for further purification.  Comparisons with a 
previous purification of the N. meningitidis KDO8P synthase enzyme using the established 
protocol,40 showed less contaminants present, as judged by SDS-PAGE.94  A third 
purification step was employed in this modified purification protocol in order to remove the 
final contaminants and desalt the protein sample obtained from HIC. 
 
 
Figure 2.3: SDS-PAGE analysis of HIC purification of NmeKDO8PS. SDS-PAGE analysis was performed 
on a 12 % polyacrylamide gel and visualised with Coomassie Brilliant Blue R 250.  Lane 1: Molecular 
marker; Lane2-5: fractions 11H-B12 (0.6 and 0.45 M ammonium sulfate) as they were eluted from the 
HIC column (Fractions from lanes 3-5 were pooled for further purification). 
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2.2.3. Purification by size exclusion chromatography (SEC) 
Size Exclusion Chromatography (SEC) is often used as a polishing step in purification 
protocols.  It separates proteins based on hydrodynamic radius, and is often used as a 
desalting step, making it useful as a final step in protein purification protocols. 
The pooled fractions of NmeKDO8PS from HIC were loaded onto a Superdex™ S200 26/60 
GL column in two aliquots and fractions containing KDO8P synthase were pooled, 
concentrated, exchanged into a low salt buffer, snap frozen with liquid nitrogen and stored at 
-80 °C.  The eluted protein was very pure as seen by the isolated KDO8P synthase peak on 
the chromatograph in Figure 2.4, and final SDS-PAGE gel showing the entire purification, as 
given in Figure 2.5. 
 
Figure 2.4: Chromatogram trace of SEC purification of NmeKDO8PS.  Fractions containing KDO8P 
synthase that were pooled are highlighted in magenta.  Purple and green traces are 280 nm and 260 nm 
detectors respectively.  Red trace is conductivity detector. 
2.2.4. Purification summary 
The three-step purification of KDO8P synthase from N. meningitidis was successful, giving a 
more than six-fold increase in purity over the three steps from the crude lysate.   
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Step Total protein 
(mg) 
Total enzyme 
activity (U) 
Specific 
activity 
(U/mg) 
% Yield Relative 
purity 
Crude lysate 170 320 1.9 100 1.0 
Anion exchange 38 78 2.1 24 1.1 
Hydrophobic interaction 19 72 3.8 22 2.0 
Size-exclusion 5.4 66 12 21 6.3 
 
Table 2.1: Summary of three-step purification of wild-type NmeKDO8P synthase.  % Yield is calculated 
from crude lysate total enzyme activity and relative purity from crude lysate specific activity. 
 
 
Figure 2.5: SDS-PAGE analysis of three-step purification of NmeKDO8PS. SDSPAGE analysis was 
performed on a 12 % polyacrylamide gel and visualised with Coomassie Brilliant Blue R 250.  Lane 1: 
Molecular marker; Lane 2: cell lysate; Lane 3: AEC pooled fractions; Lane 4: HIC pooled fractions; 
Lane 5: SEC pooled fractions. 
During the AEC purification step a large amount of protein was lost, including some of the 
protein of interest, KDO8P synthase from N. meningitidis.  This is reflected in the four-fold 
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decrease in % yield, but only 10 % increase in relative purity.  Previous purifications of N. 
meningitidis KDO8P synthase show a similar loss of total protein but a much smaller loss of 
total enzyme activity.94  This step could be further optimised by altering the gradient at which 
the KDO8P synthase protein is eluted and by further analysis of the fractions to incorporate 
all the KDO8P synthase protein, as some may be eluting earlier into the waste fractions, 
which were not analysed by SDS-PAGE.  The increase in relative purity for the HIC 
purification step was more in line with previous purifications.40,94  Purification with SEC 
produced a protein of high purity, relative to these previous purifications using the 
established protocol, and was characterised accordingly. 
2.2.5. Enzyme characterisation 
The steady-state kinetic parameters of the wild-type NmeKDO8PS were determined by 
following the consumption of PEP (ε = 2.8 × 103 M-1cm-1) by measuring the absorbance at 
232 nm at pH 7.2 and 25 °C.94  The concentration of one substrate was fixed while the other 
was varied in order to collect initial rate data that could be fitted to the Michaelis-Menten 
equation.  This gave the apparent Michaelis constant (Km) and turnover number (kcat) for each 
substrate (Figure 2.6). 
 
Figure 2.6: Michaelis-Menten plots for determination of Km for PEP (left) and A5P (right) for KDO8P 
synthase from N. meningitidis with Eadie-Hofstee plot inlay.  PEP and A5P concentrations were fixed at 
30 µM and 50 µM, for the determination of KmA5P and KmPEP respectively. 
The values of the kinetic parameters for wild-type NmeKDO8PS (KmA5P = 7.1 ± 0.5 µM,  
KmPEP = 2.5 ± 0.3 µM and kcat = 1.54 ± 0.02 s-1) are comparable to values found in three 
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previous studies, and to those found for other metal-independent KDO8P synthases from S. 
typhimurium, E. coli and Neisseria gonorrhoea (Table 2.2). 
Source of 
KDO8P 
synthase 
Assay temp. 
(°C) 
Km PEP (µM) Km A5P (µM) kcat (s-1) Reference 
N. meningitidis 30 2.5 ± 0.3 7.1 ± 0.5 1.5 ± 0.02 This study 
N. meningitidis 30 2.1 ± 0.2 4.2 ± 0.5 1.2 ± 0.03 94 
N. meningitidis 30 < 1 12±1 2.7 ± 0.6 67 
N. meningitidis 37 2.5 ± 0.2 5.7 ± 0.5 8.0 ± 0.1 55 
S. typhimurium 37 4.2 ± 0.2 9.3 ± 0.6 6.7 ± 0.5 95 
E. coli 37 5.9 20 2.5 17 
N. gonorrhoeae 37 3.1 ± 0.2 8.5 ± 0.1 1.0 ± 0.1 96 
 
Table 2.2: Comparison of kinetic parameters of microbial metal-dependent KDO8P synthase. 
2.3. Purification of KDO8P synthase from A. ferrooxidans  
Growth and purification of AfeKDO8PS were undertaken using a modification of an 
established purification protocol.62  The gene for AfeKDO8PS was previously cloned into a 
pT7-7 plasmid which was transformed into E. coli BL21(DE3) cells for expression, and 
stored in glycerol stock at -80 °C.62   A small preculture was inoculated with this glycerol 
stock and grown overnight before being used to inoculate a large culture.  The large culture 
was grown and the cells harvested by centrifugation four hours after IPTG induction.  The 
cell pellet was stored at -80 °C before being resuspended in lysis buffer and sonicated to 
obtain access to the soluble protein.  This solution was then subjected to centrifugation to 
remove the cell debris. 
2.3.1. Purification by anion exchange chromatography (AEX) 
KDO8P synthase from A. ferrooxidans has a theoretical pI of 5.54.93  The supernatant, at pH 
7.5, was loaded onto a (SOURCE™ 15Q) column with protein eluted from the column using 
a linear gradient between 0.15 and 0.3 M sodium chloride at 4 °C (Figure 2.7).  The UV trace 
in the anion exchange chromatogram shown in Figure 2.7 indicates that AfeKDO8PS was 
eluted as a single peak with slight contamination from other protein components at the 
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beginning and end of AfeKDO8P synthase elution.  This is consistent with subsequent 
analysis by SDS-PAGE (Figure 2.8) which shows only one major unknown contaminant at 
∼45 kDa. 
 
Figure 2.7: Chromatogram trace of AEC purification of AfeKDO8PS showing two injections of lysis 
supernatant.  Fractions containing KDO8P synthase are highlighted in magenta.  Purple and green traces 
are 280 nm and 260 nm detectors respectively.  Black trace shows sodium chloride gradient (0-1 M).  Red 
trace is conductivity detector. 
  
Chapter 2: Purification and characterisation of KDO8P synthase 
 
57 
 
 
 
Figure 2.8: SDS-PAGE analysis of AEC purification of AfeKDO8PS. SDSPAGE analysis was performed 
on a 12 % polyacrylamide gel and visualised with Coomassie Brilliant Blue R 250.  Lane 1: Molecular 
marker; Lane 2-6: Fractions as they eluted off the AEC column for first injection; Lane 7-11: Fractions 
as they eluted off the AEC column for second injection.  KDO8P synthase at 31 kDa and an impurity at 
∼45 kDa are both labelled. 
2.3.2. Purification by hydrophobic interaction chromatography (HIC) 
The fractions pooled from AEC were exchanged into 1 M ammonium sulfate buffer and 
loaded onto the hydrophobic interaction column as outlined in the established purification 
protocol for KDO8P synthase from A. ferrooxidans.62  Bound protein was eluted from the 
HIC column by a decreasing ammonium sulfate gradient (Figure 2.9), and the fractions 
thought to contain AfeKDO8PS were analysed by SDS-PAGE (Figure 2.10); those fractions 
that contained the desired protein, as indicated by a component at approximately 31 kDa 
(eluted between 0.15 and 0.3 M ammonium sulfate) were pooled.  The increased purity of the 
protein sample is reflected in both the chromatogram, as a single peak with small impurities 
at the end of the elution profile for the protein (Figure 2.9), and the SDS-PAGE analysis 
showing only small amounts of impurities, found above 40 kDa (Figure 2.10).  The protein 
was exchanged into low salt buffer and concentrated at this point in the purification, as per 
the established purification protocol for A. ferrooxidans KDO8P synthase.62  
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Figure 2.9: Chromatogram trace of HIC purification of AfeKDO8PS.  Fractions containing KDO8P 
synthase are highlighted in magenta.  Blue and red traces are 280 nm and conductivity measurements 
respectively.  Black trace shows ammonium sulfate gradient (1-0 M).  Red trace is conductivity detector. 
 
 
Figure 2.10: SDS-PAGE analysis of HIC purification of AfeKDO8PS. SDSPAGE analysis was performed 
on a 12 % polyacrylamide gel and visualised with Coomassie Brilliant Blue R 250.  Lane 1: Molecular 
marker; Lane 2-6: Fractions as they eluted from the HIC column. 
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2.3.3. Purification by size exclusion chromatography (SEC) 
The purification thus far had provided a large increase in purity, as discussed.  However a 
small number of components above 40 kDa remained, as determined by SDS-PAGE analysis 
(Figure 2.10).  The relative purity of the N. meningitidis KDO8P synthase sample had been 
increased more than three-fold by the addition of a third SEC purification step to the existing 
purification protocol.40  It was thought that by employing a SEC step into the existing 
purification protocol for KDO8P synthase from A. ferrooxidans the relative purity of the HIC 
sample could be similarly increased.  The concentrated HIC sample was loaded onto the 
Superdex™ S200 10/300 column for SEC purification and fractions containing KDO8P 
synthase as determined by SDS-PAGE analysis (not shown) were pooled, concentrated and 
stored at -80 °C.  The chromatogram of the SEC purification showed a single peak (Figure 
2.11) indicating a pure protein with very little contamination.  This result was also seen on 
the final SDS-PAGE analysis of the purification procedure (Figure 2.12), as a single band 
with no contaminating proteins visible on the SDS-PAGE gel. 
 
Figure 2.11: Chromatogram trace of SEC purification of AfeKDO8PS.  Fractions containing KDO8P 
synthase are highlighted in magenta.  Purple and green traces are 280 nm and 260 nm detectors 
respectively.  Red trace is conductivity detector. 
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2.3.4. Purification summary 
The three step purification achieved an almost five-fold purification of the AfeKDO8PS 
enzyme.  The purification table below (Table 2.3) shows some anomalous values which will 
be discussed below. 
Step Total protein 
(mg) 
Total enzyme 
activity (U) 
Specific 
activity 
(U/mg) 
% Yield Relative 
purity 
Crude lysate 150 290 1.9 100 1.0 
Anion exchange 22 140 6.4 48 3.4 
Hydrophobic interaction 15 190 13 66 6.8 
Size-exclusion 9.8 85 8.7 29 4.6 
Table 2.3: Summary of three-step purification of wild-type AfeKDO8PS. % Yield is calculated from 
crude lysate total enzyme activity and relative purity from crude lysate specific activity. 
The SDS-PAGE analysis of the purification (Figure 2.12) shows a substantial decrease in 
protein contaminants over the three purification steps, with the most visible difference 
between the crude lysate and AEC fractions.  This is reflected in the almost seven-fold loss of 
total protein between the two samples.  SEC purification removed all visible contaminants 
from the enzyme sample, including the rest of the major contaminant at ∼45 kDa as discussed 
in Section 2.3.1. 
However, the purification table reveals inconsistencies in the results for enzyme activity as 
the total enzyme activity increases after HIC purification (Table 2.3).  This may be a result of 
incorrect estimations of either the total protein or total enzyme activity in the samples 
obtained after the three purification steps.  A repeat of the purification of AfeKDO8PS that 
was modified for this study, reports the specific activity after AEC purification to be 4.3, and 
following HIC, 5.6.94  Though the specific activity was slightly higher following AEC in this 
study, the result following HIC is more than double the previously obtained value.  We can 
conclude from this result that the specific activity following HIC shown for the inhibition of 
AfeKDO8PS in this study is likely to be incorrect.  For the purpose of this study, enzyme 
samples that exhibit correct kinetic parameters, and are shown to be pure by SDS-PAGE 
analysis should be sufficient for use in the inhibition studies discussed in Chapters 3 and 4.  
Kinetic characterisation, shown below in Figure 2.13, in comparison with previously obtained 
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values for the A. ferrooxidans KDO8P synthase enzyme, given in Table 2.4 showed this to be 
the case. 
 
 
Figure 2.12: SDS-PAGE analysis of three-step purification of AfeKDO8PS. SDSPAGE analysis was 
performed on a 12 % polyacrylamide gel and visualised with Coomassie Brilliant Blue R 250.  Lane 1: 
Molecular marker; Lane 2: cell lysate; Lane 3: AEC pooled fractions; Lane 4: HIC pooled fractions; 
Lane 5: SEC pooled fractions. 
2.3.5. Enzyme characterisation 
The steady-state kinetic parameters of the wild-type AfeKDO8PS were measured as per 
NmeKDO8PS, following the consumption of PEP (ε = 2.8 × 103 M-1cm-1) by measuring the 
absorbance at 232 nm with modified conditions from a previous study,94 pH 7.2 and 30 °C.  
This gave the apparent Michaelis constant (Km) and turnover number (kcat) for the two 
enzyme substrates (Figure 2.13). 
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Figure 2.13: Michaelis-Menten plots for determination of Km for PEP (left) and A5P (right) for KDO8P 
synthase from A. ferrooxidans with Eadie-Hofstee plot inlay.  PEP and A5P concentrations were fixed at 
50 µM and 100 µM, for the determination of KmA5P and KmPEP respectively. 
The values of the kinetic parameters for wild-type AfeKDO8PS (KmA5P = 15 ± 2 µM and 
KmPEP = 6.4 ± 0.7 µM) are comparable to values found in three previous studies, and to those 
found for other metal-independent KDO8P synthases from H. pylori, A. aeolicus and Aquifex 
pyrophilus (Table 2.4). 
Source of 
KDO8P 
synthase 
Assay temp. 
(°C) 
Km PEP (µM) KmA5P (µM) kcat (s-1) Reference 
A. ferrooxidans 37 6.4 ± 0.7 15 ± 2 3.4 ± 0.1 This study 
A. ferrooxidans 37 4.8 ± 0.8 49 ± 3.9 5.1 ± 0.15 94 
A. ferrooxidans 37 22 ± 2 12 ± 1 4.8 ± 0.1 62 
H. pylori J99 37 1.8 ± 0.5 4.8 ± 0.3 1.2 ± 0.03 97 
A. aeolicus 90 28 ± 4 74 ± 8 2.00 ± 0.11 37 
A. pyrophilus 60 290 ± 40 70 ± 8 4 38 
 
Table 2.4: Comparison of kinetic parameters of microbial metal-independent KDO8P synthase. 
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2.4. Summary 
The three-step purification using modified existing protein purification protocols for KDO8P 
synthase from N. meningitidis40 and A. ferrooxidans62 were successful, producing milligram 
samples of pure enzyme for use in the inhibition studies of Chapters 3 and 4.  The 
characterisation of both classes of KDO8P synthase gave results for KmPEP, KmA5P and kcat that 
were similar to those previously found for the respective enzymes (Table 2.2 and Table 2.4). 
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3.1. Introduction 
The ability of enzymes to stabilise the high energy transition states and intermediates of a 
reaction is believed to be one of the factors leading to their catalytic efficiency.  This 
selective binding will lead to the reduction of the energy barrier associated with the formation 
of transient species, increasing the overall rate of reaction.98-100  This ‘Transition State 
Theory’ is the basis for the design of many modern transition state analogues as enzyme 
inhibitors.  Dissociation constants more than 90 million times higher than the Km for the 
substrate of an enzyme have been observed for inhibitors resembling the transition state.101 
The KDO8P synthase reaction, as previously discussed in Chapter 1, is thought to occur via 
an oxocarbenium ion transition state or high energy intermediate, which is attacked by a 
water molecule on either the re or si face of the PEP fragment to give a tetrahedral 
intermediate.  This tetrahedral intermediate then undergoes C-O bond breakage in a 
dephosphorylation reaction to give the eight-carbon sugar KDO8P.  Small PEP mimics that 
resemble the possible transition state or intermediate in this proposed reaction mechanism 
should show inhibition against KDO8P synthase.  Three sets of inhibitors, previously 
synthesised in our laboratory,102 were chosen for inhibitory studies against KDO8P synthase 
(Figure 3.1).   
Two sets of molecules were chosen to mimic the two potential charge distributions of the 
oxocarbenium species (3.1 and 3.2).  Glyphosate, 1.6, contains a positive charge on the 
nitrogen atom, representative of the carbocation on the C2 trigonal centre from PEP 
(oxocarbenium ion 3.1).  However, there is some charge distribution on the oxygen in the 
intermediate, with trigonal planar geometry on the C2 carbon of PEP (oxocarbenium ion 3.2).  
Vinyl phosphonate 3.3 and the fluorinated analogue 3.4 have this trigonal planar geometry at 
the C2 carbon, and so may better represent the geometric features of the transition state.  
Finally, the two stereoisomers of phospholactate ((2R)-phospholactate 3.5 and (2S)-
phospholactate 3.6) were utilised as inhibitors, as they contain a tetrahedral centre at C2, 
representative of the two possible stereoisomers of the tetrahedral hemiketal phosphate 
intermediate arising from attack of a water molecule on the re or si face of PEP. 
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Figure 3.1: Small molecule inhibitors chosen as mimics of oxocarbenium ion species and tetrahedral 
intermediate of the proposed KDO8P synthase reaction mechanism. 
These five molecules will be tested as potential inhibitors of the metal-independent KDO8P 
synthase from N. meningitidis and the metal-dependent KDO8P synthase from A. 
ferrooxidans.  The information gathered from these inhibition studies can then be used to 
infer details about the proposed mechanism, and any difference in mechanism between the 
two classes of enzyme.  The relative inhibition for each molecule can also be used in the 
design of more sophisticated inhibitors for the two classes of KDO8P synthase 
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3.2. Aminophosphonates as carbocation analogues 
Glyphosate, 1.6, was tested as the first small molecule inhibitor of KDO8P synthase in this 
study.  As discussed, it is representative of the carbocation as a potential charge distribution 
of the oxocarbenium ion species (oxocarbenium ion 3.1, Figure 3.2). 
O
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1.63.1  
Figure 3.2: Comparison of potential charge distribution of the oxocarbenium ion 3.1 with glyphosate, 1.6. 
Glyphosate, 1.6, is a known inhibitor of the shikimate pathway in bacteria and plants.  It acts 
upon 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase and has been shown to inhibit the 
E. coli enzyme with a Ki value of 1.0 µM.103  The reaction mechanism for EPSP synthase is 
also thought to occur via an oxocarbenium ion species derived from PEP.104  Glyphosate, 1.6, 
has previously been tested as an inhibitor of the related aldolase DAH7P synthase from E. 
coli where it was found to be a very poor inhibitor, only showing slight inhibition at 
concentrations of 1 mM, but has not been tested against KDO8P synthase 
3.2.1. Inhibition of KDO8P synthase by glyphosate, 1.6 
Glyphosate, 1.6, obtained from commercial sources, was tested against the metal-independent 
KDO8P synthase from N. meningitidis and the metal-dependent KDO8P synthase from A. 
ferrooxidans via kinetic assay, following the loss of PEP at 232 nm.  The initial rate data for 
each enzyme was then fitted to a Michaelis-Menten equation, modified for competitive 
inhibition and plotted as a graph of substrate concentration vs rate.  A visual inspection of the 
fit of the data was also displayed as a double-reciprocal Lineweaver-Burke plot. These results 
showed that glyphosate was a competitive inhibitor with respect to PEP, and bound to both 
enzymes with inhibition constants (Ki) of 260 ± 40 µM (Figure 3.3) and 330 ± 40 µM for the 
KDO8P synthase from N. meningitidis (Figure 3.3) and A. ferrooxidans (Figure 3.4) 
respectively (Figure 3.4). 
Chapter 3: Single site inhibitors of KDO8P synthase 
69 
 
[PEP] (µM)
0 4 8 12 16
in
iti
al
 ra
te
 (µ
M
 s
-1
)
0
20
40
60
[I] = 0 µM
[I] = 231 µM
[I] = 461 µM
[I] = 692 µM
1/[PEP] (µM-1)
0 0.04 0.08 0.12 0.16 0.2
1/
in
iti
al
 ra
te
 (s
 µ
M
-1
)
0.01
0.02
0.03
 
Figure 3.3: Inhibition of KDO8P synthase from N. meningitidis by glyphosate, 1.6, as Michaelis-Menten 
(top) and Lineweaver-Burke (bottom) plots.  Solutions of PEP (5-15 µM), A5P (50 µM), and glyphosate, 
1.6 (0-692 µM), in 1 mL BTP buffer (50 mM, pH 7.2) were initiated by addition of N. meningitidis KDO8P 
synthase (2 µg) and the loss of PEP followed spectrophotometrically at 232 nm.  Initial rates were 
obtained by linear least squares regression and converted to progress rates (µM s-1). 
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Figure 3.4: Inhibition of KDO8P synthase from A. ferrooxidans by glyphosate, 1.6, as Michaelis-Menten 
(top) and Lineweaver-Burke (bottom) plots.  Solutions of PEP (10-30 µM), A5P (100 µM), manganese 
chloride (10 µM) and glyphosate, 1.6 (0-790 µM), in 1 mL BTP buffer (50 mM, pH 7.2) were initiated by 
addition of A. ferrooxidans KDO8P synthase (2 µg) and the loss of PEP followed spectrophotometrically 
at 232 nm.  Initial rates were obtained by linear least squares regression and converted to progress rates 
(µM s-1). 
3.3. Vinyl phosphonates as oxocarbenium analogues 
 (E)-Vinyl phosphonate 3.3 was chosen as a molecule with potential inhibitory properties 
against KDO8P synthase due to the trigonal planar geometry at the C2 carbon, representative 
of the C2 trigonal centre of PEP in the oxocarbenium intermediate 3.2 (Figure 3.5).  The 
vinyl phosphonate 3.3 has been shown to be an inhibitor of the related aldolase DAH7P 
synthase from E. coli with a Ki value of 4.7 ± 0.7 µM.102 
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Figure 3.5: Comparison of potential trigonal planar oxocarbenium ion 3.2 and PEP active site geometry 
(right) (PEP structure from A. aeolicus KDO8P synthase, 1FWW)34 with (E)-vinyl phosphonate 3.3. 
The (E)-vinyl phosphonate 3.3 also retains the observed geometry of enzyme bound PEP, 
seen in a variety of enzyme crystal structures to have the syn relationship between the 
phosphorous atom and C3 of PEP (Figure 3.5).31,34,105  Phosphonate 3.3 is locked in this syn 
configuration and as such might be expected to have an entropic advantage over potential 
inhibitors that did not have this syn relationship; any entropic cost of forming the correct 
conformation of the phosphonate within the active site has already been paid during 
formation of the vinyl phosphonate alkene, rather than during association of the inhibitor with 
the enzyme active site. 
Phosphonates such as 3.3 however, have decreased acidity with respect to the analogous 
phosphate moieties, due to decreased electronegativity of the methylene group compared to 
the enol oxygen.  This decreased acidity leads to the requirement for an increased pH for the 
second ionisation of the phosphate moiety (pKa²).  As discussed in Chapter One, the second 
ionisation of the phosphate group may be important for the enzyme reaction mechanism and 
so inhibitors that contain a monoanionic phosphate or phosphonate moiety within the enzyme 
active site may bind more strongly than the dianionic equivalent. 
It has been shown that the pKa² value can be influenced by the addition of electron 
withdrawing groups adjacent to the phosphorous atom.106  Some representative data is given 
in Figure 3.6. 
X O CH2 CHF CF2
pK a² 6.4 7.6 6.5 5.4
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Figure 3.6: Acidities of phosphates, phosphonates and fluorophosphonates from Romanenko et al.106 
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The use of fluorophosphonates as an alternative to phosphonates, in order to improve 
inhibition, has been shown for a number of different enzymes including phosphoglycerate 
kinase (PGK)107,108 and purine nucleoside phosphorylase (PNP).109  In each of these cases it is 
thought that this is a result of the increased acidity of the phosphonate group, with PGK 
showing a mild correlation between the IC50 values and pKa values for the third and fourth 
ionisations for the twenty two diphosphonates tested, and the inhibitory differences for the 
difluorophosphonate over phosphonate inhibitors for PNP from four different sources became 
far more pronounced (5-26 fold lower for the fluorophosphonates) when assayed at pH 6.2 
over 7.4. 
A version of phosphonate 3.3 that is fluorinated at the C3 position was previously designed 
within our laboratory (Figure 3.7).102  Though the fluorine atoms are not on the carbon atom 
adjacent to the phosphonate moiety, they are vinylogous to it, and so should have some of the 
desired effect in increasing the overall acidity of the phosphonate group.  Fluorinated 
phosphonate 3.4 has been tested against the DAH7P synthase from E. coli where it was found 
to have a Ki value of 8.8 ± 2.5 µM.102  This is not significantly different than the results 
obtained for vinyl phosphonate 3.3.  This is not surprising however when the difference in the 
proposed mechanisms for these two aldolases are considered, as discussed in Chapter 1, 
where a monoanionic PEP molecule is not thought to be required for the DAH7P synthase 
mechanism but is possibly required for KDO8P synthase. 
F3C CO2-
P
O
-O
HO
3.4  
Figure 3.7: Trifluorinated (E)-vinyl phosphonate 
3.3.1. Inhibition of KDO8P synthase by (E)-vinyl phosphonate 3.3 
(E)-Vinyl phosphonate 3.3, obtained from Scott Walker, was tested as an inhibitor of both the 
metal-independent and metal-dependent KDO8P synthase from N. meningitidis and A. 
ferrooxidans, using the same kinetic assay as previously described.  The initial rate data was 
analysed as before, and it was determined that (E)-vinyl phosphonate 3.3 inhibits KDO8P 
synthase competitively with respect to PEP.  The Ki values for vinyl phosphonate 3.3 were 
found to be 320 ± 30 µM and 260 ± 10 µM for KDO8P synthase from N. meningitidis 
(Figure 3.8) and A. ferrooxidans (Figure 3.9) respectively. 
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Figure 3.8: Inhibition of KDO8P synthase from N. meningitidis by phosphonate 3.3 as Michaelis (top) and 
Lineweaver-Burke (bottom) plots.  Solutions of PEP (5-20 µM), A5P (50 µM), and phosphonate 3.3 (0-211 
µM) in 1 mL BTP buffer (50 mM, pH 7.2) were initiated by addition of N. meningitidis KDO8P synthase 
(2 µg) and the loss of PEP followed spectrophotometrically at 232 nm.  Initial rates were obtained by 
linear least squares regression and converted to progress rates (µM s-1). 
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Figure 3.9: Inhibition of KDO8P synthase from A. ferrooxidans by phosphonate 3.3 as Michaelis (top) and 
Lineweaver-Burke (bottom) plots.  Solutions of PEP (10-30 µM), A5P (100 µM), manganese chloride (10 
µM) and phosphonate 3.3 (0-317 µM) 1 mL BTP buffer (50 mM, pH 7.2) were initiated by addition of A. 
ferrooxidans KDO8P synthase (2 µg) and the loss of PEP followed spectrophotometrically at 232 nm.  
Initial rates were obtained by linear least squares regression and converted to progress rates (µM s-1). 
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3.3.2. Inhibition of KDO8P synthase by (E)-vinyl phosphonate 3.4 
Trifluorinated (E)-vinyl phosphonate 3.4, obtained from Scott Walker, was tested against the 
KDO8P synthase from N. meningitidis and A. ferrooxidans via kinetic assay and analysed as 
described for glyphosate, 1.6.  Vinyl phosphonate 3.4 was a competitive inhibitor with 
respect to PEP, and gave Ki values of 270 ± 30 µM for KDO8P synthase from N. meningitidis 
(Figure 3.10) and 280 ± 20 µM for KDO8P synthase from A. ferrooxidans (Figure 3.11). 
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Figure 3.10: Inhibition of KDO8P synthase from N. meningitidis by fluorinated phosphonate 3.4 as 
Michaelis (top) and Lineweaver-Burke (bottom) plots.  Solutions of PEP (5-20 µM), A5P (50 µM), and 
fluorinated phosphonate 3.4 (0-281 µM) in 1 mL BTP buffer (50 mM, pH 7.2) were initiated by addition 
of N. meningitidis KDO8P synthase (2 µg) and the loss of PEP followed spectrophotometrically at 232 nm.  
Initial rates were obtained by linear least squares regression and converted to progress rates (µM s-1). 
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Figure 3.11: Inhibition of KDO8P synthase from A. ferrooxidans by fluorinated phosphonate 3.4 as 
Michaelis (top) and Lineweaver-Burke (bottom) plots.  Solutions of PEP (10-30 µM), A5P (100 µM), 
manganese chloride (10 µM) and fluorinated phosphonate 3.4 (0-280 µM) 1 mL BTP buffer (50 mM, pH 
7.2) were initiated by addition of A. ferrooxidans KDO8P synthase (2 µg) and the loss of PEP followed 
spectrophotometrically at 232 nm.  Initial rates were obtained by linear least squares regression and 
converted to progress rates (µM s-1). 
3.4. Phospholactates as tetrahedral intermediate analogues 
The two stereoisomers of phospholactate were utilised as inhibitors of KDO8P synthase as 
they contain a tetrahedral centre at the C2 carbon (Figure 3.12), representative of the 
tetrahedral intermediate, as described in Section 1.3.4. 
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Figure 3.12: (2R)- (3.5) and (2S)-phospholactate (3.6) molecules as inhibitors of KDO8P synthase. 
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These phospholactates have been tested as possible inhibitors of other PEP utilising enzymes 
such as pyruvate kinase and enolase from rabbit muscle.110  Pyruvate kinase was inhibited 
ten-fold greater by the phospholactate 3.5 due to the methyl group on the phospholactate 3.6 
being sterically hindered by a proton donor group, normally found near the C3 carbon of 
PEP.111  Enolase did not discriminate between the two stereoisomers due to the proton donor 
group in the active site being located near the C2 rather than C3 carbon of PEP, though 
inhibition was poor for both isomers, thought to be due to the incapacity of the enzyme to 
tolerate steric bulk at the C3 position.112  In the related aldolase DAH7P synthase, 
phospholactate 3.5 was shown to inhibit the enzyme ten-fold greater than phospholactate 3.6.  
This was rationalised as the re face water attacking PEP at the C2 position, with the methyl 
group of phospholactate 3.5 binding in the re-face water pocket in the enzyme active site.86  
The enantiomeric preference shown by KDO8P synthase will be analysed in the same way as 
these three enzymes, and used to determine aspects of the mechanism and tetrahedral 
intermediate. 
The two stereoisomers of phospholactate have been tested as inhibitors of the metal-
independent KDO8P synthase from N. meningitidis where they were found to have Ki values 
of 870 ± 90 µM and 1200 ± 50 µM for phospholactate 3.5 and 3.6 respectively.113  The 
testing of these molecules on a metal-dependent KDO8P synthase has not been previously 
undertaken however, and so the two molecules were tested on the KDO8P synthase enzyme 
from A. ferrooxidans to determine whether there are any differences between the two classes 
of enzyme, and between the two stereoisomers of phospholactate. 
 
3.4.1. Inhibition of KDO8P synthase from A. ferrooxidans by phospholactates 3.5 and 3.6 
The (2R)- (3.5) and (2S)-phospholactates (3.6), obtained from Hemi Cumming and Sebastian 
Reichau respectively, were tested as inhibitors of the metal-dependent KDO8P synthase from 
A. ferrooxidans via kinetic assay and fitted to the Michaelis-Menten equation as previously 
described.  They were found to have Ki values of 390 ± 70 µM (Figure 3.13) and 1000 ± 220 
µM (Figure 3.14) respectively. 
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Figure 3.13: Inhibition of KDO8P synthase from A. ferrooxidans by (2R)-phospholactate, 3.5, as Michaelis 
(top) and Lineweaver-Burke (bottom) plots.  Solutions of PEP (5-15 µM), A5P (100 µM), manganese 
chloride (10 µM) and (2R)-phospholactate, 3.5, (0-1160 µM) in 1 mL BTP buffer (50 mM, pH 7.2) were 
initiated by addition of A. ferrooxidans KDO8P synthase (2 µg) and the loss of PEP followed 
spectrophotometrically at 232 nm.  Initial rates were obtained by linear least squares regression and 
converted to progress rates (µM s-1). 
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Figure 3.14: Inhibition of KDO8P synthase from A. ferrooxidans by (2S)-phospholactate, 3.6, as Michaelis 
(top) and Lineweaver-Burke (bottom) plots.  Solutions of PEP (5-15 µM), A5P (100 µM), manganese 
chloride (10 µM) and (2S)-phospholactate, 3.6, (0-2520 µM) in 1 mL BTP buffer (50 mM, pH 7.2) were 
initiated by addition of A. ferrooxidans KDO8P synthase (2 µg) and the loss of PEP followed 
spectrophotometrically at 232 nm.  Initial rates were obtained by linear least squares regression and 
converted to progress rates (µM s-1). 
3.5. Discussion and summary 
A number of small molecule PEP-mimics were tested as inhibitors on both the metal-
independent KDO8P synthase from N. meningitidis and the metal-dependent KDO8P 
synthase from A. ferrooxidans.  These inhibitors either mimicked the two possible charge 
distributions of the trigonal planar oxocarbenium ion species (glyphosate 1.6, and vinyl 
phosphonates 3.3 and 3.4), or the tetrahedral intermediate (phospholactates 3.5 and 3.6). 
Glyphosate, 1.6, chosen to mimic the potential oxocarbenium ion charge distribution 3.1, 
showed moderate to poor inhibition of KDO8P synthase from both the metal-independent and 
metal-dependent class of enzyme (Figure 3.15). 
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Figure 3.15: Inhibitory properties of glyphosate 1.6 with PEP for KDO8P synthase from N. meningitidis 
and A. ferrooxidans. 
The vinyl phosphonates 3.3 and 3.4 were designed to mimic the oxocarbenium ion with a 
trigonal planar centre at the C2 carbon of the PEP fragment (3.2).  Both the (E)-vinyl 
phosphonate 3.3 and the fluorinated analogue 3.4 had similar Ki values to the other 
oxocarbenium ion mimic tested, glyphosate, 1.6 (Figure 3.16). 
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Figure 3.16: Inhibitory properties of (E)-vinyl phosphonate 3.3 and fluorinated (E)-vinyl phosphonate 3.4 
with PEP for KDO8P synthase from N. meningitidis and A. ferrooxidans. 
The (2R)- (3.5) and (2S)-phospholactate (3.6) molecules were chosen as mimics of the two 
possible stereoisomers of the tetrahedral intermediate of the KDO8P synthase reaction.  They 
had previously been tested as inhibitors of the metal-independent KDO8P synthase from N. 
meningitidis were also tested here as inhibitors of the metal-dependent KDO8P synthase from 
A. ferrooxidans.  The (2R)-phospholactate 3.5 inhibited the KDO8P synthase enzyme more 
than the (2S)-phospholactate 3.6 for both the metal-independent and metal-dependent class, 
though the difference was far more pronounced for the metal-dependent enzyme (Figure 
3.17).  The Ki values were generally two to three-fold higher for the phospholactates than for 
the transition state inhibitors 1.6, 3.3 and 3.4, except in the case of phospholactate 3.5 with 
the AfeKDO8PS enzyme. 
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Figure 3.17: Inhibitory properties of (2R)-phospholactate 3.5 and (2S)-phospholactate 3.6 with PEP for 
KDO8P synthase from N. meningitidis and A. ferrooxidans. 
The results from the inhibition of these five inhibitors against KDO8P synthase from N. 
meningitidis and A. ferrooxidans reveal some interesting insights into the mechanism of 
KDO8P synthase and reveal trends that can be used in the synthesis of future inhibitors. 
Glyphosate, 1.6, and vinyl phosphonate 3.3 had similar inhibition against KDO8P synthase 
from both the metal-independent and metal-dependent class of enzyme.  This result is in 
some ways surprising as they are quite different in structure.  This is good evidence to 
suggest that they are both mimicking the same oxocarbenium ion species, as per their original 
purpose.  The fluorinated analogue of vinyl phosphonate 3.3 (3.4) did not show significantly 
different inhibition towards the KDO8P synthase from either class of enzyme.  It may be that 
the KDO8P synthase mechanism does not require a monoanionic phosphate as discussed in 
Chapter 1. 
The (2R)- (3.5) and (2S)-phospholactate (3.6) molecules showed differing results for the 
KDO8P synthase enzyme from the metal-independent and metal-dependent class.  Both 
enzymes showed binding preference for the (R)-stereoisomer over the (S)-stereoisomer but 
this was far greater for the metal-dependent enzyme from A. ferrooxidans.  At first glance it 
would appear that this preference infers that the C2 of PEP is attacked by the water molecule 
si face of PEP (Chapter 1).  Recent crystallographic studies of a tetrahedral intermediate 
analogue bound in the active site of the related aldolase DAH7P synthase show that the 
stereoisomer bound in the active site is the (R) stereoisomer which best accommodates the re 
face water molecule.  This isomer showed greater inhibition than the (S) isomer, which does 
not accommodate this re face water as well when bound in the active site (unpublished 
data).114  It may be that the phospholactate inhibitors behave the same way.  This will be 
explored further in Chapter 5 with modelling studies. 
Overall, the inhibitors that resembled the trigonal planar oxocarbenium ion species were 
more effective than the phospholactates that mimicked the tetrahedral intermediate.  The 
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inhibition constants were similar for the metal-independent KDO8P synthase from N. 
meningitidis and the metal-dependent KDO8P synthase from A. ferrooxidans even though the 
Km value for PEP is more than twice as large for the metal-dependent enzyme as it is for the 
metal-independent analogue.  This effectively makes the inhibitors twice as effective against 
the metal-dependent KDO8P synthase enzyme from A. ferrooxidans.  This may be the result 
of inhibitors binding more tightly to the active site of metal-dependent KDO8P synthases, 
possibly by bonding to the metal ion itself.  The significance of this is future inhibitors may 
be designed to be more effective against bacterial species with metal-dependent KDO8P 
synthase enzymes.   
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4.1. Introduction 
The insights into the inhibition of KDO8P synthase gained by the studies presented in 
Chapter 3 were used as the basis for development of new inhibitors with increased binding 
affinity.  The approach utilised the concept of polyvalency; altering a previously designed 
inhibitor to include additional binding motifs, allowing the inhibitor to interact with multiple 
regions of the target enzyme.  This creates a more stable enzyme-ligand complex by utilising 
the energy associated with these additional binding events (Figure 4.1).115 
 
 
Figure 4.1:  Comparison between mono and multivalent binding in an enzyme with two substrate binding 
sites. 
Utilising a polyvalent ligand makes the second binding event intramolecular.  The first 
binding event is influenced by the dissociation constant Kd (Kinter) and the concentration of 
both the enzyme and ligand, but the second binding event is only dependent on the effective 
concentration, a function of the probability of the two binding motifs being located at a 
distance that allows the second binding event to occur.115  The intramolecular binding 
interaction is stronger than for the equivalent intermolecular interaction, in part because of a 
decrease in the entropic cost of binding a polyvalent ligand over two monovalent ligands.  
This theory has been utilised in the synthesis of bisubstrate inhibitors for type 1 17β-
hydroxysteroid dehydrogenase (17β-HSD1), an enzyme which controls the formation and 
inactivation of the most potent endogenous estrogen, estradiol  and NADPH/NADP+ as the 
monovalent 
multivalent 
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proton donor/acceptor.  Bisubstrate inhibitor EM-1745 was designed to mimic both the 
substrate estradiol and NADP+ molecule, and was shown to have an apparent Ki of 3 nM for 
the oxidation of estradiol to estrone. 
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Figure 4.2: Design of 17β-HSD1 bisubstrate inhibitor EM-1745 from substrates estradiol (shown in blue 
box) and NADP+ (shown in red box). 
This concept has been previously applied in the design of a bisubstrate inhibitor for KDO8P 
synthase.26 Aminophosphonate 1.4, retains a glyphosate head group to mimic the 
oxocarbenium ion species, with A5P hydroxyl stereochemistry and terminal phosphate to 
provide additional contact points with the KDO8P synthase sugar phosphate binding site 
(Figure 4.3).  It is these additional contacts with the active site provide a large increase in 
binding and subsequent inhibition of the KDO8P synthase enzyme. 
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Figure 4.3: Aminophosphonate inhibitor 1.4 with binding motifs labelled; A5P phosphate binding site 
motif, in red; A5P hydroxyl stereochemistry binding motif, in green; PEP binding site motif, in blue. 
Chapter 3 described the inhibition of KDO8P synthase by a number of PEP analogues that 
are assumed to inhibit the enzyme by binding to the PEP binding site.  The research presented 
in Chapter 4 examines the effect of the various binding motifs in KDO8P synthase inhibition 
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by the design of five additional inhibitors based on a selection of these PEP analogues 
(Figure 4.4).  Glyphosate was selected as an oxocarbenium mimic and the phospholactates 
3.5 and 3.6 were selected as a mimics of the tetrahedral intermediate.  Extended 
phospholactate 4.1 was designed to contain the A5P hydroxyl stereochemistry functionality 
and terminal phosphate in order to take advantage of all the A5P contacts made with the 
KDO8P synthase active site to determine the effect on inhibition of the KDO8P synthase 
enzyme.  Extended phospholactate 4.33, and aminophosphonate 4.19 were designed as 
potential inhibitors with a simpler structure, retaining the A5P-like terminal phosphate, but 
lacking the hydroxyl stereochemistry of the main chain, in order to determine the effect these 
hydroxyls have on inhibition of KDO8P synthase.   
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Figure 4.4: Multivalent inhibitors to be investigated in Chapter 4. 
4.2. Extended inhibitors retaining the A5P hydroxyl stereochemistry functionality 
The extended phospholactate 4.1 contains both the terminal phosphate and hydroxyl 
stereochemistry functionality of the A5P substrate, joined to the previous KDO8P synthase 
inhibitors investigated in Chapter 3, phospholactate 3.5 and 3.6.  The proposed route to 
extended phospholactate 4.1 is outlined in Figure 4.5.  The α-hydroxy ester 4.2 required for 
synthesis of phospholactate 4.1 can be synthesised in two steps with a two carbon elongation 
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of the six carbon aldehyde 4.4, via a Darzens condensation reaction between the aldehyde and 
isopropyl dichloroacetate, 4.5,116 of which the product, 4.3, is reduced to give α-hydroxyester 
4.2.117 
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Figure 4.5: Retrosynthetic scheme showing synthesis of the extended phospholactate 4.1 from the 
aldehyde 4.4. 
The chirality of aldehyde 4.4 was derived from the relatively cheap and abundant six carbon 
carbohydrate D-mannose (Figure 4.6). 
RO
OR
OR OR
OR
O
O
OH
OHHO
HO
OH
D-mannose4.4  
Figure 4.6: The source of chirality for aldehyde 4.4; the six carbon carbohydrate D-mannose. 
The sugar 4.4 must be protected in such a way to allow selective access to the aldehyde 
moiety for the Darzens condensation reaction, followed by selective deprotection of the 
primary C6 hydroxyl group for diphosphorylation of the diol.  Two methods were 
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investigated for this deprotection, differing in whether the hydroxyl groups or aldehyde 
moiety were protected first (Figure 4.7).  In the first method, D-mannose was to be protected 
as either the diacetonide 4.6 or 4.7.  The diacetonide 4.6 is an ideal target for the synthesis of 
aldehyde 4.4 as it has the free aldehyde functionality and 1,2:3,4 hydroxyl groups protected 
so that they do not interfere in subsequent reactions.  The synthesis of diacetonide 4.6 is 
speculative however, resting on a single patent report.118  Lactol 4.7 is widely reported as an 
initial starting material in many syntheses, including the first synthesis of aminophosphonate 
1.4,26 and extended PEP mimic 1.2.84  However, this relies on lactol-aldehyde equilibration at 
the key carbon-carbon bond forming step, and Darzens condensations with lactols are not 
reported in the literature.  The second method was based on initial protection of the aldehyde 
moiety as the dithiane 4.13, and the subsequent protection of the hydroxyl.  The aldehyde 
moiety would then be unmasked in order to react in the Darzens condensation with isopropyl 
dichloroacetate, 4.5. 
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Figure 4.7: Retrosynthesis showing possible syntheses of the aldehyde 4.4 from the protected chiral 
carbohydrates 4.6, 4.7 and 4.13. 
4.2.1. Initial protection as diacetonide 
The initial protection scheme for D-mannose utilised acetonide protection of the secondary 
hydroxyl groups so that the aldehyde moiety would be free to react in the Darzens 
condensation reaction.  A literature preparation utilising a boron-trifluoride catalysed 
protection of D-mannose offered a useful starting point, reportedly giving the 3,4:5,6 
diacetonide, 4.6.118  The diacetonide 4.6 was not formed in detectable amount as judged by 
1H NMR analysis of the reaction products, all of which failed to show any trace of an 
aldehyde moiety.  However, the 2,3:5,6 diacetonide, 4.7, was found to be formed in 50 % 
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yield.  The diacetonide 4.7 was identified by 13C NMR spectra that showed the acetonide 
quaternary carbons at 110 and 114 ppm respectively, indicating they are found in five 
membered rings.119  High resolution mass spectroscopy (HRMS) identified the lactol 4.7 as a 
compound with molecular mass 283.1146 (calculated mass for sodiated lactol 4.7: 283.1158). 
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Figure 4.8: Attempted synthesis of diacetonide 4.7. 
With the availability of diacetonide 4.7, and the unsuccessful preparation of diacetonide 4.6, 
it was decided to continue to develop synthetic routes based on the 2,3:5,6 diacetonide, 4.7.  
The diacetonide 4.7 can be prepared via a protic acid catalysed reaction in acetone, and so 
two different modified procedures were trialled using sulfuric acid120 and p-toluenesulfonic 
acid monohydrate (TsOH.H2O)121 as the catalyst in order to improve the yield from the 
boron-trifluoride catalysed protection.  Stirring D-mannose in acetone with catalytic amounts 
of TsOH.H2O gave diacetonide 4.7 in an improved yield of 63 %. 
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Figure 4.9: Acetonide protection of D-mannose. 
As previously discussed, it was hoped that the lactol 4.7 could be directly reacted with 
isopropyl dichloroacetate, 4.5, to give the required α-chloroglycidic ester 4.8.  No such 
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literature examples exist for Darzens reactions, although lactols have been used in reactions 
that also utilise an anionic nucleophile, such as Wittig122 and Horner-Emmons123,124 reactions.   
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Figure 4.10: Unsuccessful synthesis of the α-chloroglycidic ester 4.8. 
Unfortunately this reaction was unsuccessful.  A number of new spots were seen by TLC 
analysis, but no product was able to be isolated by flash chromatography, and most of the 
starting material diacetonide 4.7 remained. A 2005 study by Coutrot et al., formed an α-
chloroglycidic ester from the C3-silane protected gluco-acetonide (Figure 4.11) and this 
result may reflect the need for the free aldehyde to be used in the Darzens condensation 
reaction, rather than the lactol.125  
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Figure 4.11: Darzens reaction of the gluco-diacetonide as reported by Coutrot et al.125 
The result shown in Figure 4.10 suggests that the free aldehyde functionality of protected 
aldehyde 4.4 is required for the Darzens condensation reaction, rather than the lactol of 
diacetonide 4.6.  In order to achieve this, lactol 4.6 was reduced with sodium borohydride126 
to give the diol 4.9, in 91 % yield.  This was determined by 1H NMR spectroscopic analysis 
showing the overall change in methylene and methine proton shifts from the lactol 4.7, and a 
broad two proton hydroxyl peak at 3.18 ppm. 
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Figure 4.12: Reduction of the lactol 4.6. 
The primary hydroxyl was protected by reaction with benzoyl chloride,127 chosen as a 
protecting group for its selectivity of the primary hydroxyl due to its relative steric bulk, and 
its ability to be selectively deprotected in the presence of acetonide groups using basic 
conditions, such as 1 % sodium hydroxide in methanol at room temperature.128 This ester 
linkage is also compatible with the use of the planned C6 hydroxyl protecting group, tert-
butyldiphenylsilane (TBDPS).129,130  Utilising pyridine as a base and, the primary hydroxyl 
group was protected as the benzoyl moiety in 52 % yield.  The product was identified as 
protected diacetonide 4.10 by 1H NMR showing the presence of the five aromatic protons at 
7.44 – 8.12 ppm, and 13C NMR showing the benzoyl quaternary carbon at 166.2 ppm.  
Additionally, HRMS detected diacetonide 4.10 as a compound with molecular mass 389.1567 
(calculated mass for sodiated diacetonide 4.10: 389.1571).  Nuclear Overhauser Effect 
Spectroscopy (NOESY), which shows correlation between atoms in space (distances of less 
than 5 Å), did not show correlation between any of the benzoyl group atoms and the main 
chain or acetonide groups.  However, only one product was seen by TLC analysis and 
isolated, and previous literature examples would suggest the benzoylation reaction described 
is selective for the primary over the secondary hydroxyl group.131 
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Figure 4.13: Primary benzoyl protection of the protected diacetonide 4.9. 
As previously discussed, in order to synthesise the extended phospholactate 4.1, the sugar 
must be differently protected at both the C1 and C6 hydroxyl.  This is to ensure that the C1 
hydroxyl can be selectively deprotected and oxidised to generate the aldehyde for the 
Darzens condensation, followed by deprotection of the C6 hydroxyl moiety for 
phosphorylation.  It was considered that the selective deprotection of the 1,2-acetonide and 
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protection of the C6 hydroxyl moiety may not be straight forward, and as such would best be 
performed early in the synthesis.  As such the deprotection of the primary acetonide was 
attempted.  Similar deprotections are well reported in the literature.132  A range of conditions 
were tried for this reaction, utilising modified procedures from similar compounds (Figure 
4.14).132,133 
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Figure 4.14: Failed primary acetonide deprotections. 
The first two sets of conditions, utilising hydrochloric acid in methanol, and cerium 
trichloride and oxalic acid in acetonitrile both resulted in a new compound that could be 
detected by TLC.  This new compound had a lower Rf than the diacetonide 4.10, indicating 
that it could potentially be the monoacetonide 4.11. The new product could not be isolated by 
flash chromatography however, and the diacetonide 4.10 could not be recovered, indicating 
destruction of this diacetonide starting material.  After refluxing the starting material 4.10 in 
methanol with catalytic TsOH.H2O, a product of the reaction, determined not to be the 
diacetonide 4.10 by 1H NMR spectroscopy, was able to be partially isolated by flash 
chromatography, albeit in low yield (< 20 mg, from ∼200 mg diacetonide 4.10).  1H NMR 
analysis revealed that it was two monoacetonide compounds, in a 2:1 ratio.  This was judged 
by the presence of two methyl peaks, at ∼ 1.3 ppm, and four methine and two methylene 
peaks, at 3.5 – 5.0 ppm, for each compound.  Due to the inability to see correlations for the 
acetonide methyl protons with the main chain or benzoyl protons using NOESY experiments, 
it could not be determined in what ratio the two monoacetonide compounds were.  The two 
compounds could not be separated by flash chromatography as their Rf values were too 
similar under a wide variety of solvent mixtures, but high resolution mass spectroscopic 
analysis revealed the mixture to contain a compound with a molecular mass of 349.1255  
(calculated mass: 349.1258 for both sodiated monoacetonide 4.11, and the 1:2 
monoacetonide).  The low yield and inability to separate the two monoacetonides by flash 
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chromatography led to this route being abandoned in favour of the dithiane route discussed 
below. 
4.2.2. Initial protection as dithiane 
The unsuccessful deprotection of diacetonide 4.10 to give the monoacetonide 4.11 was 
disappointing.  It was now necessary to investigate a new synthetic scheme in order to 
synthesise the required aldehyde for the Darzens condensation.  Previous reports have 
indicated that the dithiane 4.14 could be synthesised from D-mannose in three steps (Figure 
4.15).134 This compound is ideal as it has the aldehyde selectively protected as the dithiane 
moiety and the C6 primary hydroxyl moiety free, for selective protection. 
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Figure 4.15: Synthesis of the partially protected D-mannose sugar.134 
The initial step in the synthesis of protected sugar 4.14 was the protection of the aldehyde as 
the dithiane, with propandithiol stirring in a 2:1 mixture of chloroform and concentrated 
hydrochloric acid.  Overnight, the reaction mixture had become too viscous to stir and D-
mannose could no longer be detected by TLC analysis, and so the reaction mixture was 
neutralised with ammonia, and the solvents and water evaporated off to give a white solid.  
Recrystallisation from methanol as reported in the literature134 was attempted, but the 
compound stayed in solution.  However, treatment of the crude product containing dithiane 
4.12 with acetone and hydrochloric acid gave 4.13 in 46 % yield after flash chromatography, 
over two steps, only slightly less than the literature yield of 56 %.134  The diacetonide 4.13 
was identified by 1H NMR spectroscopic analysis and HRMS.  The six dithiane proton 
resonances appeared 2.98, 2.81, 2.05 and 1.95 ppm, and acetonide methyl peaks at 1.39, 1.33 
(two methyl groups) and 1.31 ppm. Additionally, the structure was confirmed by 2D proton 
Correlation Spectroscopy (COSY) showing the main chain C1-C5 methine and C6 methylene 
protons, correlated to each other with corresponding coupling constants.  The dithiane was 
detected by HRMS as a compound with molecular mass of 373.1120 (calculated mass for 
sodiated dithiane 4.10: 373.1114). 
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Figure 4.16: Two step protection of D-mannose to give the dithiane protected manno-diacetonide 4.13. 
The selective deprotection of the primary acetonide was reported in the same paper, and 
involved stirring the protected sugar 4.13 in methanol with hydrochloric acid to give the 
partially deprotected sugar 4.14 in 77 % yield. This was comparable to the literature value of 
82%.134  The structure of monoacetonide 4.14 was characterised by the disappearance of two 
acetonide peaks in the 1H NMR spectrum and HRMS, detecting the sodiated monoacetonide 
4.14 as a compound with molecular mass of 311.0995 (calculated mass: 311.0981). 
O O
OH
S
S
HO
HO
4.144.13
O O
OH
S
S
O
O
2N HCl, MeOH
(77 %)
 
Figure 4.17: Primary acetonide deprotection of 4.13. 
The bulky silyl protecting group TBDPS was chosen as the candidate to protect the primary 
C6 hydroxyl of the dithiane acetonide 4.14.  This group has been used extensively for the 
selective protection of primary hydroxyl groups over secondary hydroxyl groups.135-137  Flash 
chromatography revealed two compounds in 62 and 12 % yield respectively, that both 
contained aromatic resonances at 7 – 8 ppm, and a tert-butyl methyl resonance at ∼ 1 ppm, 
along with the main chain methylene and methine peaks, and dithioacetal peaks as seen for 
previous compounds.  Selective excitation NOESY experiments could not determine whether 
the primary or secondary hydroxyl group was silylated; however as mentioned, previous 
literature examples demonstrate that the TBDPS group is selective for primary hydroxyl 
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groups.  Therefore, it was assumed that the silylated compound formed in greater yield was 
silyl ether 4.15. 
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Figure 4.18: Selective primary silyl protection of acetonide 4.14. 
The C2 and C5 hydroxyl groups remained unprotected in the monoacetonide 4.15.  These two 
hydroxyl moieties are sterically hindered by the silyl, acetonide and dithioacetal groups and 
so a protecting group with little steric bulk was required.  It was also considered that during 
the final deprotection step in the synthesis of the extended phospholactate 4.1, it would be 
advantageous if all the secondary hydroxyl groups could be deprotected in a single step.  
Acetyl protecting groups fulfilled both requirements, and are well reported in the literature as 
a general protecting group for both primary and secondary hydroxyl moieties.132,138  Two sets 
of conditions were trialled, using either acetic anhydride or acetyl chloride as the acetyl group 
donors, with pyridine as a base, and dimethylaminopyridine (DMAP) as a nucleophilic 
catalyst.139  The former yielded a mixture of products that were unable to be isolated and 
characterised.  The reaction utilising acetyl chloride gave protected sugar 4.17, in 69 % yield.  
The product was determined by a 1H NMR spectrum showing the acetyl group methyl 
resonances at 2.09 and 2.13 ppm, and a 13C NMR spectrum showing the acetyl group 
quaternary carbon resonances at 170.0 and 170.2 ppm and HRMS detection of the sodiated 
protected sugar 4.17 as a compound with molecular mass of 655.2190 (calculated mass: 
655.2199). 
O O
OH
S
S
TBDPSO
HO
AcCl, pyridine, DMAP,
CH2Cl2
(69 %)
4.15
O O
OAc
S
S
TBDPSO
AcO
4.17  
Figure 4.19: Diacetylation of 4.15 to give protected sugar 4.17. 
With the hydroxyl groups selectively protected, the aldehyde functionality could be 
unmasked.  A wide variety of conditions have been reported for the deprotection of 
Chapter 4: Dual site inhibitors of KDO8P synthase 
96 
 
dithioacetals.138  This is perhaps a reflection of the context-dependent nature of the 
deprotection step. 
A wide variety of conditions were trialled for the removal of the dithioacetal group of 4.17.138  
However, the unmasking of the aldehyde functionality of protected sugar 4.18 proved very 
difficult.  Mercuric compounds are often used for the deprotection of dithianes, exploiting the 
specificity of the interaction between sulfur and mercury. These methods have fallen out of 
favour in recent years however, as mercury is quite toxic, and more environmentally friendly 
methods are now preferred.  A wide range of conditions were investigated.  Methyl iodide, 
calcium carbonate in acetonitrile and water; N-bromosuccinimide (NBS), silver(I) nitrate, 
2,6-lutidine in acetonitrile and water;  bis(trifluoroacetyl) peroxide, iodobenzene in methanol 
and water;  N-bromosuccinimide, collidine in methanol and acetonitrile; copper(II) oxide, 
copper(II) chloride in acetone and water were all trialled. All produced multiple compounds 
detectable by TLC.  No identifiable compounds could be isolated by flash chromatography.  
1H NMR analysis of the fractions obtained from flash chromatography of all five reaction 
mixtures showed that they contained mixed compounds, in very low yields (∼10 mg mixed 
compound from ∼200 mg starting material 4.17), that contained tert-butyl (singlet at 
approximately 1 ppm) and aromatic proton resonances (multiplets at 7-8 ppm) from the 
TBDPS protecting group, and lacked the dithioacetal methylene group resonances found at 
approximately 3 ppm.  All five reactions resulted in destruction of the starting material 4.17.  
Dithioacetal 4.17 was only able to be isolated from the unsuccessful deprotections with Dess-
Martin periodinane (DMP) in acetonitrile and dichloromethane, and mercuric oxide, mercuric 
chloride in acetone and water, in 7 and 15 % yield respectively. 
O O
OAc
S
S
TBDPSO
AcO
O O
OAc
OTBDPSO
AcO
conditions
- (CF3CO2)2IPh, MeOH/H2O, RT
- MeI, CaCO3, MeCN/H2O, 40oC
- DMP, MeCN/CH2Cl2/H2O, RT
- CuO, CuCl2.2H2O, Acetone/H2O
- NBS, collidine, MeOH/MeCN
- NBS, AgNO3, 2,6-lutidine, MeCN/H2O
- HgO, HgCl2, Acetone/H2O, RT - 70oC
4.17 4.18
 
Figure 4.20: Attempted deprotection of dithioacetal group. 
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4.2.3. Summary 
The inability to perform key deprotection steps resulted in the failure of two routes to the 
protected sugar 4.4.  Diacetonide 4.6, the most promising candidate for the Darzens 
condensation, could not be synthesised from a literature procedure.  The diacetonide 4.10, 
synthesised from the lactol 4.6, was unable to be selectively deprotected to give the 
monoacetonide 4.11.  The dithiane group of protected sugar 4.17 could not be removed to 
generate aldehyde 4.18.  It was also shown that the lactol 4.7 could not be reacted with 
isopropyl dichloroacetate, 4.5, in a Darzens condensation reaction to give the α-
chloroglycidic ester 4.8.  This route was abandoned in favour of the simplified inhibitors 
lacking the complicated A5P-like hydroxyl stereochemistry functionality. 
4.3. Extended inhibitors lacking the A5P hydroxyl stereochemistry functionality 
Recent studies have shown that for the related aldolase DAH7P synthase, extended dual-site 
inhibitors that lacked the E4P-like hydroxyl functionality associated stereochemistry still 
inhibited DAH7P synthase with Ki values in the low micromolar range.86  These compounds 
provide a basis for simpler inhibitors.  Two of the PEP analogues tested as inhibitors in 
Chapter 3 were selected as examples of an oxocarbenium mimic (glyphosate, 1.6) and 
tetrahedral intermediate (phospholactates 3.5 and 3.6) to be used as the structural basis for 
inhibitors of this type.  The design of each includes a terminal phosphate, connected via 
pentamethylene spacer group in order to represent the terminal phosphate of the five-carbon 
sugar phosphate, A5P.  These two inhibitors, aminophosphonate 4.19 and extended 
phospholactate 4.33 (Figure 4.21) were to be synthesised as part of the studies presented in 
Chapter 4.  Additionally, two monophosphorylated analogues of extended phospholactate 
4.33 were designed and synthesised that either lacked the primary (monophosphorylated 
compound 4.36) or secondary phosphate (monophosphorylated compound 4.40) (Figure 
4.21).   These four molecules, once synthesised, were to be tested as inhibitors of the metal 
independent KDO8P synthase from N. meningitidis and the metal dependent KDO8P 
synthase from A. ferrooxidans.  The information gained from these studies was used to 
investigate the contribution of the various binding motifs to inhibition of KDO8P synthase. 
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Figure 4.21: Inhibitors lacking the A5P-like stereochemistry associated functionality, to be synthesised 
and tested as inhibitors of KDO8P synthase. 
4.3.1. Aminophosphonate 4.19 
The proposed route for the synthesis of aminophosphonate inhibitor 4.19 is outlined in Figure 
4.22.  It was to be synthesised from 1,6-hexandiol, monoprotected and oxidised to the 
aldehyde 4.21 for reductive amination with glycine ethyl ester.  This would be followed by 
phosphonomethylation of the secondary amine and phosphorylation of the deprotected 
hydroxyl group which, after final deprotection of the phosphate and carboxyl esters, gives the 
desired inhibitor, 4.19. 
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Figure 4.22: Retrosynthetic scheme showing synthesis of aminophosphonate 4.19. 
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This synthetic scheme began with monoprotection of 1,6-hexandiol with a benzyl bromide, to 
give the benzyl ether 4.22140 in 50 % yield.  The benzyl protecting group was chosen due to 
its robust nature under a wide variety of conditions, and relative ease in deprotection via 
hydrogenation utilising a palladium catalyst.141,142  The dibenzyl ether, was also isolated in 32 
% yield.  The two compounds were distinguished by the presence of either three or six 
distinct methylene resonances as judged by 1H NMR spectroscopic analysis, and comparison 
with the literature 1H NMR spectroscopic data for benzyl ether 4.22.140 
HO
OH OH
BnO
BnBr, NaH, KI, THF
Δ
(50 %)
4.22  
Figure 4.23: Initial monobenzylation of the1,6-hexandiol. 
The oxidation method initially chosen utilised Dess-Martin periodinane (DMP),143 which was 
prepared in the laboratory and stored at -20 °C until use.  After flash chromatography, the 
aldehyde 4.23 was isolated in 57 % yield.  The spectroscopic properties of aldehyde 4.23 
were consistent with the reported data for this compound.140  Additionally, the Swern 
oxidation144 was investigated, and gave the aldehyde in 60 % yield following purification by 
flash chromatography.  The Swern oxidation, due to the use of oxalyl chloride as a 
dehydrating agent, must be kept below -60 °C to avoid side reactions.  In comparison, the 
Dess-Martin oxidation can be carried out at room temperature, and as the yield was not 
significantly different between the two methods, the Dess-Martin oxidation was preferred. 
OH
BnO
O
BnO
4.22 4.23
conditions
CH2Cl2
- 1. DMSO, (COCl)2, -78oC,
2. NEt3 (60 %)
- DMP, RT - Δ (57 %)
 
Figure 4.24: Oxidation of benzyl ether 4.22. 
Secondary amines can be synthesised through reductive amination of an aldehyde by a 
primary amine (Figure 4.25).  The aldehyde and primary amine first react to give a 
hydroxyamine species, which is dehydrated to give an iminium ion, which is subsequently 
reduced in situ to give the secondary amine.145,146   
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Figure 4.25: Mechanism through which aldehydes are reductively aminated with primary amines to give 
secondary amines.146 
A range of reducing agents and reaction conditions were trialled for the reductive amination 
of aldehyde 4.23 by ethyl glycine (Figure 4.26).  The initial conditions utilising sodium 
cyanoborohydride as the reducing agent, stirring in methanol, were similar to that used in the 
synthesis of known aminophosphonate inhibitor 1.4.26 A ninhydrin stain, used in the 
detection of nitrogen containing compounds, showed two faint spots by TLC analysis with Rf 
values less than the aldehyde 4.23, and a strong baseline spot, potentially being the positively 
charged iminium ion or glycine ethyl ester starting material.  However, upon aqueous workup 
and flash chromatography, no amine product was able to be isolated.  The starting material, 
aldehyde 4.23, was recovered in 11 % yield, and the monobenzylated alcohol 4.22, formed 
via reduction of the aldehyde, in 5 % yield.  Two other reducing agents (2-picoline borane147 
and triacetoxyborohydride146) were investigated because they had been shown to be 
successful in similar reactions.  Triacetoxyborohydride especially has been shown to be 
successful with electron deficient amines such as para substituted nitro-, carbethoxy- and 
cyanoanilines,146 as these, like glycine ethyl ester, have reduced nucleophilicity towards the 
aldehyde moiety.  Both of these reducing agents failed to yield the desired secondary amine 
however.  The starting material aldehyde 4.23 was not able to be recovered from reactions 
utilising either reducing agent, with the monobenzylated alcohol 4.23 isolated in 5 % or 6 % 
yield for 2-picoline borane and triacetoxyborohydride respectively. 
O
BnO
N
BnO
H2N CO2Et
4.23 4.24
CO2Et
H
conditions
- NaCNBH3, MeOH, 4 Å sieves
- 2-picoline borane, MeOH/H2O (± AcOH)
- Na(OAc)3BH, THF, (± AcOH)  
Figure 4.26: Unsuccessful reductive amination of aldehyde 4.23 and glycine ethyl ester. 
The reductive amination of aldehyde 4.23 had been unsuccessful.  Another possible synthetic 
route to the secondary amine 4.24 is the nucleophilic substitution reaction between glycine 
ethyl ester (nucleophile) and an alkylating agent (Figure 4.27).  
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Figure 4.27: Nucleophilic substitution reaction between glycine ethyl ester and six carbon electrophile 
(leaving group represented by LG). 
Two electrophiles were investigated as possible alternative routes to the secondary amine 
4.24, the mesylate 4.25 and bromo ether 4.26. 
Mesylates have proven to be good leaving groups in nucleophilic substitution reactions with 
primary amines such as glycine ethyl ester.148  The preparation of mesyl ester 4.25 involved 
stirring the monoprotected diol with triethylamine, followed by addition of mesyl chloride 
(Figure 4.28).149  After two hours the starting material 4.22 could no longer be detected by 
TLC analysis.  The reaction was quenched and the product, mesylate 4.25, was isolated in a 
54 % yield following purification by flash chromatography.  The mesylate 4.25 was 
characterised by comparison with known spectroscopic data for the compound.150  Though 
the mesylate 4.25 was synthesised successfully, it degraded quickly, as concluded by 1H 
NMR spectroscopy, even when stored at -20 °C, so was not used as an alkylating reagent 
with ethyl glycine. 
OH
BnO OMsBnO
NEt3, DMAP,
MsCl, CH2Cl2
(54 %)
4.22 4.25  
Figure 4.28: Mesylation of alcohol 4.22. 
The second target electrophile for the nucleophilic substitution reaction with glycine ethyl 
ester was the bromo ether 4.26.  Since the monobenzylated diol 4.22 was available from the 
previous attempted reductive aminations, it was decided that bromination of the alcohol 
would be an appropriate route.  Various brominating agents were tried; hydrogen bromide151 
was unsuccessful; phosphorous tribromide152 and triphenylphosphine dibromide153 
(synthesised from the reaction between bromine and triphenylphosphine)154 gave the bromo 
ether 4.25 in yields of 19 % and 25 % respectively.  The spectroscopic data for bromo ether 
4.25 matched that found for the products of the reactions utilising phosphorous tribromide 
and triphenylphosphine dibromide.155 (Figure 4.29).  The starting material, monobenzylated 
alcohol 4.22, could not be recovered from any of the reaction mixtures by flash 
chromatography. 
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OH
BnO BrBnO
conditions
- HBr, PhMe, Δ; (no rxn)
- PBr3, Pyridine, Et2O/hexane, RT; (19 %)
- PBr2Ph3, CH2Cl2, 0 oC - RT; (26 %)
4.22 4.26
 
Figure 4.29: Bromination of alcohol 4.20. 
These results can be interpreted in terms of the bromination mechanisms for the different 
reagents (Figure 4.30).  Hydrogen bromide promoted bromination involves protonation of the 
hydroxyl group and elimination of a water molecule as a leaving group.  In contrast, the two 
successful reactions involving use of phosphorous tribromide and triphenylphosphine 
dibromide occur via initial activation of the hydroxyl oxygen by the more electrophilic 
phosphorous atom to form a bromophosphate adduct and a bromine ion, followed by the 
substitution reaction.  The bromophosphate leaving group is eliminated, much more readily 
than the less electrophilic water molecule. 
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Figure 4.30: Bromination mechanisms for hydrogen bromide, phosphorous tribromide (X = Br, n = 1) 
and triphenylphosphine dibromide (X = Ph, n = 3). 
The main issue with monoalkylations of amines is that the product, secondary amine 4.24, is 
potentially more nucleophilic than the primary amine, glycine ethyl ester.156  This generally 
results in dialkylation, and in order to avoid this, a large excess of the amine must be used.  
New methods have been devised however where addition of cesium hydroxide is used to 
produce the monoalkylated product almost exclusively from the free amine and brominated 
electrophile, and these were investigated.157  
The bromo ether 4.25 was reacted with glycine ethyl ester, in the presence of cesium 
hydroxide in order to prevent dialkylation (Figure 4.31).  After twenty four hours stirring, the 
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starting material bromo ether was no longer detectable by TLC analysis.  After aqueous 
workup and flash chromatography neither the product, secondary amine 4.24, or the starting 
material, bromo ether 4.25, could be isolated.  A mixture of products in low yield (> 10 mg 
from ∼ 200 mg bromo ether 4.25) were analysed by 1H NMR spectroscopy and showed the 
presence of methylene and aromatic protons, detected as multiplets at 1.5 – 5.0 and 7 – 8 ppm 
respectively, but the structures could not be resolved by 1D or 2D NMR analysis.   
Br
BnO
N
BnO
H2N CO2Et
4.26 4.24
CO2Et
H
4Å sieves, CsOH.H2O
DMF  
Figure 4.31: Attempted substitution reaction between glycine ethyl ester and alkyl bromide 4.25. 
The secondary amine 4.24 was unable to be successfully synthesised via reductive amination 
of the aldehyde 4.23 or alkylation of ethyl glycine with bromo ether 4.26.  At this stage the 
synthesis of the extended aminophosphonate 4.19 was abandoned in favour of the extended 
phospholactates.  Their synthesis is described below. 
4.3.2. Extended phospholactates 4.33, 4.36 and 4.40 
The extended phospholactate 4.33 was proposed as an inhibitor that connected known 
KDO8P synthase inhibitors, (2R)- (3.5) and (2S)-phospholactate (3.6) with a terminal 
phosphate, via a pentamethylene chain, representative of the phosphate found in the second 
substrate, A5P.  As well as this inhibitor, two other synthetic targets were designed that 
lacked either the primary (4.36) or secondary phosphate (4.40) of inhibitor 4.33.  The 
inhibition of these two compounds relative to extended phospholactate 4.33 will determine 
the relative importance of the two phosphate functionalities to inhibition of KDO8P synthase. 
The proposed route to all three extended phospholactate molecules is outlined in Figure 4.32.  
Tert-butyldimethylsilane (TBDMS) was chosen as the initial protecting group of 1,6-
hexandiol.  It is widely reported in the literature as a hydroxyl protecting group, stable to the 
conditions of the reactions that follow, and is readily cleaved under basic or acidic 
conditions.132,138  Oxidation of the alcohol143 and subsequent Darzens condensation 
reaction116 with isopropyl dichloroacetate and reduction of the α-glycidic ester, as previously 
described, provides a route to the α-hydroxy ester117 which is used as a precursor for all three 
phospholactate derived synthetic targets.  The synthesis of phospholactates 4.33 and 4.36 
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were able to proceed by alternating TBDMS deprotection158 and phosphorylation159-161 to 
give the corresponding dibenzylphosphate ethers.  Benzyl protecting groups were selected for 
the phosphate moieties as they can be readily cleaved under a hydrogen atmosphere by 10 % 
palladium over carbon.162  The monophosphorylated compound 4.40 was synthesised via 
protection of the secondary hydroxyl of α-hydroxy ester with a benzyl moiety, selected as it 
can be deprotected in the same step as the phosphate benzyl ethers, and is stable to a wide 
range of conditions.53  The compound could then be subjected to the TBDMS deprotection 
and phosphorylation as previously described.  As a final deprotection step, the benzyl ethers 
on all three inhibitors would be hydrogenated and the isopropyl ester groups removed under 
basic conditions to give the target molecules, 4.33, 4.36 and 4.40. 
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Figure 4.32: Retrosynthesis of extended phospholactates 4.33, 4.36 and 4.40. 
When TBDMS chloride was reacted with three equivalents of 1,6-hexandiol in 
dichloromethane the monoprotected diol 4.27 was isolated in 61 % yield.  This product was 
characterised by the 13C NMR spectra showing nine distinct carbon resonances, and 1H NMR 
spectra showing the methyl group resonances, from the silyl protecting group, at 0.01 and 
0.85 ppm.  Additionally, the silane 4.27 was detected by HRMS as the protonated compound, 
with molecular mass of 233.1938 (calculated mass: 233.1937).  The yield increased to 72 % 
yield when tetrahydrofuran was used as the solvent.  The disilylated compound was 
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synthesised in low yields for the reactions reported here, as determined by TLC analysis, and 
was not isolated. 
HO
OH OHTBDMSO
TBDMSCl, Im
0°C-RT
- THF (72 %)
- CH2Cl2 (61 %)
solvent 4.27
 
Figure 4.33: Silyl monoprotection of 1,6-hexandiol. 
Dess-Martin periodinane was used as the oxidant143 for the synthesis of the aldehyde 4.28 
(Figure 4.34) as it had previously been successfully used for similar compounds.  Analysis of 
the crude product after aqueous workup by 1H NMR spectroscopy showed it to be solely 
aldehyde 4.28, as judged by the aldehyde proton resonance at 9.76 ppm (t, J = 1.7 Hz, 1H).  
The crude product was used directly in the Darzens condensation reaction with isopropyl 
dichloroacetate 4.5 (Figure 4.35). 
O
TBDMSO
OH
TBDMSO
DMP, CH2Cl2, RT
4.27 4.28
 
Figure 4.34: Oxidation of the silyl ether 4.27. 
The synthesis of the α-chloroglycidic ester 4.29 was achieved via the reaction of the aldehyde 
4.28 with isopropyl dichloroacetate 4.5.  This ester precursor 4.5, was chosen due to its 
reported applications in the literature,116,163 and availability in the laboratory from previous 
Darzens condensation reactions.86  Treatment of the isopropyl dichloroacetate 4.5 with 
potassium isopropoxide in ether and addition of the aldehyde 4.28 gave the α-chloroglycidic 
ester 4.29116 after aqueous workup, as judged by the disappearance of the aldehyde proton 
resonance at 9.76 ppm, and the appearance of two new peaks at 5.10 ppm (sept. J = 6.2 Hz, 
1H) and 3.35 ppm (t, J = 6.0 Hz, 1H), indicative of the isopropyl group methine, and epoxide 
geminal proton resonances respectively.  The crude α-chloroglycidic ester 4.29, shown to be 
pure by 1H NMR spectroscopic analysis, was immediately dissolved in isopropyl alcohol and 
treated with sodium cyanoborohydride at 65 °C.  Reduction of the α-chloroglycidic ester 4.29 
to the α-hydroxy ester 4.30117 was followed by TLC analysis.  Once the α-chloroglycidic 
ester 4.29 could no longer be detected, the reaction was quenched.  After aqueous workup 
and flash chromatography the α-hydroxy ester 4.30 was isolated in 26 % yield over three 
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steps from the silyl ether 4.27 (Figure 4.35).  The product was characterised by 2D COSY 
NMR analysis showing the presence of a methine proton at 4.10 ppm (dd, J = 7.3, 4.2 Hz, 
1H), vicinal to the methylene group at 1.37-1.46 ppm (m, 2H) formed from the aldehyde 
moiety, and coupled to both methylene protons separately.  The α-chloroglycidic ester 4.29 
does not contain this methine proton.  Additionally, the 1H NMR spectrum showed a broad 
singlet peak at 2.73 ppm, indicative of the free hydroxyl moiety.  The α-hydroxy ester 4.30 
was confirmed by HRMS detection of the protonated compound with a molecular mass of 
333.2468 (calculated: 333.2461).  The yield of α-hydroxy ester 4.30 was comparable to that 
for the seven-carbon analogue, also synthesised within our research group.164  The α-hydroxy 
ester 4.30 was used as precursor for all three phospholactates, 4.30, 4.36 and 4.40. 
TBDMSO CO2iPr
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iPrOK, iPrOH/Et2O, 0 oC
OiPr
O
Cl
Cl
(26 % over
three steps)
O
TBDMSO
TBDMSO
O
CO2iPr
Cl
4.28 4.29
4.30
NaCNBH3,
iPrOH, 65 oC
 
Figure 4.35: Synthesis of α-hydroxy ester 4.30 via a modified Darzens condensation. 
The synthesis of diphosphorylated compound 4.33 involved initial desilyation of α-hydroxy 
ester 4.30 with the mild base, tert-butylammonium fluoride (TBAF) (Figure 4.36) to produce 
the requisite diol 4.31.158  The reaction was followed by the depletion of silyl ether 4.30, 
detected by TLC analysis, and the organic solvents were removed under vacuum once the 
reaction was complete.  After purification by flash chromatography the diol 4.31 was isolated 
in 83 % yield.  1H NMR analysis confirmed the loss of the silyl ether, showing the 
disappearance of the silane tert-butyl and methyl resonances and a two proton resonance at 
2.42 ppm for the two hydroxyl protons. 
HO CO2iPr
OH
TBDMSO CO2iPr
OH
TBAF, THF
(83 %)
4.30 4.31  
Figure 4.36: Silane deprotection of 4.30. 
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The diol 4.31 was then phosphorylated in a two-step procedure (Figure 4.37).  N,N-
Diisopropyl-dibenzyl phosphoramidite, and 1H-tetrazole as a proton donor, were used to 
synthesise the bisphosphite.159  The reaction was followed to completion by consumption of 
the starting material 4.31, by TLC analysis.  This bisphosphite was then oxidised to 
bisphosphate 4.32 with meta-chloroperbenzoic acid (Figure 4.38). 159-161  After aqueous 
workup and flash chromatography the bisphosphate 4.32 was isolated in 65 % yield.  
Structural characterisation by 1H NMR analysis showed aromatic proton resonances from 
7.29-7.37 ppm, and 31P NMR analysis showed two phosphate resonances not previously seen 
at -0.38 (sext., J = 7.8 Hz) and -1.24 (sept., J = 7.3 Hz) for the secondary and primary 
phosphates respectively.  These coupling constants corresponded to the α-hydroxy ester 
methine and C6 methylene proton couplings, J = 7.8 and 7.3 Hz respectively.  This result was 
confirmed by HRMS detection of a compound with molecular mass 593.3063 (calculated 
mass for protonated bisphosphate 4.32: 593.3061). 
HO CO2iPr
OH
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(iPr)2NP(OBn)2,
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Figure 4.37: Diphosphorylation of diol 4.31. 
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Figure 4.38: Phosphorylation mechanism using N,N-diisopropyl-dibenzyl phosphoramidite.159 
Hydrogenation, with 10 % palladium over carbon, cleaved the benzyl groups from the 
phosphate moieties.  After the dibenzyl phosphate 4.32 was no longer detectable by TLC 
analysis the reaction mixture was passed through celite and the organic solvents evaporated.  
Analysis by 1H NMR spectroscopy confirmed the loss of both benzyl groups, as 
demonstrated by lack of aromatic proton resonances at 7-8 ppm.  This was followed by 
treatment of the residue with aqueous potassium hydroxide which removed the carboxy 
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isopropyl ester protecting group (Figure 4.39).  This ester hydrolysis was followed by 1H 
NMR spectral analysis, following the shift of the isopropyl protecting group methyl proton 
resonances, seen as a doublet at 1.31 ppm following hydrogenolysis of the benzyl esters, and 
a doublet at 1.50 ppm following ester hydrolysis.  This latter value matched the literature 
value for the isopropyl alcohol methyl proton resonances, in deuterated methanol.165   
The resulting mixture of products was purified by anion exchange chromatography on 
SourceQ resin, eluted with aqueous ammonium bicarbonate with the bisphosphate 4.33 
eluting at 130-170 mM ammonium bicarbonate.  Detection of the desired compound 4.33 was 
achieved by utilising the Lanzetta assay, a colourimetric assay for inorganic phosphate.166  
The assay conditions, being highly acidic, cleave organic phosphates present to inorganic 
phosphate, allowing detection of the product.  After lyophilisation of the fractions containing 
bisphosphate 4.33, the desired compound was isolated in 2 % yield from the bisphosphate 
4.32 (Figure 4.39).  31P NMR spectroscopic analysis revealed two distinct resonances at 1.1 
ppm (d, J = 8.7 Hz) and 2.5 (t, J = 6.7 Hz).  The coupling constants matched those found for 
the methine and C6 methylene peak respectively, determined by 1H NMR characterization.  
Additionally the composition of the compound was confirmed by HRMS detection of the 
mono deprotonated bisphosphate 4.33 with a molecular mass of 335.0310 (calculated mass: 
335.0297).  The yield for this final deprotection is very low, but the reaction provided 
sufficient material for the inhibitory studies presented in this thesis.  Additional fractions 
were isolated that contained the desired compound 4.33, but also contained impurities and so 
were discarded. 
(-O)2OPO CO2
-
OPO(O-)2
1. H2, Pd/C, EtOAc
2. KOH/H2O; Dowex-H+
3. AEC
(BnO)2OPO CO2iPr
OPO(OBn)2
(2 %)
4.32 4.33  
Figure 4.39: Deprotecton of precursor 4.32 to target 4.33. 
To synthesise the secondary monophosphorylated extended phospholactate 4.36, the α-
hydroxy ester 4.30 was phosphorylated via the procedure as described for the synthesis of 
4.33.160  This monophosphorylated ester was characterised by a 1H NMR spectroscopic 
analysis showing the aromatic proton resonances at 7-8 ppm, and 31P NMR showing a sextet 
phosphorous resonance at -1.39 ppm, coupled to the main chain methine and benzyl 
methylene protons, with a coupling constant of 7.6 Hz.  This was followed by deprotection of 
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the silyl ether with TBAF158 (Figure 4.40) as previously described, to give the alcohol 4.35, 
as judged by 1H NMR spectroscopic analysis, the disappearance of the two singlets 
representative of the methyl protons of the TBDMS protecting group, and the appearance of 
the broad singlet at 2.13 ppm, representative of the deprotected C6 hydroxyl group.   The 
composition of alcohol 4.35 was confirmed by HRMS detection of a compound with 
molecular mass of 479.2191, corresponding to the protonated molecule, of calculated mass 
479.2199. 
TBDMSO CO2iPr
OPO(OBn)2
TBDMSO CO2iPr
OH
(80 %)
1. 1H-tetrazole,
(iPr)2NP(OBn)2,
CH2Cl2, RT
2. m-CPBA, 0 oC
HO CO2iPr
OPO(OBn)2
TBAF, THF (56 %)
4.30 4.34
4.35  
Figure 4.40: Phosphorylation and silyl deprotection of α-hydroxy ester 4.30. 
The monophosphorylated ester 4.35 was then deprotected, as described for the synthesis of 
inhibitor 4.33 with hydrogenolysis of the benzyl esters,162,167 as judged by 1H NMR spectra 
showing a lack of aromatic proton peaks at 7-8 ppm.  This was followed by isopropyl ester 
hydrolysis with aqueous potassium hydroxide.  The hydrolysis of the isopropyl ester was 
followed by 1H NMR spectral analysis as previously described, by the shift of the isopropyl 
protecting group methyl proton resonances from a doublet at 1.31 ppm to a doublet at 1.50 
ppm, matching the literature value of the isopropyl alcohol methyl proton resonances in 
deuterated methanol.165 
HO CO2-
OPO(O-)2
1. H2, Pd/C, EtOAc
2. KOH/H2O; Dowex-H+
HO CO2iPr
OPO(OBn)2
(41 %)
4.35 4.36  
Figure 4.41: Final deprotection of phosphorylated ester 4.35. 
Purification of monophosphate 4.36 by anion exchange chromatography with an ammonium 
bicarbonate gradient as per inhibitor 4.33 resulted in streaking of the compound across 
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multiple fractions, as detected by Lanzetta assay and 1H NMR spectroscopy.  It was not 
possible to isolate pure samples of monophosphate 4.36 during three separate anionic 
exchange chromatography purifications.  Instead of purification by anion exchange 
chromatography the non-polar compounds were extracted with chloroform and the organic 
phase discarded, before the aqueous phase was passed down a DOWEX-H+ column.  The 
aqueous DOWEX-H+ fractions were freeze dried and analysed by 1H NMR spectroscopy and 
shown to be pure.  Quantification by Lanzetta assay166 showed that the monophosphorylated 
compound 4.36 was synthesised from benzylphosphate ester 4.35 in 41 % yield.  The 
deprotected monophosphate 4.36 was characterised by 31P NMR spectroscopic analysis 
showing a doublet resonance at 2.5 with a coupling constant, J = 5.5 Hz, corresponding to 
that for the methine resonance found in the 1H NMR spectra.  This structure was confirmed 
by HRMS detection of the mono deprotonated compound with a molecular mass of 255.0645 
(calculated mass: 255.0634). 
For the synthesis of the C6 primary monophosphorylated compound 4.40, the secondary 
hydroxyl of α-hydroxy ester 4.30 was protected as a benzyl ether so that the C6 hydroxyl 
moiety could be selectively phosphorylated.  Initially the benzylation was performed on a 
small 100 mg scale utilising a combination of benzyl bromide, sodium hydride and a catalytic 
amount of potassium iodide, at reflux.168,169  No product was seen however and the starting 
material remained after two days at reflux, detectable by TLC analysis.  After aqueous 
workup less than 50 mg of crude material was isolated and this mixture was not subjected to 
any further purification.  When a modified procedure using benzyl bromide, catalytic 
potassium iodide and freshly prepared silver(I) oxide in dichloromethane,170 benzylated 
compound 4.37 was isolated in 66 % yield.  The product was characterised by 1H NMR 
spectroscopic analysis showing the disappearance of the broad singlet from the hydroxyl 
group proton and the appearance of peaks indicative of benzyl group methylene proton 
resonances at 4.70 and 4.40 ppm, and aromatic proton resonances at 7.25-7.40 ppm. 
TBDMSO CO2iPr
OH
Ag2O, KI, BnBr, RT
solvent
TBDMSO CO2iPr
OBn
CH2Cl2 (66 %)
DMF (51 %)
4.30 4.37
 
Figure 4.42: Benzylation of α-hydroxy ester 4.30. 
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The silyl ether 4.37 was treated with TBAF in order to free the primary hydroxyl moiety for 
phosphorylation, which was performed under similar conditions to that previously discussed 
in the synthesis of both bisphosphate 4.33 and monophosphate 4.36.160  The alcohol 4.38 was 
characterised by 1H NMR spectroscopic analysis showing the disappearance of the methyl 
and tert-butyl proton resonances of the silyl protecting group, and a broad singlet at 2.01 
ppm, indicative of the free hydroxyl moiety.  The presence of the monophosphate 4.39 was 
confirmed by HRMS detection of the sodiated compound 4.39 with a molecular mass of 
591.2484 (calculated mass: 591.2482).  1H NMR spectroscopic analysis showed the aromatic 
proton integral increased to fifteen, and 31P NMR revealed a previously unseen septet peak at 
-0.8 ppm, coupled to the C6 methylene protons with a coupling constant of 7.0 Hz.  A second 
compound was detected by 31P NMR at 7.8 ppm (dp, J = 707.4, 9.5 Hz) and identified as the 
phosphonate molecule, a breakdown product of N,N-diisopropyl-dibenzyl phosphoramidite.  
It could not be removed from monophosphate 4.39 by flash chromatography and the mixture 
was used directly in the next step. 
(BnO)2OPO CO2iPr
OBn
(84 %)
1. 1H-tetrazole,
(iPr)2NP(OBn)2,
CH2Cl2, RT
2. m-CPBA, 0 oC
TBDMSO CO2iPr
OBn
HO CO2iPr
OBnTBAF, THF
(83 %)
4.37 4.38
4.39  
Figure 4.43: Silyl deprotection and monophosphorylation of the ester 4.40. 
The phosphorylated ester 4.39 was then deprotected by hydrogenolysis of the benzyl groups 
protecting the secondary hydroxyl group, and the phosphate hydroxyl groups, 162,167  The 
reaction was followed as previously described by 1H NMR spectroscopic analysis showing 
the removal of the benzyl ethers by the lack of aromatic proton resonances at 7-8 ppm.  This 
was followed by ester hydrolysis in aqueous potassium hydroxide, the reaction followed by 
1H NMR spectroscopic analysis of the solution showing the shift of the isopropyl methyl  
proton resonance from a doublet at 1.26 ppm to a doublet at 1.17 ppm, matching the literature 
value for the isopropyl alcohol methine proton in deuterium.165  The crude extracts were 
purified by anion exchange chromatography as described for the purification of inhibitor 4.33 
where the compound of interest, 4.40, eluted at 80-95 mM ammonium bicarbonate.  After 
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lyophilisation of these fractions, monophosphate 4.40 was obtained as a white powder in 12 
% yield (Figure 4.44).  The deprotected monophosphate 4.40 was characterised by HRMS 
detection of the mono deprotonated compound with a molecular mass of 255.0642 
(calculated: 255.0634).  Additionally 31P NMR spectroscopy revealed a triplet peak with 
coupling constant J = 5.0 Hz, corresponding to that found for the H6 methylene proton 
resonance by 1H NMR spectroscopy. 
1. H2, Pd/C, EtOAc
2. KOH/H2O; Dowex-H+
3. AEC
(12 %)(BnO)2OPO CO2iPr
OBn
(-O)2OPO CO2-
OH
4.39 4.40  
Figure 4.44: Deprotection of monophosphorylated ester 4.42. 
4.3.3. Inhibition of KDO8P synthase by extended phospholactates 4.33, 4.36 and 4.40 
The extended phospholactate 4.33, and its monophosphorylated analogues 4.36 and 4.40 
were tested as inhibitors of the metal independent KDO8P synthase from N. meningitidis and 
the metal dependent KDO8P synthase from A. ferrooxidans.  This was done via kinetic assay, 
following the loss of PEP at 232 nm.  The initial rate data was fitted to the Michaelis-Menten 
equation, modified for competitive inhibition, and this data displayed for inspection as a 
Lineweaver-Burke plot.  All three molecules were shown to be competitive inhibitors with 
respect to PEP.  The inhibition results are shown in the table below. 
Inhibitor Ki N. meningitidis Ki A. ferrooxidans 
O
O
P
O-O
-O CO2
-
P
O-
O
O-
4.33  
7.9 ± 1.6 µM 
(Figure 4.45) 
20 ± 3 µM 
(Figure 4.46) 
HO
O
CO2-
P
O-
O
O-
4.36  
1000 ± 180 µM 
(Figure 4.47) 
540 ± 50 µM 
(Figure 4.48) 
O
OH
P
O-O
-O CO2
-
4.40  
270 ± 40 µM 
(Figure 4.49) 
190 ± 40 µM 
(Figure 4.50) 
 
Table 4.1: Inhibition constants for extended phospholactates 4.33, 4.36 and 4.40 against KDO8P synthase 
from N. meningitidis and A. ferrooxidans. 
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Figure 4.45: Inhibition of KDO8P synthase from N. meningitidis by diphosphorylated extended 
phospholactate 4.33 as Michaelis (top) and Lineweaver-Burke (bottom) plots.  Solutions of PEP (12-35 
µM), A5P (50 µM), and extended phospholactate 4.33 (0-25.6 µM) in 1 mL BTP buffer (50 mM, pH 7.2) 
were initiated by addition of N. meningitidis KDO8P synthase (2 µg) and the loss of PEP followed 
spectrophotometrically at 232 nm.  Initial rates were obtained by linear least squares regression and 
converted to progress rates (µM s-1). 
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Figure 4.46: Inhibition of KDO8P synthase from A. ferrooxidans by diphosphorylated extended 
phospholactate 4.33  as Michaelis (top) and Lineweaver-Burke (bottom) plots.  Solutions of PEP (6-35 
µM), A5P (100 µM), manganese chloride (10 µM) and extended phospholactate 4.33 (0-25.6 µM) in 1 mL 
BTP buffer (50 mM, pH 7.2) were initiated by addition of A. ferrooxidans KDO8P synthase (2 µg) and the 
loss of PEP followed spectrophotometrically at 232 nm.  Initial rates were obtained by linear least squares 
regression and converted to progress rates (µM s-1). 
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Figure 4.47: Inhibition of KDO8P synthase from N. meningitidis by monophosphorylated extended 
phospholactate 4.36 as Michaelis (top) and Lineweaver-Burke (bottom) plots.  Solutions of PEP (5-15 
µM), A5P (50 µM), and extended phospholactate 4.36 (0-1670 µM) in 1 mL BTP buffer (50 mM, pH 7.2) 
were initiated by addition of N. meningitidis KDO8P synthase (2 µg) and the loss of PEP followed 
spectrophotometrically at 232 nm.  Initial rates were obtained by linear least squares regression and 
subsequently converted to progress rates. 
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Figure 4.48: Inhibition of KDO8P synthase from A. ferrooxidans by monophosphorylated extended 
phospholactate 4.36  as Michaelis (top) and Lineweaver-Burke (bottom) plots.  Solutions of PEP (5-15 
µM), A5P (100 µM), manganese chloride (10 µM) and extended phospholactate 4.36 (0-1670 µM) in 1 mL 
BTP buffer (50 mM, pH 7.2) were initiated by addition of A. ferrooxidans KDO8P synthase (2 µg) and the 
loss of PEP followed spectrophotometrically at 232 nm.  Initial rates were obtained by linear least squares 
regression and subsequently converted to progress rates. 
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Figure 4.49: Inhibition of KDO8P synthase from N. meningitidis by monophosphorylated extended 
phospholactate 4.40 as Michaelis (top) and Lineweaver-Burke (bottom) plots.  Solutions of PEP (5-20 
µM), A5P (50 µM), and extended phospholactate 4.40 (0-679 µM) in 1 mL BTP buffer (50 mM, pH 7.2) 
were initiated by addition of N. meningitidis KDO8P synthase (2 µg) and the loss of PEP followed 
spectrophotometrically at 232 nm.  Initial rates were obtained by linear least squares regression and 
converted to progress rates (µM s-1). 
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Figure 4.50: Inhibition of KDO8P synthase from A. ferrooxidans by monophosphorylated extended 
phospholactate 4.40 as Michaelis (top) and Lineweaver-Burke (bottom) plots.  Solutions of PEP (3-15 
µM), A5P (100 µM), manganese chloride (10 µM) and extended phospholactate 4.40 (0-970 µM) in 1 mL 
BTP buffer (50 mM, pH 7.2) were initiated by addition of A. ferrooxidans KDO8P synthase (2 µg) and the 
loss of PEP followed spectrophotometrically at 232 nm.  Initial rates were obtained by linear least squares 
regression and converted to progress rates (µM s-1) 
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4.4. Discussion and summary 
The research described in Chapter 4 was the synthesis of extended inhibitors containing 
features of the second KDO8P synthase substrate, A5P, from the PEP analogues tested as 
inhibitors in Chapter 3, in order to gain information for use in the design of future inhibitors.  
The synthesis of extended phospholactate 4.1 and aminophosphonate 4.19 were unsuccessful.  
The synthesis of extended phospholactate 4.33, and monophosphorylated analogues 4.36 and 
4.40, were successful however, and these three compounds were tested as inhibitors of 
KDO8P synthase from N. meningitidis and A. ferrooxidans. 
The extended phospholactate 4.33 had vastly improved inhibition over (2R)- and (2S)-
phospholactate (3.5 and 3.6 respectively) with a Ki of 7.9 ± 1.6 µM against NmeKDO8PS and 
20 ± 3 µM against AfeKDO8PS, improvements of 20-100 fold over the single site 
phospholactate inhibitors and only three fold higher than the KmPEP for each enzyme, reported 
in Chapter 2 (Figure 4.51).  Extended phospholactate 4.33 can be reported as one of the most 
potent inhibitors of KDO8P synthase known. 
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Figure 4.51: Inhibitory properties of extended phospholactate 4.33 compared with PEP for KDO8P 
synthase from N. meningitidis and A. ferrooxidans. 
The two monophosphorylated analogues of extended phospholactate 4.33, 4.36 and 4.40, had 
Ki values that were much higher than this, indicating far poorer binding to the enzyme active 
site.  For the inhibitor 4.36 that lacked the primary phosphate moiety, the Ki values increased 
to 1000 ± 180 µM against NmeKDO8PS and 540 ± 50 µM for AfeKDO8PS (Figure 4.52).  
This two fold difference between the two enzymes can be explained by the significant 
difference between the metal-dependent and metal-independent KDO8P synthase for the 
(2R)-phospholactate, 3.6.  The extended phospholactates are all a 1:1 enantiomeric ratio 
between the (R) and (S) isomers and so increased binding of the (R) isomer could decrease 
the apparent inhibition constant for the metal-dependent KDO8P synthase from A. 
ferrooxidans down by two-fold.  The Ki values for inhibitor 4.40, lacking the secondary 
phosphate group, were similar for both enzymes at 270 ± 40 µM for the metal-independent 
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KDO8P synthase from N. meningitidis and 190 ± 40 µM for the metal-dependent KDO8P 
synthase from A. ferrooxidans (Figure 4.52).  They were however decreased from inhibitor 
4.36, lacking the primary rather than secondary phosphate moiety.  This is perhaps due to the 
ability of the inhibitor to bind at both ends of the KDO8P synthase binding pocket, and this 
greater stability should have an increased entropic effect, leading to increased affinity for the 
enzyme.  The consequences of the inhibitor 4.40 containing an enzyme binding motif at 
either end of the pentamethyl chain, rather than both binding motifs contained in the PEP-like 
region in inhibitor 4.36 will be discussed further in Chapter 5 in regards to modelling studies 
with the three extended phospholactate inhibitors. 
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Figure 4.52: Inhibitory properties of monophosphorylated inhibitors 4.36 and 4.40 compared with PEP 
for KDO8P synthase from N. meningitidis and A. ferrooxidans. 
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The inhibition results of Chapters 3 and 4 could now be interpreted together in order to gain a 
greater understanding of the inhibition of KDO8P synthases from the metal-independent (N. 
meningitidis) and metal-dependent (A. ferrooxidans) class of enzyme.  
A number of molecules were tested as potential inhibitors of the metal independent KDO8P 
synthase from N. meningitidis and the metal dependent KDO8P synthase from A. 
ferrooxidans (Figure 5.1).  They were initially selected as mimics of either the oxocarbenium 
ion species (glyphosate, 1.6, and vinyl phosphonates 3.3 and 3.4) or the tetrahedral 
intermediate (phospholactates 3.5 and 3.6, extended phospholactate 4.33 and 
monophosphorylated analogues 4.36 and 4.40). 
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Figure 5.1: Molecules tested as potential inhibitors of KDO8P synthase from N. meningitidis and A. 
ferrooxidans, as mimics of the oxocarbenium ion species or tetrahedral intermediate of the KDO8P 
synthase reaction mechanism. 
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All of the molecules tested proved to be competitive inhibitors of KDO8P synthase, with 
respect to PEP, from N. meningitidis and A. ferrooxidans.  This chapter will focus on 
interpretation of these results, as well as the direction this research can now take in order to 
both complete and advance the studies contained in this thesis. 
5.1. Oxocarbenium ion mimics as inhibitors 
Glyphosate, 1.6, was selected as an oxocarbenium ion mimic with a positively charged amine 
group, representative of the carbocation at the C2 trigonal centre arising from PEP. It was 
found to be a moderate inhibitor of KDO8P synthases from both N. meningitidis and A. 
ferrooxidans with Ki values of 260 ± 40 µM and 330 ± 40 µM respectively.  (E)-Vinyl 
phosphonate 3.5 was selected as a geometric mimic of the oxocarbenium ion, containing the 
observed geometry of PEP as seen in a number of crystal structures of PEP bound KDO8P 
synthase.31,34,105 It inhibited KDO8P synthases from N. meningitidis and A. ferrooxidans 
similarly, giving Ki values of 320 ± 30 and 260 ± 10 µM for the two enzymes respectively.  
Fluorinated vinyl phosphonate 3.6 also had similar Ki values to the non-fluorinated 
counterpart 3.5, and glyphosate, 1.6, of 270 ± 30 and 280 ± 20 µM for KDO8P synthase from 
N. meningitidis and A. ferrooxidans respectively. 
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Figure 5.2: Inhibitors as oxocarbenium ion mimics tested against KDO8P synthase, compared with PEP. 
The three oxocarbenium mimics used as inhibitors differ structurally, but were found to have 
remarkably similar Ki values.  Although all three inhibitors contain both carboxyl and 
phosphonate motifs for binding, the linker portion between these two binding motifs is very 
different between glyphosate, 1.6, and the vinyl phosphonates.  Glyphosate, 1.6, has far more 
flexibility within the molecule than the vinyl phosphonates, and this molecule also has an 
additional methylene group between the carboxyl group and nitrogen atom.     
The (E)-isomer of the two vinyl phosphonates were selected due to their similarity with the 
bound PEP conformation shown in a number of crystal structures.31,34,105  It was proposed 
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that the vinyl phosphonates with the (E) configuration may bind more strongly than a more 
flexible inhibitor compound due to entropic effects.  Docking studies with the related aldolase 
DAH7P synthase have indicated that vinyl phosphonate 3.3 does have a similar mode of 
binding to PEP.86  It is likely that vinyl phosphonate 3.3 would bind similarly to KDO8P 
synthase.  Glyphosate, 1.6, has not been computationally docked in either the related aldolase 
DAH7P synthase’s or KDO8P synthase’s active site.  However, the aminophosphonate 1.4 
has been crystallised with AaeKDO8PS.30  If we assume that glyphosate, 1.6, binds similarly 
to aminophosphonate 1.4, and (E)-vinyl phosphonate 3.3 binds similarly to PEP, we can 
compare the two modes of binding in the crystal structures of KDO8P synthase from A. 
aeolicus (Figure 5.3). 
 
Figure 5.3: Comparison of PEP and aminophosphonate 1.4 binding in the active site of KDO8P synthase 
from A. aeolicus (drawn from 1FWW34 (PEP) and 1JCX30 (aminophosphonate 1.4)).  For crystal 
structure 1FWW, PEP is coloured magenta, associated residues in green, potential bonds in green and 
bond distances in blue.  For crystal structure 1JCX, aminophosphonate 1.4 is coloured yellow, associated 
residues in cyan, potential bonds in black and bond distances in black.  Cadmium ion is shown in gold.  
All residues within 4 Å of PEP or the PEP portion of aminophosphonate 1.4 are shown, and bond 
distances are reported in angstroms.  Some bond distances that are not significantly different between the 
two structures have been removed for clarity.   
The nitrogen atom of aminophosphonate 1.4 binds in a similar position to the C2 atom of 
PEP, which it corresponds to.  This causes the carboxyl group of aminophosphonate 1.4 to 
probe further into the active site of KDO8P synthase than that of PEP, due to an additional 
methylene group between the amine and carboxyl moieties.  The change in binding that 
results from this alters a number of interactions with surrounding residues such as H185, 
however new interactions with the metal ion (cadmium) are seen.  The phosphate moiety of 
both PEP and aminophosphonate 1.4 bind in the same location, emphasising the importance 
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of this region for inhibitor positioning.  Overall a similar number of active site contacts are 
formed for both PEP and the PEP-like portion of aminophosphonate 1.4.  The similar, 
moderate (50-100 times KmPEP) Ki values for the three inhibitors may be a result of this 
similar number of active site contacts, and not the ability of either molecule to mimic PEP or 
KDO8P synthase reaction intermediates. 
The Ki values of the inhibitors against both classes of KDO8P synthase tested were very 
similar too, even though, as determined in the studies presented in Chapter 2, the KmPEP value 
for the metal dependent KDO8P synthase from A. ferrooxidans is more than twice that for the 
metal-independent KDO8P synthase from N. meningitidis.  This may be a result of the 
inhibitor molecules interacting more strongly with the metal ion found in metal-dependent 
KDO8P synthases than the asparagine residue found in the metal-independent enzyme, as 
shown in Figure 5.3, where the carboxyl moiety of aminophosphonate 1.4 interacts with the 
cadmium ion in the KDO8P synthase crystal structure.  
The final result from the testing of the oxocarbenium ion mimic inhibitors, was the 
comparison between the two vinyl phosphonates, 3.3 and 3.4.  It has been proposed that the 
phosphate of PEP bound in the KDO8P active site is monoanionic,30 and so monoanionic 
inhibitors may bind with greater affinity than the dianionic equivalent.  Although 
phosphonates have higher pKa² values than their phosphate analogues (Section 3.3), previous 
investigations had shown that fluorine atoms adjacent to the phosphorous atom can decrease 
these values, through electron withdrawing effects on the phosphorous atom.106  The 
fluorinated analogue 3.4 was originally designed in order to decrease the pKa² value for the 
phosphonate moiety.  These effects are reported for adjacent fluorine atoms, and although not 
reported for vinylogous fluorine atoms, it was assumed that some of the same effect would be 
seen.  This effect was not seen however, and vinyl phosphonate 3.3 and the fluorinated 
analogue 3.4 gave similar Ki values for both KDO8P synthases investigated here.  These 
results indicate that inhibitors that bind with the phosphate or phosphonate moiety in the 
monoanionic state may not have greater binding affinities than the dianionic equivalent.  
There are two possible reasons for this, depending on whether the inhibitors are binding as 
PEP mimics, or mimics of the high energy intermediate or transition state.  If the inhibitors 
bind as transition state mimics, this could be a result of the oxocarbenium ion binding with 
phosphate in the dianionic state, which is predicted to bind with greater affinity than the 
product or substrates of the KDO8P synthase reaction due to Transition State Theory,98-100 as 
discussed in Chapter 3.  If they bind as PEP mimics, recent computational studies have 
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suggested that PEP itself may bind as the dianion, and be involved in deprotonation of the 
water on the si face of PEP before attack of the hydroxide ion on the C2 of PEP as per the 
KDO8P synthase mechanism.171 
5.2. Tetrahedral intermediate mimics as inhibitors 
The (2R)- (3.5) and (2S)-phospholactate (3.6) molecules (Figure 5.4) were selected as mimics 
of the tetrahedral intermediate (Figure 5.1) to be used as inhibitors of these KDO8P synthases 
from N. meningitidis and A. ferrooxidans.  They were found to be moderate to poor inhibitors 
of both enzymes.  The addition of A5P phosphate functionality in bisphosphate 4.33 
increased the inhibition dramatically giving Ki values of 7.9 ± 1.6 and 20 ± 3 µM for KDO8P 
synthase from N. meningitidis and A. ferrooxidans respectively.  These values are 
approximately three-fold higher than the KmPEP value for both enzymes (Figure 5.4).  The 
absence of either the secondary PEP-like phosphate, or the terminal A5P-like phosphate 
reduced inhibition significantly, returning Ki values similar to those found for the PEP 
analogues of Chapter 3 (Figure 5.4). 
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Figure 5.4: Phospholactate inhibitors as tetrahedral intermediate mimics (3.5, 3.6 and 4.33) and 
monophosphorylated  inhibitors (4.36 and 4.40) as part of a structure-activity-relationship (SAR) study 
on bisphosphate inhibitor 4.33. 
The dramatic increase in inhibition from the two phospholactate isomers to bisphosphate 4.33 
is presumed to be due entirely to the increase in the number of polar contacts the inhibitor 
forms with the KDO8P synthase active site. Induced fit docking studies of both enantiomers 
of bisphosphate 4.33 helps to visualise this.  The crystal structure of AfeKDO8PS is not 
available, and the NmeKDO8PS structure available is missing key residues as the structure 
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does not contain bound substrates, and so the L7 loop is disordered30,34 as discussed in 
Chapter 1.  Instead both enantiomers of extended phospholactate 4.33 were docked into 
crystal structure 1FWW of the KDO8P synthase from A. aeolicus,34 and energy minimised 
using an induced fit method, by Wanting Jiao (Figure 5.5).  The AaeKDO8PS enzyme shows 
sequence similarity with both enzymes (44 % for NmeKDO8PS and 51 % for AfeKDO8PS, 
calculated using ClustalW2) and so is appropriate as a model. 
The resulting model shows that the (R)- and (S)-isomer of extended phospholactate 4.33 have 
similar IDF scores (a measure of the interactions of the docked molecule with the enzyme 
active site) (Figure 5.5) with the (R)-isomer being calculated as having slightly tighter 
binding, as indicated by the lower induced fit (IDF) score.  The number, and nature of the 
active site contacts by both enantiomers of inhibitor 4.33 are very similar, except for the 
carboxyl moiety.  The (S)-isomer binds as per PEP with the carboxyl moiety forming contacts 
with three lysine residues (K41, K46, K124) and R154 with a possible weak metal ion 
interaction.  The (R)-isomer in comparison forms a strong interaction with the metal ion, with 
a loss of amino acid interactions with K41, K124 and R154, with a new interaction with N48 
formed.  Even though this difference in binding of the carboxyl moiety has caused the 
terminal phosphate moiety of the (R)-isomer of inhibitor 4.33 to protrude further from the 
active site, the number of contacts formed between the terminal phosphate moiety and active 
site is similar for the two enantiomers.   
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Figure 5.5: Comparison of the calculated positions of the (R)- (yellow) and (S)- (magenta) isomers of 
bisubstrate inhibitor 4.33 with bonding contacts (top), in stereo (middle) and scores for inhibitor docking 
studies (bottom).  Metal ions (Mn2+) are coloured as per inhibitor molecules.  Bonding residues, within 4 
Å of the phosphate or carboxyl moieties, are shown.  Residues are labelled, and coloured green 
(calculated positions for (R) isomer) and cyan (calculated positions for (S) isomer).  Polar contacts, within 
4 Å of the phosphate or carboxyl moieties are coloured as per active site residues. 
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The enantioselectivity of the related aldolase DAH7P synthase for the phospholactates and 
extended phospholactates has been investigated crystallographically with the enzyme from 
M. tuberculosis.114  This revealed that the selectivity of the (R)-isomer of the extended 
phospholactate (Ki = 360 ± 40 nM) over the (S)-isomer (Ki = 630 ± 110 nM) may be due to 
the ability for each to accommodate the water molecule responsible for attack of the C2 atom 
of PEP.  In the case of the crystal structure of DAH7P synthase from M. tuberculosis the (R)-
isomer is able to accommodate the water molecule on the re face of PEP where as the (S)-
isomer cannot.  The re face water is considered to be the most viable candidate for the attack 
on PEP for DAH7P synthase.  An overlay of the docked bisphosphate 4.33 with the original 
1FWW crystal structure34 reveals similar attributes for KDO8P synthase (Figure 5.6).  As 
shown, the (R)-isomer of inhibitor 4.33 does not allow for binding of the si face water 
molecule due to steric clashes with the carboxyl moiety which also is shown to bind the metal 
ion (Figure 5.5).  The docking studies suggest that the enantioselectively is not reliant on the 
ability to accommodate the si face water molecule.  The PEP-like phosphate moiety of both 
enantiomers is close to the re side water, and may form polar contacts.  However, these 
contact distances are slightly longer for the (R)-isomer (3.22 Å, 3.53 Å) than the (S)-isomer 
(2.22 Å), perhaps causing less steric clash and resulting in better accommodation of this 
water molecule. 
 
Figure 5.6: Overlay of the original 1FWW crystal structure34 with PEP (green) and re and si face water 
molecules (blue) with that calculated from 1FWW for induced fit docking of (R)- (pink) and (S)-isomers 
(yellow) of inhibitor 4.33.  Bond distances are coloured as per inhibitor enantiomer and distances are in 
angstroms. 
The two monophosphate inhibitors, lacking either of the two phosphate moieties of inhibitor 
4.33 had reduced inhibition compared to the bisphosphate inhibitor.  Monophosphorylated 
inhibitor 4.36, lacking the A5P phosphate functionality, had much less potent inhibition 
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against KDO8P synthase from N. meningitidis and A. ferrooxidans with Ki values of 1000 ± 
80 µM and 540 ± 50 µM respectively.  These Ki values can be rationalised as being close to 
the average of the Ki values for the two enantiomers of phospholactate (3.5 and 3.6), being 
1040 µM against NmeKDO8PS and 700 µM against AfeKDO8PS.  This is likely due to the 
loss of active site contacts with the terminal (A5P-like) end of the inhibitor.  When this 
molecule is docked into the AaeKDO8PS crystal structure 1FWW34 by Wanting Jiao as per 
bisphosphate 4.33, this becomes more clear.  The two enantiomers bind similarly, with the 
carboxyl moieties bound to the metal ion as per the (R)-isomer of inhibitor 4.33 rather than 
the PEP carboxyl binding pocket.  This presumably indicates the increased flexibility of the 
inhibitor without the terminal phosphate interactions with the enzyme.  The two phosphate 
moieties also bind similarly, in the PEP phosphate binding pocket and form a similar number 
of active site contacts, indicating the importance of this region for inhibitor placement.  The 
hydroxyl moieties of both the respective inhibitor enantiomers are hydrogen bonded to a 
conserved arginine and serine (R49 and S50), part of the conserved KANRS(T) sequence in 
KDO8P synthase enzymes.  This is the only interaction observed at this end of the inhibitor 
molecule with the enzyme active site, and a substantial decrease in contacts with the active 
site.  This reinforces the hypothesis that the Ki values found for the monophosphorylated 
inhibitor 4.36 were similar to that found for the phospholactates 3.5 and 3.6 due to the small 
number, and relative weakness, of the contacts at the “A5P” terminal end of the inhibitor.   
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Figure 5.7: Comparison of the calculated positions of the (R)- (green) and (S)- (cyan) isomers of 
bisubstrate inhibitor 4.33 with bonding contacts (top), in stereo (middle) and scores for inhibitor docking 
studies (bottom).  Metal ions (Mn2+) are coloured as per inhibitor molecules.  Bonding residues, within 4 
Å of the phosphate or carboxyl moieties, are shown.  Residues are labelled, and coloured magenta 
(calculated positions for (R) isomer) and yellow (calculated positions for (S) isomer).   Polar contacts, 
within 4 Å of the phosphate, carboxyl or terminal hydroxyl moieties are coloured as per active site 
residues. 
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The monophosphate 4.40, missing the PEP phosphate functionality, gave better inhibition 
than monophosphate 4.36.  This is maybe due to increased rigidity of the KDO8P synthase 
active site due to bonding in both the PEP and A5P binding pockets.  Both isomers of 
inhibitor 4.40 were docked into the active site of AaeKDO8PS from the 1FWW structure34 by 
Wanting Jiao (Figure 5.8).  Interestingly the A5P-like phosphate moiety bound in the PEP 
binding pocket, so that the inhibitor was “flipped” from what is seen for inhibitors 4.33 and 
4.36, so that the terminal phosphate, representative of A5P, bound in the PEP phosphate 
binding site.  This adds weight to the hypothesis that the PEP phosphate binding site is 
responsible for positioning of the inhibitors.  Compared with the docked structure of inhibitor 
4.36, some of the active site contacts in the PEP binding pocket have been lost, such as those 
with residues R106 (still shown in Figure 5.8, but do not form contacts with the inhibitor) and 
K41.  However, many of the contacts in the A5P phosphate binding site have been restored, 
forming contacts with the carboxyl moiety of inhibitor 4.40. 
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Figure 5.8: Comparison of the calculated positions of the (R)- (purple) and (S)- (dark blue) isomers of 
bisubstrate inhibitor 4.40 with bonding contacts (top), in stereo (middle) and scores for inhibitor docking 
studies (bottom).  Metal ions (Mn2+) ions are coloured as per inhibitor molecules.  Bonding residues, 
within 4 Å of the phosphate or carboxyl moieties, are shown.  Residues are labelled, and coloured pink 
(calculated positions for (R) isomer) and grey (calculated positions for (S) isomer).   Polar contacts, within 
4 Å of the phosphate, carboxyl or terminal hydroxyl moieties are coloured as per active site residues. 
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5.3. Conclusions on the inhibition of KDO8P synthase 
The five PEP analogues selected as mimics of two reaction intermediates were all shown to 
be poor inhibitors of KDO8P synthase, competitive with respect to PEP, with Ki values 
ranging from 260 to 1200 µM.  Those molecules chosen as mimics of the oxocarbenium ion 
(glyphosate, 1.6, and vinyl phosphonates 3.3 and 3.4) inhibited KDO8P synthase from both 
classes more effectively than those chosen as mimics of the tetrahedral intermediate 
(phospholactates 3.5 and 3.6).  As discussed, the inhibition of each molecule may be due to 
the number of active site contacts with the carboxyl and phosphate moieties, and not the 
ability of each molecule to mimic the KDO8P synthase reaction intermediates.  The increased 
inhibition of the oxocarbenium mimics over the phospholactates may be due to this, and not 
the tighter binding of the more unstable oxocarbenium ion over the tetrahedral intermediate, 
as per Transition State Theory.98  Additionally all PEP analogue inhibitors tested gave 
smaller Ki/KmPEP ratios (more effective inhibition) for the metal-dependent KDO8P synthase 
from A. ferrooxidans.  It is proposed that this may be a result of the inhibitors forming 
stronger contacts with the metal ion in AfeKDO8PS than the active site residues in this 
binding pocket in NmeKDO8PS.  The metal ion is thought to be involved in ordering the 
active site residues and substrates, so increased interactions with the metal ion may cause 
rigidity in the active site that reduces the rate of dissociation of the inhibitor from the KDO8P 
synthase active site. 
The docking studies of bisphosphate 4.33 with the active site of AaeKDO8P synthase reveal a 
possible source of the enantioselectivity of the enzyme, giving greater inhibition for 
phospholactate 3.5 than 3.6.  This is due to the ability of each isomer to accommodate the 
water molecule (that found on the re face of PEP) involved in the KDO8P synthase reaction.  
This is in line with that found for the related aldolase DAH7P synthase, and agrees with the 
proposal that the re face water molecule attacks the C2 of PEP by anti addition as discussed 
in Chapter 1. 
The addition of a terminal phosphate moiety in extended phospholactate 4.33 dramatically 
increased inhibition of KDO8P synthase 130-fold against the enzyme from N. meningitidis 
and 70-fold against that from A. ferrooxidans (averaging the Ki values for the two 
phospholactate isomers, 3.5 and 3.6 for each KDO8P synthase enzyme).  This effect was 
lessened when either of the two phospholactate moieties were absent, as seen for the 
inhibition results for compounds 4.36 and 4.40, with the Ki values returning to those found 
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for the small molecule PEP analogues as shown in the studies presented in Chapter 3.  These 
results confirm the initial hypothesis that extending a single-substrate mimic (PEP analogues) 
to include elements of the second substrate (A5P) can dramatically increase inhibitor binding 
to the enzyme active site, and therefore increase the inhibition of the KDO8P synthase 
enzyme. 
5.4. Future directions 
The investigations into inhibition of KDO8P synthase had revealed a number of interesting 
insights which could now be used in the proposal of future studies in order to complete and 
advance the research presented here. 
5.4.1. Extended oxocarbenium ion mimics 
The PEP analogues tested as inhibitors of KDO8P synthase in Chapter 3 that were selected as 
mimics of the oxocarbenium ion, glyphosate, 1.6, and vinyl phosphonates 3.3 and 3.4, were 
more effective inhibitors than the phospholactates, 3.5 and 3.6.  In order to determine whether 
this effect is apparent for inhibitors incorporating structural aspects of A5P, extended 
aminophosphonate 4.19 was proposed in Chapter 4.  The synthesis of aminophosphonate 4.19 
failed due to the inability to generate the secondary amine 4.19, from reductive amination of 
the aldehyde or electrophilic substitution of the bromo ether, potentially due to the electron 
withdrawing ester substituent on the amine, reducing its nucleophilicity.  An alternative to 
this, not trialled in the studies presented here, is the alkylation by electrophilic substitution of 
sulfonamides rather than amines, formed from the reaction of a primary amine (such as an 
amino acid) and 2- or 4-nitrophenylsulfonyl chloride.  This sulfonamide anion, formed from 
the reaction between the sulfonamide and cesium carbonate as a base, can then be reacted 
with a bromo ether such as compound 4.26 (Chapter 4) to yield an alkylsulfonamide which 
can be purified, or treated with phenylthiolate to cleave the nitrophenylsulfonyl protecting 
group to give the secondary amine in high yield (Figure 5.9).172 
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Figure 5.9: N-alkylation of amino acids via sulfonamide intermediate.172 
Alternatively, and perhaps more readily, the extended vinyl phosphonate, based on the vinyl 
phosphonate 3.3, could be synthesised via the same α-chloroglycidic ester utilised in the 
synthesis of extended phospholactates 4.33, 4.36 and 4.40.  The α-chloroglycidic esters are 
versatile synthetic intermediates.  As well as being reduced to the corresponding α-hydroxy 
ester, they can undergo rearrangements to the β-halo-α-keto ester, which can be reduced to 
give the α-keto ester.173  This α-keto ester can then undergo a Horner-Wadsworth-Emmons 
reaction to form the vinyl phosphonate moiety (Figure 5.10).  The advantage of this route is 
that it incorporates chemistry previously proven to be successful in this thesis.  Additionally, 
it provides a small number of synthetic steps to what can be considered a complicated motif 
(the vinyl phosphonate ester), an advantage discussed in Chapter 4 for the synthesis of the 
extended phospholactates. 
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Figure 5.10: Retrosynthetic analysis of extended vinyl phosphonate 5.2. 
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5.4.2. Extended inhibitors with A5P-like hydroxyl functionality associated stereochemistry 
The addition of an A5P-like terminal phosphate moiety was shown to increase inhibition by 
around 100-fold for the phospholactates 3.5 and 3.6.  It was originally proposed that this 
principle of including structural elements of the second substrate, A5P, to known PEP 
analogues, would include the A5P-like hydroxyl functionality associated stereochemistry as 
presented in extended phospholactate 4.1.  Additionally, an extended (E)-vinyl phosphonate 
inhibitor containing this same hydroxyl stereochemistry could be synthesised via the same 
Darzens chemistry as presented in Section 5.4.1.  Both these compounds require the 
appropriately protected aldehyde.  The synthesis of this aldehyde was unsuccessful due to the 
inability to perform a vital deprotection step in both routes investigated in Chapter 4.  In 
order to synthesise this aldehyde other protecting groups for the aldehyde moiety are 
proposed, which may offer a viable synthetic route to phospholactate 4.1 and an extended 
(E)-vinyl phosphonate. 
Oxathianes have been considered as potential replacements for the dithianes because they can 
be deprotected under mild conditions,174 and have been shown to undergo hydrolysis more 
readily than the dithianes, but are more stable than the O,O-acetals which are readily cleaved 
under acidic conditions.175  The drawbacks to the oxathiane protecting group is that their 
formation often require harsh conditions, long reaction times or expensive reagents such as 
TMSOTf.174  In the context of the synthesis of the appropriately protected aldehyde for 
synthesis of extended phospholactate 4.1 or the extended (E)-vinyl phosphonate, this 
oxathiane protection may have to be performed before the protection of the hydroxyl groups 
of D-mannose.  Acetonide protection of the hydroxyl groups may not be as straight forward 
as it was for the dithiane 4.12, and an extensive study into the acetonides formed under 
various protection conditions would have to be undertaken in order to synthesise the 
appropriately protected compound.   
Recently 5-methoxysalicylic alcohol, 5.1, has been proposed as a photo labile O,O-acetal 
protecting group that shows stability under acidic conditions, but is able to be removed by 
exposure to light from a 450 W medium pressure mercury lamp (Figure 5.11).176  The 
conditions for formation of the O,O-acetal require catalytic TsOH.H2O in benzene at room 
temperature, with the requirement of copper(II) sulfate in some cases.  These conditions may 
result in cleavage of acetonide moieties, so would have to be investigated, but it may be 
possible to directly protect the aldehyde functionality of lactol 4.6.  Because of the stability of 
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the 5-methoxysalicylic alcohol O,O-acetal to mildly acidic conditions, the selective 
deprotection of the primary acetonide could be reinvestigated. 
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Figure 5.11: Protection of carbonyls with 5-methoxysalicylic alcohol, 5.1. 
 
5.4.3. New scaffolds as potential inhibitors of KDO8P synthase 
The synthesis of the appropriately protected aldehyde necessary for the synthesis of extended 
phospholactate 4.1 was shown to be problematic, and although new routes have been 
proposed in Section 5.4.2, these are not without their own problems.  Alternatively it may be 
possible to synthesise inhibitors that incorporate some of the hydroxyl functionality 
associated stereochemistry via a much simpler route incorporating chemistry, previously 
established in this thesis. 
A promising target for this are inhibitors that incorporate a hydroxyl group representative of 
that formed from the A5P aldehyde moiety upon attack by the C3 carbon of PEP.  The crystal 
structure of aminophosphonate inhibitor 1.4 bound in the active site of AaeKDO8PS shows 
this hydroxyl moiety within bonding distance of the metal ion (Figure 5.12), and so this 
group may provide a potentially useful way of of increasing inhibition of the metal-dependent 
KDO8P synthases via metal coordination. 
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Figure 5.12: Aminophosphonate 1.4 (API) bound in the active site of KDO8P synthase from A. 
ferrooxidans (1JCX)30 showing potential bonding between the hydroxyl representative of that formed 
from the aldehyde of A5P and the metal ion (Cd2+).  Distances are measured in angstroms.  
This hydroxyl can be incorporated into the previously designed inhibitors via the Sharpless 
asymmetric dihydroxylation combined with the previously utilised Darzens chemistry.  The 
Sharpless asymmetric dihydroxylation involves stereospecific dihydroxylation of an alkene 
moiety by osmium tetroxide in the presence of a chiral quinine ligand to produce a vicinal 
diol.177  The secondary hydroxyl moiety can be selectively protected by protection of the 1,2-
diol as the methoxymethyl ether (MOM) and selective deprotection of the primary 
hydroxyl.178  The primary hydroxyl, oxidised to the aldehyde, can then be reacted in the 
Darzens condensation reaction as previously described to give the α-glycidic ester (Figure 
5.13).  As previously discussed, the α-chloroglycidic ester is a versatile intermediate able to 
be used in the synthesis of extended vinyl phosphonates and phospholactates.  The additional 
advantage of these compounds for the synthesis of the extended phospholactates is that the 
diastereoisomers formed from the racemic reduction of the α-chloroglycidic ester may be 
separable by flash chromatography, where as the enantiomers formed in the synthesis of 
extended phospholactate 4.33 were not.  This can be used to determine the difference the two 
phospholactate isomers have on inhibition of KDO8P synthase. 
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Figure 5.13: Retrosynthetic analysis of α-chloroglycidic ester containing additional hydroxyl moiety for 
synthesis of extended phospholactates and vinyl phosphonates containing additional metal coordinating 
hydroxyl moiety. 
5.5. Summary 
This project describes investigations into the inhibition of the metal-independent KDO8P 
synthase from N. meningitidis and the metal-dependent KDO8P synthase from A. 
ferrooxidans.  A number of small molecules were selected as mimics of reaction 
intermediates and tested as inhibitors.  The information gathered from these studies was then 
used in the design of new inhibitors of KDO8P synthase incorporating aspects of both 
substrates.  Based on the results of this investigation, new directions have been proposed for 
the inhibition of KDO8P synthase, and it is hoped that this will lead to the development of 
more potent KDO8P synthase inhibitors. 
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6.1. General experimental 
6.1.1. Chromatography 
All buffers and solvents used during FPLC chromatography were filtered using a 0.45 µM 
filter (Millipore) before use. 
Anion exchange chromatography was carried out on a SOURCE™ 15Q (Amersham) column, 
using a Biorad Biologic® FPLC pump, quad wavelength detector and automated fraction 
collection system at 4 °C. 
Hydrophobic interaction chromatography was carried out on a SOURCE™ 15Phe 
(Amersham) column using a Biorad Biologic® FPLC pump, quad wavelength detector and 
automated fraction collection system at 4 °C. 
Size exclusion chromatography was carried out on a HiLoad 26/60 Superdex™ S200 pg (N. 
meningitidis) and Superdex™ S200 10/300 GL (A. ferrooxidans) (GE Healthcare) using a 
Biorad Biologic® FPLC pump, quad wavelength detector and automated fraction collection 
system at 4 °C. 
TLC was carried out on Merck Silica Gel 60 F254 aluminium-backed sheets and visualised 
under UV light (254 nm), followed by staining with basic aqueous potassium permanganate 
(general stain) or ethanolic ninhydrin (amines) and developed using a stream of hot air.  Flash 
chromatography was carried out on silica gel (230-400 mesh).  Chromatographic hexane, 
petroleum ether and ethyl acetate were distilled prior to use from calcium hydride if 
necessary; analytical grade diethyl ether, petroleum ether and ethyl acetate were used as 
supplied. 
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6.1.2. Polyacrylamide gel electrophoresis 
SDS-PAGE was performed using the method of Laemmli179 with a NuPAGE® Novex® 10% 
bis-tris gel, using a Mini Protean III cell (Biorad).  A current of 200 V was applied for 50 
minutes so that the dye front reached the bottom of the resolving gel.  Novex® Sharp pre-
stained protein weight standards were used.  Protein in the gels were detected by staining the 
gels for at least 30 mnutes in a solution of 1 g L-1 Coomassie Brilliant Blue R 250 (Park 
Scientific) in 50 % (v/v) methanol and 10 % (v/v) acetic acid in water.  Excess dye was 
removed by soaking gels overnight in 40 % (v/v) methanol and 10 % (v/v) acetic acid in 
water. 
6.1.3. Determination of protein concentration 
Protein concentration was determined by the method of Bradford,180 using bovine serum 
albumin (BSA) as a standard.  BSA protein standards were made to concentrations of 0, 0.1, 
0.2, 0.4, 0.6, 0.8 and 1 mg mL-1.  1 mL of Bradford reagent (Biorad) was added to 20 µL of 
each standard and the samples left for 10 minutes to develop colour.  A standard curve was 
constructed from absorbance readings of each sample at 595 nm.  Protein samples of 
unknown concentration were diluted to 20 µL and treated as previously described for the 
BSA standards.  The absorbance readings of these unknown protein samples at 595 nm were 
used to determine the concentrations of the original samples. 
6.1.4. Enzyme assays 
Enzyme assays were performed by following the change in absorbance at 232 nm due to the 
consumption of PEP.  Assays were either performed in duplicate so that there was a 
difference of less than 10 % between the two values obtained, or globally fitted over the 
whole data set in order to obtain error of less than 10 % in the final value.  Enzyme assays 
were conducted with recombinant N. meningitidis and A. ferrooxidans KDO8P synthase, 
prepared as previously described and stored at -80 °C until required.  Enzyme solutions were 
thawed and vortexed before use and stored at 0 °C during use. 
Bis-tris-propane (BTP) buffer used for activity measurements was prepared by dissolving 
sufficient BTP free base in MilliQ water to give a 50 mM solution, then adjusting the pH to 
7.2 with hydrochloric acid.  Stock solutions of PEP, A5P and inhibitor were prepared from 
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monopotassium-PEP (Sigma) and sodium-A5P (Sigma) respectively, in MilliQ water.  
Inhibitor solutions and 10 mM stock solutions of manganese(II) chloride were similarly 
prepared in MilliQ water.  BTP buffer, PEP, A5P and inhibitor solutions were treated with 
Chelex® resin for one hour, filtered through a 0.45 µM membrane and stored at 4 °C until 
use.  Stock solutions of manganese(II) chloride were filtered through a 0.45 µM membrane 
and  stored at 4 °C until use.  Substrate solution concentrations were determined prior to use 
by the loss of PEP as determined by UV spectrophotometric measures of the absorbance at 
232 nm.   
Enzyme activity data and inhibition constants were measured by enzyme assay.  Curvettes (1 
mL) containing PEP, A5P, manganese(II) chloride (for assays with AfeKDO8PS) and 
inhibitor in BTP buffer were incubated at 30 °C (NmeKDO8PS) or 37 °C (AfeKDO8PS) for 
10-15 minutes, initiated by the addition of ∼2 µg enzyme, and the initial rate of reaction 
determined by linear least-squares fitting of the change in absorbance with time.  To 
determine KDO8P synthase kinetic data for each substrate, initial rate data for was collected 
at a range of concentrations of each substrate, converted to positive values and globally fitted 
by multivariable non-linear least squares regression using Grafit® to the Michealis-Menten 
equation: 
ݒ = ୫ܸୟ୶ሾܵሿܭ୫ + ሾܵሿ 
 Where v = intial rate 
            Vmax = maximum rate 
 [S] = competitive substrate concentration 
   Km = Michealis constant in the absence of inhibitor 
To determine inhibition constants, initial rate data for specified substrate and inhibitor 
concentrations was collected and fitted by multivariable non-linear least squares regression 
using Grafit® to the Michealis-Menten equation modified for competitive inhibition: 
ݒ = ୫ܸୟ୶ሾܵሿ
ܭ୫ ൬1 + ሾܫሿܭ୧ ൰ + ሾܵሿ
 
 Where the variables are as stated above and, 
 [I] = inhibitor concentration 
 Ki = inhibition constant 
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6.1.5. Reactions and work-ups 
All reactions were carried out under an inert atmosphere of nitrogen unless otherwise stated.  
Crude organic extractions were dried with magnesium sulfate followed by filtration, unless 
otherwise stated.  Evaporations were carried out on a rotary evaporator under reduced 
pressure, preferably utilising a water bath of less than 50 °C. 
6.1.6. Solvents and reagents 
Solvents and reagents were dried by standard methods181 where required before use.  Diethyl 
ether and tetrahydrofuran were freshly distilled from sodium/benzophenone.  
Dichloromethane, ethyl acetate and pyridine were freshly distilled from calcium hydride.  
Methanol and isopropyl alcohol were distilled from calcium hydride and stored over dried 4 
Å molecular sieves until needed.  Sodium borohydride, tert-butyldiphenylsilyl chloride and 
tert-butyldimethylsilyl chloride were obtained from commercial sources, and once opened 
stored in a desiccator over silica.  Benzoyl chloride was purified by dilution with benzene, 
washing with aqueous sodium bicarbonate and distillation over calcium hydride.  Acetyl 
chloride was dried by refluxing with PCl5 and distillation.  Sodium hydride was obtained 
from an oil dispersion by washing with hexane or petroleum ether and drying under vacuum.  
Dimethylsulfoxide (DMSO) was dried azeotropically by distilling out ∼25 % of the volume 
and discarding.  The remaining DMSO was distilled and storing over dried 4 Å molecular 
sieves until use.  Oxalyl chloride was stored frozen at -20 °C.  Dess-Martin periodinane 
(DMP) was prepared from the oxidation of 2-iodobenzoic acid with Oxone® to give 
iodoxybenzoic acid (IBX),182 which was acetylated with hot acetic anhydride and p-
toluenesulfonic acid to give DMP,143 which was filtered under nitrogen and stored at -20 °C 
under nitrogen until use.  Methanesulfonyl chloride was distilled from P2O5 under vacuum.  
Triphenylphosphine dibromide was synthesised by bromination of triphenylphosphine in 
dichloromethane.154  The solid formed was filtered, washed with hexane and dried under 
vacuum.  Isopropyl dichloroacetate was obtained from Scott Walker183 or synthesised from 
the esterification of dichloroacetic acid using isopropyl alcohol and concentrated sulfuric 
acid.  The reagent was stored at 4 °C until use.  TBAF was obtained from commercial sources 
as a 1 M solution in tetrahydrofuran and stored under nitrogen at all times.  Meta-
chloroperbenzoic acid was recrystallised from dichloromethane and stored at 4 °C until 
needed.  Silver(I) oxide was prepared fresh from 1 M sodium hydroxide solution and aqueous 
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silver nitrate at 80 °C; filtered and washed with boiling ethanol and water, dried under 
vacuum at 50 °C and stored under nitrogen before use.  Commercial DOWEX resin was 
washed well with 1.2 M hydrochloric acid until the filtrate ran colourless; washed with water 
until the filtrate ran neutral as detected by pH paper, and air dried before use.  All other 
reagents were obtained from commercial sources, and used as received. 
6.1.7. NMR spectroscopy 
NMR spectroscopy was carried out at the Institute of Fundamental Sciences at Massey 
University, Palmerston North on a Bruker Avance® 400 MHz NMR spectrometer utilising a 
quad-nuclei 1H/13C/19F/31P detection probe; or at the Department of Chemistry, University of 
Canterbury, Christchurch on a Varian UNITY 300 MHz or Varian INOVA 500 MHz NMR 
spectrometer, utilising a variable temperature direct broadband or inverse 1H/13C probe 
respectively.  1H and 13C spectra are referenced to CHCl3, TMS or another solvent standard; 
31P spectra are referenced to external 85% phosphoric acid. 
6.1.8. Mass spectrometry 
High-resolution mass spectroscopy was carried by the Department of Chemistry, University 
of Canterbury on either a Micromass LCT spectrometer or Bruker maXis™ 3G Ultra High 
Resolution Time of Flight tandem mass spectrometer (positive and negative ion electrospray 
techniques).  High resolution mass spectroscopic data (HRMS) refers to positive electrospray 
data unless otherwise stated. 
6.1.9. UV-visible spectrometry 
UV-visible spectrophotometry was carried out on a Varian Cary® One UV-visible 
spectrophotometer in stoppered quartz cells (UV) or plastic cells (visible).  The temperature 
was continuously controlled at 298 K unless otherwise stated by the use of a jacketed 
multicell holder and external Varian Peltier temperature controller filled with either water or 
ethylene glycol.  
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6.1.10. Lanzetta phosphate assay for detection of products 
The Lanzetta reagent was prepared fresh prior to use by the following preparation: 
 
3 parts 0.045 % w/v malachite green chloride in water (freshly prepared),  
 1 part 4.2 % w/v ammonium molybdate in 4M HCl,     
 0.1 parts 1.5 % v/v Triton X-100 
The reactions were mixed in the dark and stirred for 30 minutes before filtering through a 
0.45 µM filter before use.  For qualitative detection of anion exchange products, 25 µL of 
Lanzetta reagent was added to 150 µL of sample  and incubated for 30 minutes.  The change 
in absorbance due to organic phosphate cleavage in an acidic environment was detected 
visually over a white surface.  For quantitative analysis of inhibitor solutions, 300 µL of 
sample is mixed with 10 µL of calf alkaline phosphatase solution (10 units/mL, in 4 mM 
MgCl2) and incubated for three hours.  A 100 µL digest sample was then mixed with 700 µL 
of Lanzetta reagent and incubated for 30 minutes.  The absorbance was determined at 630 nm 
and compared to the absorbance values from a series of known standards (0-100 µM) in order 
to determine the inorganic phosphate concentration in the digested inhibitor samples. 
6.1.11. Computational methods 
All protein structures were drawn from files downloaded from the Protein Data Bank and 
drawn using the PyMol Molecular Graphics System. 
Computational docking studies were undertaken by Wanting Jiao.   
Inhibitor molecules were built in Maestro and minimized with MacroModel.  A 
conformational search was undertaken and the low energy conformers selected with Xcluster, 
based on the atomic RMSD of heavy atoms in the molecule, for modelling into the KDO8P 
synthase active site. 
The KDO8P synthase receptor was prepared from chain A of the A. aeolicus KDO8P 
synthase structure 1FWW.  The receptor was prepared via the following procedure; 
1. Import crystal structure of KDO8PS (PDB 1FWW) 
2. Delete all water molecules except water coordinated to the metal ion, HOH 3194 and 
HOH 3211. 
Chapter 6: Experimental 
150 
 
3. Correct bond order of PEP in both chains, add -1 charges to the carboxylic acid group and 
the phosphate group on PEP. The residue PEP is left in the active site at this stage, so that 
the residues interacting with PEP are oriented correctly during minimization and 
refinement of the receptor. The substrate A5P in both chains in the crystal structure is 
deleted. Covalent bonds to the metal ion are deleted. MacroModel is unable to model 
Cd2+ ion, which is the active site metal ion present in the crystal structure, therefore, this 
ion is changed to a Mn2+ ion for modelling purposes.  
4. Add hydrogen atoms to all appropriate positions. 
5. Atom type of the P atom in PEP phosphate is changed to P5 for pentavalent phosphorus 
as in the Macromodel atom typing system. 
6. Minimization of the corrected KDO8PS receptor structure. The residues within 5 Å of the 
active site Mn2+ ion in chain A, and all residues in chain B except Arg2106, Gln2107, 
Asn2136 and Lys2140 are frozen during the minimization. 
7. Refine minimized structure. 
8. Delete PEP and water molecules in the active site in both chains. 
 
The centre of the grid is defined as the centroid of residues within 5 Å of the PEP and A5P 
molecule in the original crystal structure (residues 1101, 1041, 1043, 1046, 1048, 1049, 1050, 
1051, 1054, 1081, 1099, 1100, 1101, 1102, 1103, 1124, 1127, 1154, 1182, 1185, 1188, 1191, 
1195, 1196, 1197, 1220, 1222, 1233, 1270 and 2106 from chain B). The vad der Waals radii 
of the active site atoms are not scaled, while a scale factor of 0.80 is applied to the van der 
Waals radii of the inhibitor atoms. The side chains of residues within 5 Å of the docked 
ligand are optimized, with an additional optimization for side chain of Arg2106 from chain B.  
 
Induced Docking Fit (IDF) scores are relative numbers associated with the overall stability of 
the docked molecule in the enzyme active site.  They are used to find the most stable 
conformer of the molecule in the enzyme active site from the number of confirmations 
produced during computational docking. 
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6.2. Experimental procedures 
6.2.1. Experimental for Chapter 2 
Purification of KDO8P synthase from N. meningitidis 
Overnight precultures of E. coli BL21(DE3) cells containing pT7-7-NmekdsA were grown in 
50 mL Luria Bertani (LB) broth supplemented with ampicillin (0.1 mg mL-1) and used the 
following day to inoculate a 1 L LB broth supplemented with ampicillin (0.1 mg mL-1).  The 
culture was grown at 37 °C to an OD600 of 0.734 whereupon IPTG was added (final 
concentration 1 mM).  The culture was grown for a further four hours then harvested by 
centrifugation (14000 G, 30 minutes, 4 °C).  Cell pellet was resuspended in 10 mL MilliQ 
water and centrifuged (12000 G, 5 minutes, 4 °C) before being stored at -80 °C overnight.  
Cell pellet was resuspended in 10 mL cold lysis buffer (10 mM BTP, 1mM EDTA, 0.2 M 
potassium chloride, pH 7.5) and lysed by sonication on ice (3 x 4 minutes at 80 % pulse, 1 x 
2 minutes at 40 % pulse).  Cell debris was removed by centrifugation (24000 G, 30 minutes, 
4 °C) and the supernatant diluted five-fold with Buffer A (10 mM BTP, 1 mM EDTA, pH 
7.5).  The dilute protein sample was loaded onto an AEC column in two separate runs (20 mL 
and 30 mL, 4 °C) pre-equilibrated with Buffer A.  After washing the column with two 
column volumes (CV) of Buffer A, a linear sodium chloride gradient (0.1 to 0.2 M, 7 CV, 2 
mL fractions) was used to elute the N. meningitidis KDO8P synthase protein.  Fractions were 
analysed by SDS-PAGE using Laemmli’s179 buffer system under denaturing and reducing 
conditions.  Fractions determined to contain NmeKDO8PS were pooled (49 mL) and solid 
ammonium sulfate was added (final concentration 1 mM).  The protein was loaded onto an 
HIC column pre-equilibrated with Buffer B (10 mM BTP, 1 mM EDTA, 1 M (NH4)2SO4, pH 
7.5).  The column was washed with three and a half CV of Buffer B, and a linear gradient of 
0.7 to 0 M (NH4)2SO4 (13 CV) was applied to the column.  The KDO8P synthase protein was 
eluted from 0.61 to 0.42 M (NH4)2SO4 (1 mL fractions, 3.5 CV).  The fractions were 
analysed by SDS-PAGE and those determined to contain KDO8P synthase were pooled (26 
mL) and loaded onto SEC column pre-equilibrated with Buffer C (50 mM BTP, 50 mM 
sodium chloride, pH 7.5) in two separate runs (13 mL each).  The protein was eluted in 340 
mL Buffer C in 2 mL fractions, and those fractions analysed by SDS-PAGE.  Those fractions 
determined to contain KDO8P synthase were pooled and concentrated using a 20 mL 
Vivaspin 10 kDa MWCO concentrator (Sartorius Stedim).  The protein was divided into 50 
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µL aliquots and flash frozen in liquid nitrogen before storage at -80 °C.  Protein 
concentration was determined by the Bradford method180 using bovine serum albumin as a 
standard. 
Purification of KDO8P synthase from A. ferrooxidans 
Overnight precultures of E. coli BL21(DE3) cells containing pT7-7-AfekdsA were grown in 
50 mL LB broth supplemented with ampicillin (0.1 mg mL-1) and used the following day to 
inoculate a 1 L LB broth supplemented with ampicillin (0.1 mg mL-1).  The culture was 
grown at 37 °C to an OD600 of 0.652 whereupon IPTG was added to give a final 
concentration of 1 mM.  The large culture was grown for four hours and harvested by 
centrifugation (14000 G, 30 minutes, 4 °C).  The cell pellet was resuspended in MilliQ water 
(10 mL) and centrifuged again (12000 G, 5 minutes, 4 °C) before storage of the cell pellet at  
-80 °C overnight.  The cell pellet was responded in 10 mL cold lysis buffer (10 mM BTP, 
1mM EDTA, 0.2 M potassium chloride, pH 7.5) and lysed by sonication on ice (3 x 4 
minutes at 80 % pulse, 1 x 2 minutes at 40 % pulse).  Cell debris was removed by 
centrifugation (24000 G, 30 minutes, 4 °C) and the supernatant was diluted four-fold with 
Buffer A (10 mM BTP, 1 mM EDTA, pH 7.5) before being loaded onto the AEC column in 
two separate runs (20 mL and 20 mL, 4 °C).  After washing the column with two column 
volumes (CV) of Buffer A, a linear sodium chloride gradient (0.14 to 0.38 M, 7 CV, 2 mL 
fractions) was used to elute the A. ferrooxidans KDO8P synthase protein.  The fractions were 
analysed by SDS-PAGE and those fractions containing the KDO8P synthase protein had 
ammonium sulfate added to give a final concentration of 1 M and were loaded onto an HIC 
column pre-equilibrated with Buffer B (10 mM BTP, 1 mM EDTA, 1 M (NH4)2SO4, pH 7.5).  
The column was washed with 2 CV of Buffer B, and a linear gradient of 0.5 to 0 M 
(NH4)2SO4 (8.5 CV) was applied to the column.  The KDO8P synthase protein was eluted 
from 0.3 to 0.15 M (NH4)2SO4 (1 mL fractions, 3 CV).  The fractions were analysed by SDS-
PAGE and those determined to contain KDO8P synthase were pooled (26 mL), concentrated 
using a 20 mL Vivaspin 10 kDa MWCO concentrator (Sartorius Stedim) and exchanged into 
a low salt buffer (10 mM BTP, 1 mM EDTA, pH 7.5) to give 1.25 mL of concentrated 
protein.  This sample was loaded onto a SEC column pre-equilibrated with Buffer C (50 mM 
BTP, 50 mM sodium chloride, pH 7.5).  The protein was eluted in 48 mL Buffer C in 1 mL 
fractions, and those fractions analysed by SDS-PAGE.  Those fractions determined to contain 
KDO8P synthase were pooled, and concentrated using a 20 mL Vivaspin 10 kDa MWCO 
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concentrator (Sartorius Stedim).  The protein was divided into 50 µL aliquots and flash 
frozen in liquid nitrogen before storage at -80 °C.  Protein concentration was determined by 
the Bradford method180 using bovine serum albumin as a standard. 
6.2.2. Experimental for Chapter 4 
(4S)-6-(2,2-Dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyltetrahydrofuro[3,4-
d][1,3]dioxol-4-ol via boron-trifluoride diethyl etherate catalysis 
O
OH
OHHO
HO
OH
OO
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O
4.7
OH
(50 %)
12
3
4
5
6
BF3-Et2O, Acetone
Ac2O, 58oC - Δ
 
Boron trifluoride diethyl etherate (10 µL, 0.079 mmol) was added to D-mannose (1.0859 g, 
6.03 mmol) stirring in acetone (15 mL).  The solution was warmed to 58 °C and acetic 
anhydride (850 µL, 9.01 mmol) was added dropwise over 5 minutes.  The solution was 
heated to reflux and stirred for five hours before being quenched with 25 % w/w aqueous 
sodium hydroxide (20 mL).  The volatile components were evaporated and the aqueous phase 
extracted with chloroform (2 x 100 mL).  The combined organic phase was washed with 
water (50 mL), brine (50 mL), dried over magnesium sulfate and evaporated to give an oil 
which was subjected  to flash chromatography (20 % ethyl acetate in hexane) to give 
furanose 4.7 as a white solid (0.7807 g, 50 %).  Rf (75 % ethyl acetate/petroleum ether): 0.74; 
1H NMR (500 MHz, CDCl3): δ ppm  5.37 (s, 1H, H1), 4.80 (dd, J = 5.9, 3.7 Hz, 1H, H3), 
4.60 (d, J = 5.9 Hz, 1H, H2), 4.42-4.28 (m, 1H, H5), 4.17 (dd, J = 7.1, 3.7 Hz, 1H, H4), 4.09-
4.03 (m, 2H, H6), 3.40 (br, 1H, OH), 1.46 (s, 3H, C(CH3)2), 1.45 (s, 3H, C(CH3)2), 1.37 (s, 
3H, C(CH3)2), 1.32 (s, 3H, C(CH3)2); 13C NMR (126 MHz, CDCl3) δ ppm 112.8 (C(CH3)2), 
109.3 (C(CH3)2), 101.4 (C1), 80.3 (C4), 85.7 (C2), 79.8 (C3), 73.5 (C5), 66.7 (C6), 27.0 
(C(CH3)2), 26.0 (C(CH3)2), 25.4 (C(CH3)2), 24.7 (C(CH3)2); HRMS required for C12H20NaO6: 
283.1158, Found: 283.1146. 
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(4S)-6-(2,2-Dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyltetrahydrofuro[3,4-
d][1,3]dioxol-4-ol via toluenesulfonic acid mono hydrate catalysis 
O
OH
OHHO
HO
OH
OO
O
O
O
4.7
OH
TsOH.H2O, Acetone, 70oC
(63 %)
 
Toluenesulfonic acid mono hydrate (31.8 mg, 0.167 mmol) was added to D-mannose (1.4735 
g, 8.18 mmol) stirring in acetone (50 mL).  After 23 hours at 70 °C the pH of the solution was 
adjusted to 7 with saturated sodium bicarbonate solution, and then filtered.  The filtrate was 
washed with acetone (200 mL) and the organic solvents evaporated to give an off-white solid 
that was dissolved in diethyl ether and filtered before the volatile solvents were evaporated to 
give a white solid, that was recrystallised from petroleum ether to give furanose 4.7 as a 
white solid (1.3368 g, 63 %).  
Spectral data as above for (4S)-6-(2,2-Dimethyl-1,3-dioxolan-4-yl)-2,2-
dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-ol via boron-trifluoride diethyl etherate 
catalysis. 
(R)-((R)-2,2-Dimethyl-1,3-dioxolan-4-yl)((4S,5R)-5-(hydroxymethyl)-2,2-dimethyl-
1,3-dioxolan-4-yl)methanol 
OO
O
OH
O
O
4.7
OH
O O
OH
O
O
NaBH4, EtOH
0oC - RT
(91 %)
4.9
 
Sodium borohydride (0.1390 g, 3.67 mmol) was added portion wise to furanose 4.7 (0.4786 
g, 1.84 mmol) in ethanol (5 mL) cooled to 0 °C.  The reaction mixture was allowed to warm 
to room temperature and stirred for 21 hours before it was neutralised with acetic acid and the 
volatile components evaporated under reduced pressure.  The resin was redissolved in ethyl 
acetate (50 mL), washed with brine (15 mL) and the aqueous phase extracted with ethyl 
acetate (2 x 50 mL).  The combined organic phase was dried over anhydrous magnesium 
sulfate and evaporated to give an oil that was subjected to flash chromatography to give 
diacetonide 4.9 as a white solid (0.4395 g, 91 %). Rf (75 % ethyl acetate/petroleum ether): 
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0.41; 1H NMR (500 MHz, CDCl3) δ ppm 4.35 (dd, J = 7.3, 1.4 Hz, 1H, H4), 4.27 (td, J = 
7.3, 4.4 Hz, 1H, H5), 4.08 (dd, J = 7.9, 6.0 Hz, 1H, H3), 4.06-4.02 (m, 1H, H1), 3.98 (dd, J = 
7.9, 4.9 Hz, 1H, H1’), 3.87 (dd, J = 12.2, 4.4 Hz, 1H, H6), 3.79 (dd, J = 12.2, 4.4 Hz, 1H, 
H6’), 3.55 (dd, J = 7.9, 1.4 Hz, 1H, H2), 3.17 (s, 2H, OH), 1.48 (s, 3H, C(CH3)2), 1.37 (s, 
3H, C(CH3)2), 1.36 (s, 3H, C(CH3)2), 1.32 (s, 3H, C(CH3)2); 13C NMR (126 MHz, CDCl3) δ 
ppm 109.2 (C(CH3)2), 108.1 (C(CH3)2), 76.9 (C4), 75.8 (C5), 75.6 (C3), 70.1 (C2), 67.1 (C1), 
60.5 (C6), 26.6 (C(CH3)2), 26.5 (C(CH3)2), 25.1 (C(CH3)2), 24.7 (C(CH3)2); HRMS required 
for C12H22NaO6: 285.1309, Found: 285.1313. 
((4R,5S)-5-((R)-((R)-2,2-Dimethyl-1,3-dioxolan-4-yl)(hydroxy)methyl)-2,2-dimethyl-
1,3-dioxolan-4-yl)methyl benzoate 
OH
O O
OH
O
O
4.9
BzCl, Pyridine, CH2Cl2
(52 %)
OBz
O O
OH
O
O
4.10  
Benzoyl chloride (700 µL, 6.03 mmol) was added to diacetonide 4.9 (1.501 g, 5.43 mmol) in 
pyridine (10 mL) and dichloromethane (10 mL) at 0 °C and left to warm to room 
temperature.  The reaction was stirred for 17 hours and quenched with ethyl acetate (200 
mL).  The organic phase was washed with saturated aqueous copper sulphate (2 x 100 mL) 
and water (100 mL) before being dried over anhydrous magnesium sulfate and evaporated to 
give an oil.  This crude product was subjected to flash chromatography (25 % ethyl acetate/ 
petroleum ether) to give a clear oil (1.0748 g, 52 %). Rf (80 % ethyl acetate/petroleum ether): 
0.62; 1H NMR (500 MHz, CDCl3) δ ppm 8.08-8.03 (m, 2H, OCOPhb), 7.58-7.52 (m, 1H, 
OCOPhd), 7.45-7.40 (m, 1H, OCOPhc), 4.68-4.55 (m, 3H, H6 and H4), 4.50-4.46 (m, 1H, 
H5), 4.15-4.09 (m, 1H, H1’), 4.07-4.01 (m, 2H, H1 and H2), 3.66 (dd, J = 7.8, 1.6 Hz, 1H, 
H3), 1.53 (s, 3H, C(CH3)2), 1.41 (s, 3H, C(CH3)2), 1.40 (s, 3H, C(CH3)2), 1.35 (s, 3H, 
C(CH3)2); 13C NMR (126 MHz, CDCl3) δ ppm 166.2 (OCOPh), 133.1 (OCOPha), 130.1 
(OCOPhd), 129.7 (OCOPhb), 128.3 (OCOPhc), 109.5 (C(CH3)2), 108.8 (C(CH3)2), 76.1 (C2), 
75.4 (C5), 75.0 (C4), 70.2 (C3), 67.1 (C1), 64.2 (C6), 26.8 (C(CH3)2), 26.7 (C(CH3)2), 25.2 
(C(CH3)2), 24.6 (C(CH3)2); HRMS required for C19H26NaO7: 389.1571, Found: 389.1567.  
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(S)-(1,3-Dithian-2-yl)((4R,4'R,5R)-2,2,2',2'-tetramethyl-4,4'-bi(1,3-dioxolan)-5-
yl)methanol 
4.13
HO OH
OH
S
S
HO
HO
O
OH
OHHO
HO
OH
HS SH
CHCl3, conc. HCl
Acetone,
conc. HCl
(46 % over
two steps)
4.12
O O
OH
S
S
O
O
1
2
34
56
 
Propandithiol (2 mL, 19.9 mmol) was added to D-mannose (3.0921 g, 17.2 mmol) in 
chloroform (3 mL).  Concentrated hydrochloric acid (1.5 mL) was added and the mixture 
stirred vigorously for 18 hours.  The solid formed was transferred to another flask with water 
(75 mL) and adjusted to pH 8 with aqueous ammonia.  The liquids were evaporated under 
reduced pressure, and co-distilled with n-butanol (180 mL) and toluene (100 mL) to give a 
brown solid (4.98 g).  Hydrochloric acid (6.0 M, 10 mL) was added to this crude product 
dissolved in acetone (500 mL).  The solution was stirred for 24 hours and neutralised with 
aqueous ammonia.  The liquids were evaporated and co-distilled with toluene (800 mL) and 
the solid redissolved in chloroform (500 mL) and filtered before the chloroform was 
evaporated to give a white solid (7.117 g).  The crude product was subjected to flash 
chromatography (50 % ethyl acetate in petroleum ether) to give diacetonide 4.13 as a white 
solid (2.741 g, 46 % over two steps from D-mannose). Rf (33 % ethyl acetate/hexane): 0.66; 
1H NMR (500 MHz, CDCl3): δ ppm 4.28 (d, J = 2.8 Hz, 1H, H1), 4.14 (dd, J = 8.7, 5.7 Hz, 
1H, H6’), 4.05 (dd, J = 8.3 Hz, 7.3 Hz, 1H, H3), 4.02 (dd, J = 5.7, 2.8 Hz, 1H, H5), 3.94 (dd, 
J = 8.7, 5.7 Hz, 1H, H6), 3.89 (dd, J = 8.3, 2.8 Hz, 1H, H2), 3.73 (dd, J = 8.3, 7.3 Hz, 1H, 
H4), 2.98 (ddd, J = 13.9, 6.5, 2.9 Hz, 2H, (SCH2)2CH2), 2.86 (ddd, J = 13.9, 10.1, 2.9 Hz, 
1H, (SCH2)2CH2), 2.79 (ddd, J = 13.9, 10.1, 2.9 Hz, 1H, (SCH2)2CH2), 2.11-2.02 (m, 1H, 
(SCH2)2CH2), 2.01-1.91 (m, 1H, (SCH2)2CH2), 1.39 (s, 3H, C(CH3)2), 1.33 (s, 6H, C(CH3)2), 
1.31 (s, 3H, C(CH2)2); 13C NMR (126 MHz, CDCl3): δ ppm 110.4 (C(CH3)2), 109.8 
(C(CH3)2), 80.8 (C2), 79.8 (C5), 76.6 (C4), 76.2 (C2), 67.2 (C1), 49.2 (C6), 29.9 
((SCH2)2CH2), 29.1 ((SCH2)2CH2), 26.8 (C(CH3)2), 26.8 (C(CH3)2), 26.3 (C(CH3)2), 26.1 
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(S(CH2)2CH2), 25.1 (C(CH3)2); HRMS required for C15H26NaO5S2: 373.1114, Found: 
373.1120.  
(S)-(1,3-Dithian-2-yl)((4R,4'R,5R)-2,2,2',2'-tetramethyl-4,4'-bi(1,3-dioxolan)-5-
yl)methanol 
O O
OH
S
S
HO
HO
4.144.13
O O
OH
S
S
O
O
2N HCl, MeOH
(77 %)
 
Hydrochloric acid (2.0 M, 5 mL) was added to diacetonide 4.13 (5.335 g, 15.2 mmol) 
dissolved in methanol (800 mL), and the reaction stirred for 23 hours before the pH of the 
solution was adjusted to 7 with aqueous ammonia and the liquids evaporated under reduced 
pressure.  The solid formed was dissolved in chloroform (400 mL), filtered, and the 
chloroform evaporated under reduced pressure to give a white solid (4.6928 g) that was 
subjected to flash chromatography (20 % petroleum ether/ethyl acetate) to give 
monoacetonide 4.14 as a white solid (3.6523 g, 77 %). Rf (20 % ethyl acetate/hexane): 0.39; 
1H NMR (500 MHz, CDCl3) δ ppm 4.38 (d, J = 1.8 Hz, H1), 4.36 (s, 1H, OH), 4.10 (dd, J = 
8.8, 7.3 Hz, 1H, H3), 3.87 (dd, J = 7.3, 7.3 Hz, 1H, H4), 3.86 (dd, J = 8.8, 1.8 Hz, 1H, H2), 
3.82 (dd, J = 11.2, 2.6 Hz, 1H, H6), 3.71 (dd, J = 5.2, 2.6 Hz, 1H, H5), 3.66 (dd, J = 11.2, 5.2 
Hz, 1H, H6), 2.99-2.86 (m, 3H, (SCH2)2CH2), 2.82 (dd, J = 13.8, 10.1, 2.3 Hz, 1H, 
(SCH2)2CH2), 2.10-2.02 (m, 1H, (SCH2)2CH2), 1.96-1.85 (m, 1H, (SCH2)2CH2), 1.35 (s, 3H, 
C(CH3)2), 1.34 (s, 3H, C(CH3)2); 13C NMR (126 MHz, CDCl3) δ ppm 109.66 (C(CH3)2), 
79.61 (C5), 78.89 (C3), 76.63 (C2), 72.68 (C4), 63.73 (C6), 50.29 (C1), 30.19 ((SCH2)2CH2), 
29.33 ((SCH2)2CH2), 26.84 ((SCH2)2CH2), 26.78 (C(CH3)2), 25.90 (C(CH3)2); HRMS 
required for C15H27O5S2: 311.0981, Found: 311.0995. 
 
 
 
 
 
Chapter 6: Experimental 
158 
 
(R)-1-((4R,5R)-5-((S)-(1,3-Dithian-2-yl)(hydroxy)methyl)-2,2-dimethyl-1,3-dioxolan-
4-yl)-2-(tert-butyldiphenylsilyloxy)ethanol 
O O
OH
S
S
TBDPSO
HO
4.154.14
O O
OH
S
S
HO
HO
TBDPSCl,
Im, CH2Cl2
(62 %)
 
Tert-butyldiphenylsilyl chloride (3.97 mL, 15.3 mmol) was added drop-wise to imidazole 
(2.4134 g, 35.4 mmol) and monoacetonide 4.14 (4.4073. 14.2 mmol) dissolved in 
dichloromethane (140 mL) at 0 °C.  The mixture was allowed to warm to room temperature 
and stirred for 19 hours before being quenched with chloroform (600 mL) and the organic 
phase washed with water (600 mL).  The aqueous phase was extracted with chloroform (2 x 
300 mL) and the combined organic fractions washed with brine (400 mL) and dried over 
magnesium sulfate and evaporated under reduced pressure to give an oil that was subjected to 
flash chromatography (20 % ethyl acetate/ petroleum ether) to give silyl ether 4.15 as a clear 
oil (4.8423 g, 62 %). Rf (20 % ethyl acetate/hexane): 0.36; 1H NMR (500 MHz, CDCl3) δ 
ppm: 7.65 (d, J = 6.9 Hz, 4H, OSi(Phb)2C(CH3)3), 7.43 (dd, J = 7.1, 7.1 Hz, 4H, 
OSi(Phc)2C(CH3)3), 7.38 (t, J = 7.1 Hz, 2H, OSi(Phd)2C(CH3)3), 4.33 (d, J = 2.0 Hz, 1H, H1), 
4.15-4.08 (m, 1H, H3), 3.96-3.89 (m, 2H, H6’ and H2), 3.82 (dd, J = 7.3, 7.3 Hz, 1H, H4), 
3.77 (dd, J = 10.3, 6.3 Hz, 1H, H6), 3.71 (dd, J = 7.3, 2.7 Hz, 1H, H5), 3.09-2.99 (m, 2H, 
(SCH2)2CH2), 3.31 (s, 1H, OH), 2.92-2.85 (m, 1H, (SCH2)2CH2), 2.83-2.76 (m, 1H, 
(SCH2)2CH2), 2.12-1.94 (m, 2H, (SCH2)2CH2), 1.33 (s, 3H, C(CH3)2), 1.30 (s, 3H, C(CH3)2), 
1.06 (s, 9H, OSi(Ph)2C(CH3)3); 13C NMR (126 MHz, CDCl3) δ ppm 135.5, 135.5 
(OSi(Phb)2C(CH3)3), 132.7, 132.7 (OSi(Pha)2C(CH3)3), 129.8 (OSi(Phc)2C(CH3)3), 127.7, 
127.7 (OSi(Phd)2C(CH3)3), 80.1 (s, C2), 79.1 (s, C4), 77.3 (s, C3), 72.9 (s, C5), 65.2 (s,C6), 
49.0 (s, C1), 29.7 (s, (SCH2)2CH2), 29.0 (s, (SCH2)2CH2), 26.8 (s, OSi(Ph)2C(CH3)3), 26.7 (s, 
C(CH3)2), 26.7 (s, C(CH3)2), 25.9 (s, (SCH2)2CH2), 19.2 (s, OSi(Ph)2C(CH3)3); HRMS 
required for C28H40NaO5S2Si: 571.1984, Found: 571.1979. 
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(R)-1-((4R,5S)-5-((S)-Acetoxy(1,3-dithian-2-yl)methyl)-2,2-dimethyl-1,3-dioxolan-4-
yl)-2-(tert-butyldiphenylsilyloxy)ethyl acetate 
O O
OH
S
S
TBDPSO
HO
AcCl, Pyridine, DMAP,
CH2Cl2
(69 %)
4.15
O O
OAc
S
S
TBDPSO
AcO
4.17  
Acetyl chloride (1.7 mL, 23.9 mmol) was added drop-wise to silyl ether 4.15 (3.3033 g, 6.03 
mmol), pyridine (1.95 mL, 24.2 mmol) and DMAP (0.2947 g, 2.41 mmol) stirring in 
dichloromethane (40 mL) at 0 °C.  The reaction was refluxed for 20 hours before being 
quenched with dichloromethane (350 mL).  The organic phase was washed with water (200 
mL) and the aqueous phase extracted with dichloromethane (2 x 250 mL).  The organic phase 
was dried over magnesium sulfate and the organic solvents evaporated under reduced 
pressure to give an oil that was subjected to flash chromatography (33 % ethyl acetate/ 
petroleum ether) to give protected sugar 4.17 as a clear oil (2.615 g, 69 %). Rf (25 % ethyl 
acetate/petroleum ether): 0.60; 1H NMR (500 MHz, CDCl3) δ ppm 7.66 (td, J = 8.1, 1.6 Hz, 
2H, OSi(Phd)2C(CH3)3), 7.45-7.35 (m, 10H, OSi(Phb-d)2C(CH3)3), 5.43 (dd, J = 6.2, 6.2 Hz, 
1H, H2), 5.09 (dt, J = 6.2, 3.4 Hz, 1H, H5), 4.45 (dd, J = 6.2, 6.2 Hz, 1H, H3), 4.29 (dd, J = 
6.2, 6.2 Hz, 1H, H4), 4.18 (d, J = 6.2 Hz, 1H, H1), 3.91 (dd, J = 11.3, 3.4 Hz, 1H, H6), 3.85 
(dd, J = 11.3, 6.2 Hz, 1H, H6’), 2.93 (ddt, J = 13.9, 7.5, 2.9 Hz, 2H, SCH2)2CH2), 2.80 (ddd, J 
= 13.9, 8.9, 2.9 Hz, 1H, SCH2)2CH2), 2.73 (ddd, J = 13.9, 8.9, 2.9 Hz, 1H, SCH2)2CH2), 2.13 
(s, 3H, OCOCH3), 2.09 (s, 3H, OCOCH3), 2.09-1.92 (m, 2H, (SCH2)2CH2), 1.38 (s, 3H, 
C(CH3)2), 1.33 (s, 3H, C(CH3)2), 1.04 (s, 9H, OSi(Ph)2C(CH3)3); 13C NMR (126 MHz, 
CDCl3) δ ppm 170.2 (OCOCH3), 170.0 (OCOCH3), 135.5 (OSi(Phd)2C(CH3)3), 133.1 
(OSi(Pha)2C(CH3)3), 129.7, 129.7 (OSi(Phb,c)2C(CH3)3), 127.6, 127.6 (OSi(Phb,c)2C(CH3)3), 
77.2 (C3), 76.6 (C4), 74.4 (C5), 73.2 (C2), 62.3 (C6), 46.1 (C1), 28.4 ((SCH2)2CH2), 28.3 
((SCH2)2CH2), 27.2 (C(CH3)2), 27.1 (C(CH3)2), 26.6 (OSi(Ph)2C(CH3)3), 25.5 ((SCH2)2CH2), 
21.1 (OCOCH3), 20.8 (OCOCH3), 19.2 (OSi(Ph)2C(CH3)3); HRMS required for 
C32H44NaO7S2Si: 655.2199, Found: 655.2190. 
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6-(Benzyloxy)hexan-1-ol140 
HO
OH OH
BnO
BnBr, NaH, KI, THF
D
(50 %)
4.22
1
2
3
4
5
6
 
To a stirred solution of sodium hydride (0.5700g, 23.8 mmol) in dry tetrahydrofuran (30 mL) 
was added 1,6-hexandiol (4.011 g, 33.9 mmol) in dry tetrahydrofuran (20 mL), potassium 
iodide (0.560 g, 3.37 mmol) and benzyl bromide (2.8 mL, 23.6 mmol).  After 24 hours at 
reflux the solution was quenched with ethyl acetate (125 mL) and water (120 mL).  The 
organic phase was washed with saturated sodium bicarbonate (3 x 100 mL) and the combined 
aqueous phase extracted with ethyl acetate (3 x 100 mL).  The combined organic phase was 
washed with brine (150 mL), dried over anhydrous magnesium sulfate and evaporated to give 
an oil which was subjected to flash chromatography (33 % ethyl acetate/hexane) to give a 
clear oil (2.446 g, 50 %). Rf (50 % ethyl acetate/hexane): 0.66; 1H NMR (400 MHz, CDCl3) δ 
ppm 7.37-7.24 (m, 5H), 4.50 (s, 2H), 3.58 (t, J = 6.6 Hz, 2H), 3.47 (t, J = 6.6 Hz, 2H), 1.63 
(quin, J = 6.6 Hz, 2H), 1.55 (quin., J = 7.0 Hz, 2H), 1.45-1.30 (m, 4H); 13C NMR (101 MHz, 
CDCl3) δ ppm 138.4, 128.2, 127.5, 127.3, 72.7, 70.2, 62.4, 32.5, 29.5, 25.8, 25.4.  
6-(Benzyloxy)hexanal via Swerns oxidation140 
OH
BnO
O
BnO
4.22 4.23
(60 %)
1. DMSO, (COCl)2,
CH2Cl2, -78oC,
2. NEt3
 
Dimethylsulfoxide (1.75 mL, 25.7 mmol) was dissolved in dry dichloromethane (56 mL) and 
cooled to -78 °C before oxalyl chloride (1.05 mL, 12.0 mmol) was added over ten minutes.  
The reaction was stirred for a further ten minutes before benzyl ester 4.22 (2.172 g, 10.4 
mmol) dissolved in dichloromethane (9 mL) was added drop-wise over eight minutes.  The 
reaction was stirred for one hour before triethylamine (7.2 mL, 51.7 mmol) was added and 
the reaction allowed to warm to room temperature.  After one hour the reaction was quenched 
with diethyl ether (130 mL) and the organic phase washed with saturated aqueous ammonium 
chloride solution (130 mL).  The organic phase was diluted with hexane (300 mL) and 
washed with saturated aqueous potassium carbonate solution (130 mL), water (130 mL), 
brine (2 x 130 mL), dried over magnesium sulfate and the organic solvents evaporated to give 
an oil that was subjected to flash chromatography (15% ethyl acetate/hexane) to give 
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aldehyde 4.23 (1.293 g, 60 %) as a clear oil. Rf (20 % ethyl acetate/hexane): 0.21; 1H NMR 
(400 MHz, CDCl3) δ ppm 9.75 (t, J = 1.7 Hz, 1H), 7.36-7.24 (m, 1H), 4.49 (s, 2H), 3.47 (t, J 
= 6.5 Hz, 2H), 2.42 (dt, J = 7.4, 1.7 Hz, 2H), 1.69-1.59 (m, 4H), 1.47-1.37 (m, 2H); 13C 
NMR (101 MHz, CDCl3) δ ppm 202.6, 138.5, 128.3, 127.6, 127.5, 72.9, 70.0, 43.8, 29.4, 
25.8, 21.8.  
6-(Benzyloxy)hexanal via Dess-Martin oxidation140 
 
OH
BnO
O
BnO
4.22 4.23
DMP, CH2Cl2, RT - Δ
(55 %)
 
Benzyl ester 4.22 (1.230 g, 5.90 mmol) was dissolved in dichloromethane (45 mL) and Dess-
Martin periodinane (3.633, 8.57 mmol) was added in portions over ten minutes.  The reaction 
was stirred for three hours before a second amount of Dess-Martin periodinane (3.684, 8.69 
mmol) was added.  The reaction was stirred for 24 hours at room temperature and refluxed a 
further 20 hours before being quenched with ethyl acetate (250 mL) and saturated aqueous 
sodium bicarbonate solution (120 mL).  The organic phase was washed with saturated 
aqueous sodium thiosulfate (80 mL), water (250 mL), brine (250 mL), dried over anhydrous 
magnesium sulfate and the organic solvents evaporated to give an oil that was subjected to 
flash chromatography to give aldehyde 4.23 (0.670 g, 55 %) as a clear oil.  
Spectral data as above for 6-(Benzyloxy)hexanal via Swern oxidation.  
6-(Benzyloxy)hexylmethanesulfonate150 
OH
BnO OMsBnO
NEt3, DMAP,
MsCl, CH2Cl2
(54 %)
4.22 4.25  
Methanesulfonyl chloride (80 µL,  1.03 mmol) was added drop-wise over five minutes to a 
solution of alcohol 4.22 (0.1055 g, 0.51 mmol), 4-dimethylaminopyridine (6.5 mg, 53 µmol) 
and triethylamine (210 µL, 1.51 mmol) in dichloromethane (1 mL), cooled to 0 °C.  The 
reaction was stirred at 0 °C for 90 minutes before it was quenched with water (15 mL) and 
the aqueous phase extracted with ethyl acetate (3 x 10 mL).  The combined organic phase 
was washed with brine (15 mL), dried over magnesium sulfate and the organic phase 
evaporated under reduced pressure to afford an oil.  This crude oil was subjected to flash 
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chromatography to give mesylate 4.25 (72.8 mg, 54 %) as a clear oil. Rf (50 % ethyl 
acetate/hexane): 0.63; 1H NMR (400 MHz, CDCl3) δ ppm 7.36-7.31 (m, 5H), 4.50 (s, 2H), 
4.21 (t, J = 6.5 Hz, 2H), 3.47 (t, J = 6.4 Hz, 2H), 2.98 (s, 3H), 1.48-1.38 (m, 2H), 1.81-1.69 
(m, 2H), 1.69-1.56 (m, 2H); 13C NMR (101 MHz, CDCl3) δ ppm 138.5, 128.2, 127.5, 127.4, 
72.8, 70.2, 69.8, 37.2, 29.4, 29.0, 25.6, 25.2.  
((6-Bromohexyloxy)methyl)benzene via phosphorous tribromide bromination155 
OH
BnO BrBnO
PBr3, Pyridine,
Et2O/Hexane, RT - 0o C
(19 %)
4.22 4.26  
Pyridine (6.5 µL, 0.08 mmol) was added to benzyl ester 4.22 (0.2111 g, 1.01 mmol) stirring 
in diethyl ether (1.25 mL) and the solution cooled to 0 °C before the addition of phosphorous 
tribromide (40 µL, 0.41 mmol) dissolved in hexane (0.4 mL) drop-wise over eight minutes.  
Upon addition of phosphorous tribromide a white precipitate formed.  After 150 minutes the 
reaction was decanted into a 1:1 mixture of water and ice (30 mL) and the precipitate washed 
with hexane (20 mL).  The aqueous phase was extracted with diethyl ether (3 x 10 mL) and 
the combined organic extracts washed with brine (2 x 20 mL), dried over magnesium sulfate 
and evaporated under reduced pressure to give an oil that was subjected to flash 
chromatography (50 % ethyl acetate/hexane) to give bromo ether 4.26 (51.9 mg, 19 %) as a 
clear oil. Rf (50 % ethyl acetate/hexane): 0.89; 1H NMR (400 MHz, CDCl3) δ ppm 7.37-7.27 
(m, 5H), 4.50 (s, 1H), 3.47 (t, J = 6.5 Hz, 2H), 3.39 (t, J = 6.8 Hz, 2H), 1.90-1.80 (m, 2H), 
1.65-1.59 (m, 2H), 1.49-1.35 (m, 4H); 13C NMR (101 MHz, CDCl3) δ ppm 138.5, 128.3, 
127.6, 127.4, 72.8, 70.1, 33.8, 32.7, 29.5, 27.9, 25.4.  
((6-Bromohexyloxy)methyl)benzene via triphenylphosphine dibromide 
bromination155 
OH
BnO BrBnO
PBr2Ph3, CH2Cl2,
0 oC - RT
(26 %)4.22 4.26  
Alcohol 4.22 (0.2545 g, 1.20 mmol in dichloromethane (1 mL) was added to 
triphenylphosphine dibromide (0.6044 g, 1.43 mmol) dissolved in dichloromethane (2 mL) at 
0 °C drop-wise, over five minutes.  The reaction was stirred for twenty minutes at 0 °C and 
then left to warm to room temperature.  After five hours, an additional portion of 
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triphenylphosphine dibromide (0.5044 g, 1.20 mmol) was added and the reaction stirred for 
20 hours before being quenched with ethyl acetate (20 mL).  The organic phase was washed 
with saturated aqueous sodium thiosulfate (2 x 10 mL), water (3 x 10 mL), brine (2 x 10 mL), 
dried over magnesium sulfate and the organic solvents evaporated under reduced pressure to 
give an oil that was subjected to flash chromatography (50 % ethyl acetate/hexane) to give 
bromide 4.25 (82.3 mg, 25 % yield) as a clear oil. 
Spectral data as above for ((6-Bromohexyloxy)methyl)benzene via phosphorous tribromide 
bromination.  
6-(Tert-butyldimethylsilyloxy)hexan-1-ol 
OH
HO
OH
TBDMSO
TBDMSCl, Im,
THF, 0°C-RT
(72 %) 4.27
1
2
3
4
5
6
 
Tert-butyldimethylsilyl chloride (2.9031 g, 19.3 mmol) dissolved in tetrahydrofuran (50 mL) 
was added over 30 minutes to a stirred solution of 1,6-hexandiol (6.7580 g, 57.2 mmol) and 
imidazole (2.5912 g, 37.0 mmol) in dichloromethane (200 mL) at 0 °C.  The reaction was 
stirred at room temperature for 26 hours, filtered and the volatile components evaporated to 
give a resin that was purified by flash chromatography (50 % diethyl ether/petroleum ether) 
to give silyl ether 4.27 as a clear oil (3.228 g, 72 %). Rf (20 % ethyl acetate/petroleum ether): 
0.25; 1H NMR (500 MHz, CDCl3) δ ppm 3.57 (t, J = 6.7 Hz, 2H, H1 or H6), 3.57 (t, J = 6.5 
Hz, 2H, H1 or H6), 2.42 (s, 1H, OH), 1.55-1.46 ( m, 4H, H2 and H5), 1.35-1.28 (m, 4H, H3 
and H4), 0.85 (s, 9H, Si(CH3)2C(CH3)3), 0.01 (s, 6H, Si(CH3)2C(CH3)3); 13C NMR (126 
MHz, CDCl3) δ ppm 63.12 (C1 or C6), 62.60 (C1 or C6), 32.70 (C2 or C5), 32.62 (C2 or 
C5), 25.88 (Si(CH3)2C(CH3)3), 25.54 (C3 or C4), 25.48 (C3 or C4), 18.27 
(Si(CH3)2C(CH3)3), -5.36 (Si(CH3)2C(CH3)3); HRMS required for C12H29O2Si: 233.1937, 
Found: 233.1938. 
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Isopropyl 8-(tert-butyldimethylsilyloxy)-2-hydroxyoctanoate 
O
TBDMSO
OH
TBDMSO
DMP, CH2Cl2, RT
iPrOH/Et2O,
iPrOK, 0 oC
NaCNBH3, iPrOH, 65 oC
OiPr
O
Cl
Cl
(26 % over three steps)
TBDMSO
O
CO2iPr
Cl
TBDMSO CO2iPr
OH
4.5
4.27 4.28
4.294.30
 
To a stirred solution of Dess-Martin periodinane (8.772 g, 20.7 mmol) in dichloromethane 
(60 mL) was added silyl ether 4.27 (3.228 g, 13.8 mmol) in dichloromethane (40 mL) over 
fifteen minutes.  The reaction was stirred for three hours and quenched with aqueous sodium 
hydroxide (1.0 M, 70 mL).  The organic phase was separated and the aqueous phase extracted 
with dichloromethane (3 x 100 mL).  The combined organic phases were washed with 
aqueous sodium hydroxide (1.0 M, 50 mL), brine (50 mL), dried over anhydrous magnesium 
sulfate and evaporated to give a crude oil containing aldehyde 4.28 (2.6709 g).  Potassium 
isoproponate (25.5 mL, 25.5 mmol) was added to a solution of isopropyl dichloroacetate 4.5 
(3.947 g, 23.1 mmol) in dry isopropyl alcohol (25.5 mL) and dry diethyl ether (25.5 mL), 
cooled to 0 °C, over ten minutes.  After ten minutes of stirring, a solution of crude aldehyde 
4.28 (2.6709 g, 11.5 mmol crude) in dry isopropyl alcohol (13 mL) was added over five 
minutes and the reaction stirred at 0 °C for 95 minutes.  The reaction was quenched with 
diethyl ether (150 mL) and water (100 mL) and the aqueous layer extracted with diethyl ether 
(2 x 200 mL).  The combined organic phases were washed with brine (100 mL), dried and 
evaporated to give a crude oil containing α-chloroglycidic ester 4.29 (3.685 g).  To a solution 
of this crude mixture in dry isopropyl alcohol (70 mL) was added sodium cyanoborohydride 
(1.2818 g, 20.4 mmol) and the reaction heated to 70 °C under a calcium hydride drying tube.  
After 24 hours, sodium cyanoborohydride (0.6012 g, 9.56 mmol) was added and the reaction 
stirred at 70 °C for a further 19 hours before quenched with saturated ammonium chloride 
solution (70 mL) and the isopropyl alcohol evaporated.  Water (25 mL) was added to dissolve 
solids in the remaining solution and the aqueous phase extracted with diethyl ether (3 x 200 
mL).  The combined organic phases were washed with brine, dried over anhydrous 
magnesium sulfate and evaporated to give an oil that was subjected to flash chromatography 
(20% diethyl ether/petroleum ether) to give the α-hydroxy ester 4.30 as a clear oil (1.309 g, 
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28 % over three steps from silyl ether 4.27). Rf (20 % ethyl acetate/petroleum ether): 0.69; 1H 
NMR (500 MHz, CDCl3) δ ppm 5.07 (sept., J = 6.3 Hz, 1H, CHCOOCH(CH3)2), 4.10 (dd, J 
= 7.3, 4.2 Hz, 1H, CHCOOCH(CH3)2), 3.57 (t, J = 6.7 Hz, 2H, H6), 2.73 (s, 1H, OH), 1.78-
1.69 (m, 1H, H1’), 1.64-1.55 (m, 1H, H1), 1.52-1.45 (m, 2H, H5), 1.46-1.37 (m, 2H, H2), 
1.41-1.26 (m, 4H, H3 and H4), 1.25 (d, J = 6.3 Hz, 3H, CHCOOCH(CH3)2), 1.25 (d, J = 6.3 
Hz, 3H, CHCOOCH(CH3)2), 0.86 (s, 9H, Si(CH3)2C(CH3)3), 0.02 (s, 6H, Si(CH3)2C(CH3)3); 
13C NMR (126 MHz, CDCl3) δ ppm 174.8 (CHCOOCH(CH3)2), 70.4 (CHCOOCH(CH3)2), 
69.2 (CHCOOCH(CH3)2), 63.1 (C6), 34.3 (C1), 32.7 (C5), 29.1 (C3), 25.9 
(Si(CH3)2C(CH3)3), 24.6 (C2), 25.6 (C4), 21.7, 21.7 (CHCOOCH(CH3)2), 18.3 
(Si(CH3)2C(CH3)3), -5.34 (Si(CH3)2C(CH3)3); HRMS required for C17H37O4Si: 333.2461, 
Found 333.2468. 
Isopropyl 2,8-dihydroxyoctanoate 
HO CO2iPr
OH
TBDMSO CO2iPr
OH
TBAF, THF
(83 %)
4.30 4.31  
 Tetrabutylammonium fluoride dissolved in tetrahydrofuran (6.70 mL, 6.70 mmol) was added 
to α-hydroxy ester 4.30 (0.637 g, 1.92 mol) stirring in dry tetrahydrofuran (25 mL).  The 
reaction was stirred for four hours and the organic solvents evaporated to give a crude oil that 
was subjected to flash chromatography (75 % ethyl acetate/petroleum ether) to give ester 4.31 
as a clear oil (0.3483 g, 83 %). Rf (75 % ethyl acetate/petroleum ether): 0.31; 1H NMR (500 
MHz, CDCl3) δ ppm 5.07 ( sept., J = 6.3 Hz, 1H, CHCOOCH(CH3)2), 4.10 (dd, J = 7.3, 4.1 
Hz, 1H, CHCOOCH(CH3)2), 3.61 (t, J = 6.6 Hz, 2H, H6), 2.42 (s, 2H, OH), 1.79-1.70 (m, 
H1’), 1.65-1.56 (m, 1H, H1), 1.59-1.51 (m, 2H, H5), 1.50-1.39 (m, 2H, H4), 1.40-1.29 (m, 
4H, H2 and H3), 1.25 (d, J = 6.3 Hz, 3H, CHCOOCH(CH3)2), 1.25 (d, J = 6.3 Hz, 3H, 
CHCOOCH(CH3)2); 13C NMR (126 MHz, CDCl3) δ ppm 174.9 (CHCOOCH(CH3)2), 70.4 
(CHCOOCH(CH3)2), 69.4 (CHCOOCH(CH3)2), 62.8 (C6), 34.2 (C1), 32.5 (C5), 29.0 (C3), 
25.5 (C2), 24.6 (s, C4), 21.7, 21.7 (CHCOOCH(CH3)2); HRMS required for C11H23O4: 
219.1596, Found 219.1592. 
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Isopropyl 2,8-bis(bis(benzyloxy)phosphoryloxy)octanoate 
HO CO2iPr
OH
(BnO)2OPO CO2iPr
OPO(OBn)2
1. 1H-tetrazole,
(iPr)2NP(OBn)2,
CH2Cl2, RT
2. m-CPBA, 0 oC
4.31 4.32
(65 %)
 
Dibenzyl N,N-diisopropylphosphoramidite (1.45 mL, 4.41 mmol) was added to diol 4.31 
(0.2359 g, 10.8 mmol) dissolved in dry dichloromethane (20 mL).  After twenty minutes 1H-
tetrazole (0.5314 g, 7.59 mmol) was added and the reaction stirred at room temperature for a 
further three hours before being cooled to 0°C and meta-chloroperbenzoic acid, 75% by 
weight (1.1279 g, 4.90 mol) was added in one portion and the reaction stirred for two hours.  
The reaction was then quenched with saturated sodium thiosulfate solution (10 mL) and the 
organic phase washed twice with saturated sodium bicarbonate solution (10 mL), brine (10 
mL), dried over anhydrous sodium sulfate and evaporated to give a white solid (1.1696 g) 
that was subjected to column chromatography (50 % ethyl acetate/petroleum ether) to give 
diphosphate 4.32 as a clear oil (0.4895 g, 65 %). Rf (50 % ethyl acetate/petroleum ether): 
0.27; 1H NMR (500 MHz, CDCl3) δ ppm 7.37-7.29 (m, 20H, Phb-d), 5.13 (m, 4H, 
OPO(OCH2Ph)2), 5.07-4.99 (m, 5H, CHCOOCH(CH3)2 and OPO(OCH2Ph)2), 4.76 (ddd, J = 
7.8, 6.0, 6.0 Hz, 1H, CHCOOCH(CH3)2), 3.95 (dt, J = 7.2, 6.7 Hz, 2H, H6), 1.76 (dt, J = 7.3, 
7.3 Hz, 2H, H1), 1.59-1.50 (m, 2H, H5), 1.37-1.28 (m, 2H, H2), 1.29-1.21 (m, 4H, H3 and 
H4), 1.21 (d, J = 6.3 Hz, 1H, CHCOOCH(CH3)2); 13C NMR (126 MHz, CDCl3) δ ppm  
169.42 (d, J = 3.2 Hz, CHCOOCH(CH3)2), 135.7, 135.7 (OPO(OCH2Pha)2), 128.4, 128.4, 
128.3, 127.8, 127.8, 127.7 (OPO(OCH2Phb-d)2), 75.5 (d, J = 5.8 Hz, CHCOOCH(CH3)2), 
69.3 (d, J = 5.8 Hz, OPO(OCH2Ph), 69.3 (d, J = 5.8 Hz, OPO(OCH2Ph), 69.1 (t, J = 5.5 Hz, 
CHCOOCH(CH3)2), 67.7 (d, J = 6.1 Hz, C1), 32.7 (d, J = 6.7 Hz, C6), 29.8 (d, J = 7.0 Hz, 
C2), 28.4 (C3), 25.0 (C4), 24.2 (C5), 21.5 (CHCOOCH(CH3)2). 31P NMR (121 MHz, 
CDCl3) δ ppm -0.38 (sext., J = 7.8 Hz, CHOPO(OBn)2), -1.24 (sept., J = 7.2 Hz, 
CH2OPO(OBn)2); HRMS required for C39H49NaO10P2: 761.2620, Found: 761.2601. 
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2,8-Bis(phosphonatooxy)octanoate 
(-O)2OPO CO2
-
OPO(O-)2
1. H2, Pd/C, EtOAc
2. KOH/H2O; Dowex-H+
3. AEC
(BnO)2OPO CO2iPr
OPO(OBn)2
(2 %)
4.32 4.33  
10 % palladium over carbon (0.3398 g) was added to phosphorylated ester 4.32 (0.7033 g, 
952 mmol) dissolved in ethyl acetate (40 mL).  The reaction vessel was purged with 
hydrogen gas and stirred for 26 hours before being washed through a celite plug with ethyl 
acetate (250 mL) and methanol (250 mL).  The organic solvents were evaporated to give an 
oil  that was stirred in 10 % w/v aqueous potassium hydroxide (5 mL) for two hours before 
being passed down a column (20 x 100 mm) of Dowex-50X8 H+ resin.  This solution was 
lypholised to give a pink solid (0.3162 g).  0.1624 g of this solid was further purified by 
anion exchange chromatography (0-1 M ammonium bicarbonate).  The fractions containing 
product were lypholised to give the synthetic target 4.33 (28.7 mg, 2 %). 
1H NMR (500 MHz, D2O) δ ppm 4.38 (td, J = 8.7, 5.3 Hz, 1H, CHCOO-), 3.77 (dt, J = 6.8, 
6.7 Hz, 2H, H6), 1.78-1.67 (m, 2H, H1), 1.62-1.54 (m, 2H, H5), 1.44-1.34 (m, 2H, H2), 1.37-
1.25 (m, 4H, H3 and H4); 13C NMR (75 MHz, D2O) δ ppm 182.6 (CHCOO-), 78.6 (d, J = 5.3 
Hz, CHCOO-), 67.7 (d, J = 5.2 Hz, C6), 36.0 (d, J = 5.3 Hz, C1), 32.5 (d, J = 6.8 Hz, C5), 
30.9 (C4), 27.3 (C3), 26.5 (C2); 31P NMR (121 MHz, D2O) δ ppm 1.1 (d, J = 8.7 Hz, 
CHOP(O-)2), 2.5 (t, J = 6.7 Hz, CH2OP(O-)2); HRMS (electrospray, negative ion) required 
for C8H17O10P2: 335.0297, Found 335.0310. 
Isopropyl 2-(bis(benzyloxy)phosphoryloxy)-8-(tert-butyldimethylsilyloxy)octanoate 
TBDMSO CO2iPr
OPO(OBn)2
TBDMSO CO2iPr
OH
(80 %)
1. 1H-tetrazole,
(iPr)2NP(OBn)2,
CH2Cl2, RT
2. m-CPBA, 0 oC
4.30 4.34  
Dibenzyl N,N-diisopropylphosphoramidite (1.40 mL, 4.17 mmol) was added to α-hydroxy 
ester 4.30 (0.3566 g, 1.07 mmol) and 1-H tetrazole (0.5257 g, 7.51 mmol) in dry 
dichloromethane (20 mL).  The reaction was stirred for two hours and cooled to 0 °C before 
the addition of meta-chloroperbenzoic acid (1.1216 g, 6.50 mmol).  The solution was stirred 
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for two hours before being quenched with diethyl ether (100 mL).  The organic phase was 
washed with saturated sodium thiosulfate solution (2 x 20 mL), saturated sodium bicarbonate 
solution (2 x 20 mL), brine (20 mL), dried over anhydrous magnesium sulphate and 
evaporated to give an oil which was subjected to column chromatography to give 
phosphorylated ester 4.34 (0.5061 g, 80 %). Rf (25 % ethyl acetate/petroleum ether): 0.39; 1H 
NMR (500 MHz, CDCl3) δ ppm:  7.37-7.32 (m, 10H, OPO(OCH2Phb-d)2), 5.13 (m, 4H, 
OPO(OCH2Ph)2), 5.06 (hept., J = 6.6 Hz, 1H, CHCOOCH(CH3)2), 4.76 (ddd, J = 7.6, 6.1, 
6.1 Hz, 1H, CHCOOCH(CH3)2), 3.57 (t, J = 6.5 Hz, 1H, H6), 1.79 (dt, J = 7.6, 7.4 Hz, 2H, 
H1), 1.51-1.43 (m, 2H, H5), 1.43-1.32 (m, 2H, H2), 1.33-1.23 (m, 4H, H3 and H4), 1.22 (d, J 
= 6.6 Hz, 6H, COOCH(CH3)2), 0.89 (s, 9H, Si(CH3)2C(CH3)3), 0.04 (s, 6H, 
Si(CH3)2C(CH3)3); 13C NMR (126 MHz, CDCl3): δ ppm: 169.6 (d, J = 3.2 Hz, 
CHCOOCH(CH3)2), 128.5, 128.4, 128.4, 128.4, 127.9, 127.7 (OPO(OCH2Phb-d)2), 75.7 (d, J 
= 5.7 Hz, CHCOOCH(CH3)2), 69.3, 69.3 (d, J = 5.7 Hz, OP(OCH2Ph)2), 69.1 
(CHCOOCH(CH3)2), 63.1 (C6), 32.9 (d, J = 6.4 Hz, C1), 32.6 (C5), 28.9 (C3), 25.9 
(Si(CH3)2C(CH3)3), 25.5 (C4), 24.4 (C2), 21.6, 21.6 (CHCOOCH(CH3)2), 18.3 
(Si(CH3)2C(CH3)2), -5.3 (Si(CH3)2C(CH3)3); 31P NMR (121 MHz, CDCl3) δ ppm -1.39 (sext, 
J = 7.6 Hz, CHOPO(OBn)2); HRMS required for C39H42O7PSi: 593.3063, Found: 593.3055.  
Isopropyl 2-(bis(benzyloxy)phosphoryloxy)-8-hydroxyoctanoate 
TBDMSO CO2iPr
OPO(OBn)2
HO CO2iPr
OPO(OBn)2TBAF, THF
(56 %)
4.34 4.35
 
A 1M solution of tetrabutylammonium fluoride in tetrahydrofuran (3.0 mL, 3.0 mmol) was 
added to phosphorylated silyl ether 4.34 (0.5061 g, 0.854 mmol) in dry tetrahydrofuran (6 
mL) and stirred for 28 hours.  The tetrahydrofuran was evaporated to give a brown oil which 
was purified by flash chromatography (75 % ethyl acetate/petroleum ether) to give alcohol 
4.35 as a clear oil (0.2288 g, 56 %). Rf (50 % ethyl acetate/petroleum ether): 0.13; 1H NMR 
(CDCl3): δ ppm 7.37-7.32 (m, 10H, PO(OCH2Phb-d)2, 5.11 (dq, J = 11.7, 7.4 Hz, 2H, 
CHOPO(OCH2Bn)2), 5.08-5.00 (m, 3H, CHOPO(OCH2Bn)2 and CHCOOCH(CH3)2), 4.75 
(ddd, J = 7.6, 6.1, 6.1 Hz, 1H, CHCOOCH(CH3)2), 3.59 (t, J = 6.6 Hz, 1H, H6), 2.13 (s, 1H, 
OH), 1.79 (dt, J = 7.6, 7.1 Hz, 2H, H1), 1.54-1.47 (m, 2H, H5), 1.42-1.31 (m, 2H, H2), 1.34-
1.24 (m, 4H, H3 and H4), 1.21 (d, J = 6.3 Hz, 6H, CHCOOCH(CH3)2); 13C NMR (126 MHz, 
CDCl3): δ ppm: 169.6 (d, J = 3.1 Hz, CHCOOCH(CH3)2), 135.7, 135.7 (d, J = 7.6 Hz, 
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CHOPO(OCH2Pha)2), 128.4, 127.9, 127.7, (br, CHOPO(OCH2Phb-d), 75.6 (d, J = 5.7 Hz, 
CHCOOCH(CH3)2), 69.3, 69.3 (d, J = 5.6 Hz, CHOPO(OCH2Ph)2), 69.2 
(CHCOOCH(CH3)2),  62.6 (C6), 32.8 (d, J = 6.4 Hz, C1), 32.4 (C5), 28.6 (C3), 25.4 (C4), 
24.3 (C2), 21.6, 21.6 (CHCOOCH(CH3)2); 31P NMR (121 MHz, CDCl3) δ ppm -1.62 (sext., J 
= 7.6 Hz, CHOPO(OPh)2); HRMS required for C25H36O7P: 479.2199, Found: 479.2191. 
8-hydroxy-2-(phosphonatooxy)octanoate 
HO CO2-
OPO(O-)2
1. H2, Pd/C, EtOAc
2. KOH/H2O; Dowex-H+
HO CO2iPr
OPO(OBn)2
(41 %)
4.35 4.36  
Ethyl acetate (15 mL) was added to 10 % palladium over carbon (162.4 mg) and the reaction 
mixture stirred under hydrogen for 10 minutes before protected phosphate 4.35 (272.0 mg, 
0.568 mmol) in ethyl acetate (5 mL) was added by syringe.  The reaction vessel was repurged 
with hydrogen and stirred for 18 hours before being filtered through a celite plug with ethyl 
acetate (100 mL) and methanol (100 mL).  The filtrate was evaporated and the residue was 
resuspended in aqueous potassium hydroxide (1 M, 3 mL) and stirred at room temperature for 
one hour.  The solution was diluted with 5 mL water and extracted twice with 
dichloromethane (5 mL each) and the organic phase discarded.  The aqueous phase was 
passed down a column of Dowex-50X8-H+ resin (20 x 100 mm) and eluted with water (50 
mL).  The solution was lypholised to give the product 4.36 (0.2053 g, 41 %). 1H NMR (500 
MHz, D2O) δ ppm 4.40 (td, J = 8.7, 5.5 Hz, 1H, CHCOO-), 3.62 (t, J = 6.6 Hz, 2H, H6), 2.26 
(s, 1H, OH), 1.80-1.72 (m, 2H, H1), 1.63-1.52 (m, 2H, H5), 1.50-1.26 (m, 6H, H2, H3 and 
H4); 13C NMR (126 MHz, D2O) δ ppm 181.2 (d, J = 4.7 Hz, CHCOO-), 76.2 (d, J = 5.5 Hz, 
CHCOO-), 62.4 (C6), 34.17 (d, J = 3.9 Hz, C1), 31.7 (C2), 29.0 (C3), 25.4 (C4), 24.5 (C2); 
31P NMR (121 MHz, D2O) δ ppm 2.5 (d, J = 5.5 Hz, CHOPO(O-)2); HRMS (electrospray, 
negative ion) required for C8H16O7P: 255.0634, Found 255.0645. 
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Isopropyl 2-(benzyloxy)-8-(tert-butyldimethylsilyloxy)octanoate 
TBDMSO CO2iPr
OH Ag2O, KI, BnBr,
CH2Cl2, RT
(66 %) TBDMSO CO2iPr
OBn
4.30 4.37
 
To a stirred solution of silver oxide (0.2402 g, 1.04 mmol), potassium iodide (11.8 mg, 
0.00711 mmol) and α-hydroxy ester 4.30 (0.2304 g, 0.693 mmol) in dry dichloromethane (1.5 
mL) was added benzyl bromide (205 µL, 1.72 mmol) and the solution stirred for nine hours 
before being washed through a celite plug with diethyl ether (140 mL).  The organic phase 
was washed with water (25 mL), brine (25 mL), dried and evaporated to give an oil that was 
subjected to flash chromatography (5 % diethyl ether/petroleum ether) to give benzylated 
ester 4.37 as an oil (0.1924 g, 66 %). Rf (20 % ethyl acetate/petroleum ether): 0.66; 1H NMR 
(500 MHz, CDCl3) δ ppm 7.40-7.25 (m, 5H, CHOCH2Phb-d), 5.11 (sept., J = 6.3 Hz, 1H, 
CHCOOCH(CH3)2), 4.70 (d, J = 11.6 Hz, 1H, OCH2Ph), 4.40 (d, J = 11.6 Hz, 1H, OCH2Ph), 
3.89 (t, J = 5.8 Hz, 1H, CHCOOCH(CH3)2), 3.59 (t, J = 6.6 Hz, 2H, H6), 1.80-1.70 (m, 2H, 
H1), 1.55-1.23 (m, 8H, H2, H3, H4 and H5), 1.30-1.25 (m, 6H, CHCOOCH(CH3)2), 0.90 (s, 
9H, Si(CH3)2C(CH3)3), 0.05 (s, 6H, Si(CH3)2C(CH3)3); 13C NMR (CDCl3): δ 172.4 
(COOCH(CH2)2), 137.6 (CH2Pha), 127.950 (CH2Phb-c), 128.3 (CH2Phb-c), 127.7 (CH2Phd), 
78.1 (CHCOOCH(CH2)2), 72.1 (CH2C6H6), 63.1 (C1), 68.1 (CHCOOCH(CH2)2), 32.8 (C2), 
32.7 (C6), 29.0 (C4), 25.9 (OSi(CH3)2C(CH3)3), 25.6 (C3), 25.2 (C5), 21.8, 21.8 
(CHCOOCH(CH3)2), 18.3 (OSi(CH3)2C(CH3)3), -5.3 (Si(CH3)2C(CH3)3); HRMS required for 
C24H43O4Si: 423.2931, Found: 423.2930.  
Isopropyl 2-(benzyloxy)-8-hydroxyoctanoate 
TBDMSO CO2iPr
OBn
HO CO2iPr
OBnTBAF, THF
(83 %)
4.37 4.38  
A 1M solution of tetrabutylammonium fluoride in dry tetrahydrofuran (2.8 mL, 2.8 mmol) 
was added to silyl ether 4.37 (0.3429 g, 0.811 mmol) in dry tetrahydrofuran (10 mL) and 
stirred for four hours.  The volatile components were evaporated to give a viscous oil that 
was subjected to flash chromatography (40 % ethyl acetate/petroleum ether) to give alcohol 
4.38 as a clear oil (0.2073 g, 83 % yield). Rf (50 % ethyl acetate/petroleum ether): 0.49; 1H 
NMR (500 MHz, CDCl3) δ ppm 7.35-7.23 (m, 5H, CHOCH2Phb-d), 5.07 (sept., J = 6.3 Hz, 
1H, CHCOOCH(CH3)2), 4.66 (d, J = 11.6 Hz, 1H, CHOCH2Ph), 4.37 (d, J = 11.6 Hz, 1H, 
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CH2Ph), 3.85 (dd, J = 7.2, 5.6 Hz, 1H, CHCOOCH(CH3)2), 3.56 (t, J = 6.7 Hz, 2H, H6), 2.01 
(br, 1H, OH), 1.75-1.68 (m, 2H, H1), 1.53-1.46 (m, 2H, H5), 1.47-1.35 (m, 2H, H2), 1.38-
1.25 (m, 2H, H3 and H4), 1.25, 1.25 (d, J = 6.3 Hz, 6H, CHCOOCH(CH3)2); 13C NMR (126 
MHz, CDCl3) δ ppm: 172.4 (CHCOOCH(CH3)2), 137.5 (OCH2Pha), 128.2, 127.9 (OCH2Phb-
c), 127.7 (OCH2Phd), 78.0 (CHCOOCH(CH3)2), 72.0 (OCH2Ph), 68.2 (CHCOOCH(CH3)2) 
62.6 (C6), 32.7 (C1) 32.4 (C5), 28.9 (C3), 25.4 (C2), 25.1 (C4), 21.7, 21.7 
(CHCOOCH(CH3)2); HRMS required for C18H29O4: 309.2066, Found: 309.2066. 
Isopropyl 2-(benzyloxy)-8-(bis(benzyloxy)phosphoryloxy)octanoate 
(BnO)2OPO CO2iPr
OBn
HO CO2iPr
OBn
(84 %)
1. 1H-tetrazole,
(iPr)2NP(OBn)2,
CH2Cl2, RT
2. m-CPBA, 0 oC
4.38 4.39  
Dibenzyl N,N-Diisopropylphosphoramidite (200 µL, 0.596 mmol) was added to a solution of 
alcohol 4.38 (0.1438 g, 0.301 mmol) and 1H-tetrazole (74.6 mg, 1.06 mmol) dissolved in 
dichloromethane (10 mL) and the reaction stirred for four hours before being cooled to 0 °C 
and meta-chloroperbenzoic acid (0.1564 g, 0.906 mmol) was added.  The mixture was stirred 
for a further two hours before quenching with diethyl ether (40 mL) and the organic phase 
washed with aqueous 10 % solution of sodium thiosulfate (2 x 5 mL), saturated aqueous 
sodium bicarbonate (2 x 5 mL), brine (5 mL),  dried over anhydrous magnesium sulfate and 
the organic solvents evaporated to give an oil which was subjected to flash chromatography 
(25% ethyl acetate/petroleum ether) to give a clear oil (0.1579 g) that contained 
monophosphate 4.39 (0.1446 g, 84 %) and dibenzyl phosphite (14.4 mg, 8.9 % w/w) and was 
used in the next reaction step without any further purification. Rf (50 % ethyl 
acetate/petroleum ether): 0.41; 1H NMR (500 MHz, CDCl3) δ ppm 7.42-7.27 (m, 15H, 
OPO(OCH2Phb-d)2 and CHOCH2Phb-d), 5.12 (sept., J = 6.2 Hz, 1H, CHCOOCH(CH3)2), 5.05 
(dd, J = 8.3, 6.5 Hz, 4H, OPO(OCH2Ph)2), 4.71 (d, J = 11.6 Hz, 1H, CHOCH2Ph), 4.41 (d, J 
= 11.6 Hz, 1H, CHOCH2Ph), 3.98 (dt, J = 6.7, 6.7 Hz, 2H, H6), 3.89 (dd, J = 7.2, 5.5 Hz, 
1H, CHCOOCH(CH3)2), 1.79-1.70 (m, 2H, H1), 1.63-1.56 (m, 2H, H5), 1.50-1.21 (m, 6H, 
H2, H3 and H4), 1.29 (dd, J = 6.2 Hz, 6H, CHCOOCH(CH3)2); 13C NMR (126 MHz, CDCl3) 
δ ppm 172.3 (CHCOOCH(CH3)2), 137.5 (CHOCH2Pha), 135.8, 135.8 (OPO(OCH2Pha)2), 
128.6, 128.4, 128.4, 128.2, 127.9, 127.9, 127.8, 127.7 (OCH2Phb-d and OPO(CH2Phb-d)2), 
77.9 (CHOOCH(CH3)2), 72.05 (CHOCH2Ph), 69.0, 69.0 (dd, J = 4.1 Hz, OPO(OCH2Ph)2), 
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68.1 (CHOOCH(CH3)2), 67.8 (d, J = 6.2 Hz, C6), 32.7 (C1), 29.9 (d, J = 7.1 Hz, C5), 28.6 
(s,C3), 25.1 (C4), 25.0 (C2), 21.8, 21.7 (CHCOOCH(CH3)2); 31P NMR (121 MHz, CDCl3): δ 
ppm -0.8 (sept., J = 7.7 Hz, CH2OPO(OBn)2), 7.8 (dp, J = 707.4, 9.5 Hz, HPO(OBn)2); 
HRMS required for C32H41NaO7P: 591.2482, Found: 591.2484.  
2-Hydroxy-8-(phosphonatooxy)octanoate 
1. H2, Pd/C, EtOAc
2. KOH/H2O; Dowex-H+
3. AEC
(12 %)(BnO)2OPO CO2iPr
OBn
(-O)2OPO CO2-
OH
4.39 4.40  
10 % palladium over carbon (83.7 mg) was added to phosphorylated ester 4.39 (0.149 g, 952 
mmol) in ethyl acetate (15 mL).  The reaction vessel was purged with hydrogen gas and 
stirred for 18 hours before being washed through a celite plug with ethyl acetate (100 mL) 
and methanol (100 mL).  The volatile components were evaporated.  The resin was 
resuspended in 10% w/v aqueous potassium hydroxide (5 mL) and stirred for one hour before 
being passed down a column (20 x 100 mm) of Dowex-50X8 H+ type resin and eluted with 
water (50 mL).  This solution was lypholised to give a white powder which was dissolved in 
MilliQ water (20 mL), filtered using a 0.45 µM membrane and further purified by anion 
exchange chromatography (0-1 M ammonium bicarbonate).  The fractions containing product 
were lypholised to give the synthetic target 4.40 (35.4 mg, 12 %).  1H NMR (500 MHz, D2O): 
δ ppm 3.93 (dd, J = 7.3, 4.3 Hz, CHCOOH), 3.64 (dt, J = 6.9, 6.9 Hz, 2H, H6), 1.67-1.57 (m, 
1H, H1), 1.53-1.46 (m, 3H, H5 and H1’), 1.34-1.19 (m, 6H, H2, H3 and H4); 13C NMR (126 
MHz, Solvent) δ ppm 182.5 (CHCOO-), 72.9 (CHCOO-), 65.3 (d, J = 4.3 Hz, C6), 34.5 (C1), 
30.8 (d, J = 7.0 Hz, C5), 29.0, 25.5, 24.92 (C2, C3 and C4); 31P NMR (121 MHz, D2O) δ 
ppm 3.6 (t, J = 5.0 Hz, CH2OPO(O-)2); HRMS (electrospray, negative ion) required for 
C8H16O7P: 255.0634, Found 255.0642. 
 
 173 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References 
 
The findings of one, 
impossible without the 
knowledge of many
  References 
 
174 
 
 
1. Raetz, C. R. H.; Whitfield, C., Lipopolysaccharide endotoxins, Annu. Rev. Biochem. 
2002, 71, 635-700. 
2. Holst, O., Chemical structure of the core region of lipopolysaccharides - an update, 
Trends Glycosci. Glycotechnol. 2002, 14, 87-103. 
3. Doong, R. L., Isolation and characterization of KDOP synthase and two isozymes of 
DAHP synthase in Spinacia oleracea L. and Solanum tuberosum L.; MSc, University of 
Florida, 1990. 
4. Cipolla, L.; Polissi, A.; Airoldi, C.; Galliani, P.; Sperandeo, P.; Nicotra, F., The KDO 
biosynthetic pathway toward OM biogenesis as target in antibacterial drug design and 
development, Curr. Drug Discovery Technol. 2009, 6, 19-33. 
5. Meredith T., C.; Woodard R., W., Escherichia coli YrbH is a D-arabinose 5-phosphate 
isomerase, J. Biol. Chem. 2003, 278, 32771-7. 
6. Bateman, A., The SIS domain: a phosphosugar-binding domain, Trends Biochem. Sci. 
1999, 24, 94-95. 
7. Jeffery, C. J.; Hardre, R.; Salmon, L., Crystal structure of rabbit phosphoglucose 
isomerase complexed with 5-phospho-D-arabinonate identifies the role of Glu357 in 
catalysis, Biochemistry 2001, 40, 1560-1566. 
8. Straus, D.; Raines, R.; Kawashima, E.; Knowles, J. R.; Gilbert, W., Active site of 
triosephosphate isomerase: in vitro mutagenesis and characterization of an altered enzyme, 
Proc. Natl. Acad. Sci. U. S. A. 1985, 82, 2272-6. 
9. Lolis, E.; Petsko, G. A., Crystallographic analysis of the complex between 
triosephosphate isomerase and 2-phosphoglycolate at 2.5 Å resolution: implications for 
catalysis, Biochemistry 1990, 29, 6619-25. 
10. Bigham, E. C.; Gragg, C. E.; Hall, W. R.; Kelsey, J. E.; Mallory, W. R.; Richardson, 
D. C.; Benedict, C.; Ray, P. H., Inhibition of arabinose 5-phosphate isomerase. An approach 
to the inhibition of bacterial lipopolysaccharide biosynthesis, J. Med. Chem. 1984, 27, 717-
26. 
11. Goldman, R. C.; Devine, E. M., Isolation of Salmonella typhimurium strains that 
utilize exogenous 3-deoxy-D-manno-octulosonate for synthesis of lipopolysaccharide, J. 
Bacteriol. 1987, 169, 5060-5. 
12. Goldman, R.; Kohlbrenner, W.; Lartey, P.; Pernet, A., Antibacterial agents 
specifically inhibiting lipopolysaccharide synthesis, Nature 1987, 329, 162-4. 
  References 
 
175 
 
13. Goldman, R. C.; Doran, C. C.; Capobianco, J. O., Analysis of lipopolysaccharide 
biosynthesis in Salmonella typhimurium and Escherichia coli by using agents which 
specifically block incorporation of 3-deoxy-D-manno-octulosonate, J. Bacteriol. 1988, 170, 
2185-91. 
14. Tadanier, J.; Lee, C. M.; Whittern, D.; Wideburg, N., Synthesis of some C-8-modified 
3-deoxy-β-D-manno-2-octulosonic acid analogs as inhibitors of CMP-KDO synthetase, 
Carbohydr. Res. 1990, 201, 185-207. 
15. Adachi, H.; Kondo, K.-I.; Kojima, F.; Umezawa, Y.; Ishino, K.; Hotta, K.; Nishimura, 
Y., Synthesis and inhibitory activity of 8-substituted 2-deoxy-β -KDO against CMP-KDO 
synthetase, Nat. Prod. Res., Part B 2006, 20, 361-370. 
16. Levin, D. H.; Racker, E., Condensation of arabinose 5-phosphate and phosphoryl enol 
pyruvate by 2-keto-3-deoxy-8-phosphooctonic acid synthetase, J. Biol. Chem. 1959, 234, 
2532-9. 
17. Ray, P. H.; Benedict, C. D., Purification and characterization of specific 3-deoxy-D-
manno-octulosonate 8-phosphate phosphatase from Escherichia coli B, J. Bacteriol. 1980, 
142, 60-8. 
18. Rick, P. D.; Fung, L. W. M.; Ho, C.; Osborn, M. J., Lipid A mutants of Salmonella 
typhimurium. Purification and characterization of a lipid A precursor produced by a mutant in 
3-deoxy-D-manno-octulosonate-8-phosphate synthetase, J. Biol. Chem. 1977, 252, 4904-12. 
19. Meredith, T. C.; Aggarwal, P.; Mamat, U.; Lindner, B.; Woodard, R. W., Redefining 
the requisite lipopolysaccharide structure in Escherichia coli., ACS Chem. Biol. 2006, 1, 33-
42. 
20. Stryer, L.; Editor, Biochemistry, 4th Revised Edition, 1996. 
21. Hedstrom, L.; Abeles, R., 3-Deoxy-D-manno-octulosonate-8-phosphate synthase 
catalyzes the carbon-oxygen bond cleavage of phosphoenolpyruvate, Biochem. Biophys. Res. 
Commun. 1988, 157, 816-20. 
22. Dotson, G. D.; Nanjappan, P.; Reily, M. D.; Woodard, R. W., Stereochemistry of 3-
deoxyoctulosonate 8-phosphate synthase, Biochemistry 1993, 32, 12392-7. 
 
 
23. Baasov, T.; Sheffer-Dee-Noor, S.; Kohen, A.; Jakob, A.; Belakhov, V., Catalytic 
mechanism of 3-deoxy-D-manno-2-octulosonate-8-phosphate synthase. The use of synthetic 
  References 
 
176 
 
analogs to probe the structure of the putative reaction intermediate, Eur. J. Biochem. 1993, 
217, 991-9. 
24. D'Souza, F. W.; Benenson, Y.; Baasoy, T., Catalytic mechanism of KDO8P synthase: 
synthesis and evaluation of a putative reaction intermediate, Bioorg. Med. Chem. Lett. 1997, 
7, 2457-2462. 
25. Liang, P.-H.; Lewis, J.; Anderson, K. S.; Kohen, A.; D'Souza, F. W.; Benenson, Y.; 
Baasov, T., Catalytic mechanism of KDO8P synthase: transient kinetic studies and evaluation 
of a putative reaction intermediate, Biochemistry 1998, 37, 16390-16399. 
26. Du, S.; Tsipori, H.; Baasov, T., Synthesis and evaluation of putative oxocarbenium 
intermediate mimic in the KDO8P synthase-catalyzed reaction as a tool for the design of 
potent inhibitors for lipopolysaccharide biosynthesis, Bioorg. Med. Chem. Lett. 1997, 7, 
2469-2472. 
27. Du, S.; Faiger, H.; Belakhov, V.; Baasov, T., Towards the development of novel 
antibiotics: synthesis and evaluation of a mechanism-based inhibitor of Kdo8P synthase, 
Bioorg. Med. Chem. 1999, 7, 2671-2682. 
28. Li, Z.; Sau, A. K.; Shen, S.; Whitehouse, C.; Baasov, T.; Anderson, K. S., A snapshot 
of enzyme catalysis using electrospray ionization mass spectrometry, J. Am. Chem. Soc. 
2003, 125, 9938-9939. 
29. Li, Z.; Sau, A. K.; Furdui, C. M.; Anderson, K. S., Probing the role of tightly bound 
phosphoenolpyruvate in Escherichia coli 3-deoxy-D-manno-octulosonate 8-phosphate 
synthase catalysis using quantitative time-resolved electrospray ionization mass spectrometry 
in the millisecond time range, Anal. Biochem. 2005, 343, 35-47. 
30. Wang, J.; Duewel, H. S.; Woodard, R. W.; Gatti, D. L., Structures of Aquifex aeolicus 
KDO8P synthase in complex with R5P and PEP, and with a bsubstrate Inhibitor: role of 
active site water in catalysis, Biochemistry 2001, 40, 15676-15683. 
31. Asojo, O.; Friedman, J.; Adir, N.; Belakhov, V.; Shoham, Y.; Baasov, T., Crystal 
structures of KDO8P synthase in its binary complexes with the substrate 
phosphoenolpyruvate and with a mechanism-based inhibitor, Biochemistry 2001, 40, 6326-
6334. 
32. Alberg, D. G.; Lauhon, C. T.; Nyfeler, R.; Faessler, A.; Bartlett, P. A., Inhibition of 5-
enolpyruvoylshikimate 3-phosphate (EPSP) synthase by analogs of the tetrahedral 
intermediate and of EPSP, J. Am. Chem. Soc. 1992, 114, 3535-46. 
33. Kim, D. H.; Lees, W. J.; Haley, T. M.; Walsh, C. T., Kinetic characterization of the 
inactivation of UDP-GlcNAc enolpyruvyl transferase by (Z)-3-fluorophosphoenolpyruvate: 
  References 
 
177 
 
evidence for two oxocarbenium ion intermediates in enolpyruvyl transfer catalysis, J. Am. 
Chem. Soc. 1995, 117, 1494-502. 
34. Duewel, H. S.; Radaev, S.; Wang, J.; Woodard, R. W.; Gatti, D. L., Substrate and 
metal complexes of 3-deoxy-D-manno-octulosonate-8-phosphate synthase from Aquifex 
aeolicus at 1.9 Å. resolution. Implications for the condensation mechanism, J. Biol. Chem. 
2001, 276, 8393-8402. 
35. Kona, F.; Xu, X.; Martin, P.; Kuzmic, P.; Gatti, D. L., Structural and mechanistic 
changes along an engineered path from metallo to nonmetallo 3-Deoxy-D-manno-
octulosonate 8-phosphate synthases, Biochemistry 2007, 46, 4532-4544. 
36. Tao, P.; Gatti, D. L.; Schlegel, H. B., The energy landscape of 3-deoxy-D-manno-
octulosonate 8-phosphate synthase, Biochemistry 2009, 48, 11706-11714. 
37. Duewel, H. S.; Woodard, R. W., A metal bridge between two enzyme families. 3-
Deoxy-D-manno-octulosonate-8-phosphate synthase from Aquifex aeolicus requires a 
divalent metal for activity, J. Biol. Chem. 2000, 275, 22824-22831. 
38. Shulami, S.; Yaniv, O.; Rabkin, E.; Shoham, Y.; Baasov, T., Cloning, expression, and 
biochemical characterization of 3-deoxy-D-manno-2-octulosonate-8-phosphate (KDO8P) 
synthase from the hyperthermophilic bacterium Aquifex pyrophilus, Extremophiles 2003, 7, 
471-481. 
39. Birck, M. R.; Woodard, R. W., Aquifex aeolicus 3-Deoxy-D-manno-2-octulosonic 
acid 8-phosphate synthase: a new class of KDO 8-P synthase?, J. Mol. Evol. 2001, 52, 205-
214. 
40. Ahn, M.; Cochrane, F. C.; Patchett, M. L.; Parker, E. J., Arabinose 5-phosphate 
analogues as mechanistic probes for Neisseria meningitidis 3-deoxy-D-manno-octulosonate 
8-phosphate synthase, Bioorg. Med. Chem. 2008, 16, 9830-9836. 
41. Walker, G. E.; Dunbar, B.; Hunter, I. S.; Nimmo, H. G.; Coggins, J. R., Evidence for 
a novel class of microbial 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase in 
Streptomyces coelicolor A3(2), Streptomyces rimosus and Neurospora crassa, Microbiology 
(Reading, U. K.) 1996, 142, 1973-1982. 
42. Jensen, R. A.; Xie, G.; Calhoun, D. H.; Bonner, C. A., The correct phylogenetic 
relationship of KdsA (3-deoxy-D-manno-octalosonate 8-phosphate synthase) with one of two 
independently evolved classes of AroA (3-deoxy-D-arabino-heptulosonate 7-phosphate 
synthase), J. Mol. Evol. 2002, 54, 416-423. 
43. Webby C., J.; Baker H., M.; Lott, J. S.; Baker E., N.; Parker E., J., The structure of 3-
deoxy-D-arabino-heptulosonate 7-phosphate synthase from Mycobacterium tuberculosis 
  References 
 
178 
 
reveals a common catalytic scaffold and ancestry for type I and type II enzymes, J. Mol. Biol. 
2005, 354, 927-39. 
44. Webby C., J.; Patchett M., L.; Parker E., J., Characterization of a recombinant type II 
3-deoxy-D-arabino-heptulosonate-7-phosphate synthase from Helicobacter pylori, Biochem. 
J. 2005, 390, 223-30. 
45. Stephens, C. M.; Bauerle, R., Analysis of the metal requirement of 3-deoxy-D-
arabino-heptulosonate-7-phosphate synthase from Escherichia coli, J. Biol. Chem. 1991, 
266, 20810-17. 
46. Schofield, L. R.; Patchett, M. L.; Parker, E. J., Expression, purification, and 
characterization of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase from Pyrococcus 
furiosus, Protein Expression Purif. 2004, 34, 17-27. 
47. Wu, J.; Howe, D. L.; Woodard, R. W., Thermotoga maritima 3-deoxy-D-arabino-
heptulosonate 7-phosphate (DAHP) synthase: The ancestral eubacterial DAH7P synthase?, J. 
Biol. Chem. 2003, 278, 27525-27531. 
48. Wu, J.; Sheflyan, G. Y.; Woodard, R. W., Bacillus subtilis 3-deoxy-D-arabino-
heptulosonate 7-phosphate synthase revisited: resolution of two long-standing enigmas, 
Biochem. J. 2005, 390, 583-590. 
49. Wagner, T.; Kretsinger, R. H.; Bauerle, R.; Tolbert, W. D., 3-Deoxy-D-manno-
octulosonate-8-phosphate Synthase from Escherichia coli. Model of binding of 
phosphoenolpyruvate and D-arabinose-5-phosphate, J. Mol. Biol. 2000, 301, 233-238. 
50. Furdui, C. M.; Sau, A. K.; Yaniv, O.; Belakhov, V.; Woodard, R. W.; Baasov, T.; 
Anderson, K. S., The use of (E)- and (Z)-phosphoenol-3-fluoropyruvate as mechanistic 
probes reveals significant differences between the active sites of KDO8P and DAHP 
synthases, Biochemistry 2005, 44, 7326-7335. 
51. Li, J.; Wu, J.; Fleischhacker, A. S.; Woodard, R. W., Conversion of Aquifex aeolicus 
3-deoxy-D-manno-octulosonate 8-Phosphate Synthase, a metalloenzyme, into a 
nonmetalloenzyme, J. Am. Chem. Soc. 2004, 126, 7448-7449. 
52. Shulami, S.; Furdui, C.; Adir, N.; Shoham, Y.; Anderson, K. S.; Baasov, T., A 
reciprocal single mutation affects the metal requirement of 3-Deoxy-D-manno-2-
octulosonate-8-phosphate (KDO8P) synthases from Aquifex pyrophilus and Escherichia coli, 
J. Biol. Chem. 2004, 279, 45110-45120. 
53. Oliynyk, Z.; Briseno-Roa, L.; Janowitz, T.; Sondergeld, P.; Fersht, A. R., Designing a 
metal-binding site in the scaffold of Escherichia coli KDO8PS, Protein Eng., Des. Sel. 2004, 
17, 383-390. 
  References 
 
179 
 
54. Radaev, S.; Dastidar, P.; Patel, M.; Woodard, R. W.; Gatti, D. L., Structure and 
mechanism of 3-deoxy-D-manno-octulosonate 8-phosphate synthase, J. Biol. Chem. 2000, 
275, 9476-9484. 
55. Cochrane, F. C.; Cookson, T. V. M.; Jameson, G. B.; Parker, E. J., Reversing 
evolution: re-establishing obligate metal ion dependence in a metal-independent KDO8P 
synthase., J. Mol. Biol. 2009, 390, 646-661. 
56. Kelly, D. P.; McDonald, I. R.; Wood, A. P., Proposal for the reclassification of 
Thiobacillus novellus as Starkeya novella gen. nov., comb. nov., in the α-subclass of the 
Proteobacteria, Int J Syst Evol Microbiol 2000, 50 Pt 5, 1797-802. 
57. Shumilin I., A.; Bauerle, R.; Kretsinger R., H., The high-resolution structure of 3-
deoxy-D-arabino-heptulosonate-7-phosphate synthase reveals a twist in the plane of bound 
phosphoenolpyruvate, Biochemistry 2003, 42, 3766-76. 
58. Shumilin I., A.; Bauerle, R.; Wu, J.; Woodard R., W.; Kretsinger R., H., Crystal 
structure of the reaction complex of 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase 
from Thermotoga maritima refines the catalytic mechanism and indicates a new mechanism 
of allosteric regulation, J. Mol. Biol. 2004, 341, 455-66. 
59. Konig, V.; Pfeil, A.; Braus, G. H.; Schneider, T. R., Substrate and metal complexes of 
3-deoxy-D-arabino-heptulosonate-7-phosphate synthase from Saccharomyces cerevisiae 
provide new insights into the catalytic mechanism, J. Mol. Biol. 2004, 337, 675-690. 
60. Wierenga, R. K., The TIM-barrel fold: a versatile framework for efficient enzymes, 
FEBS Lett. 2001, 492, 193-198. 
61. Li, Z.; Sau, A. K., Structural studies on Helicobacter pylori 3-deoxy-D-manno-2-
octulosonate-8-phosphate synthase using electrospray ionization mass spectrometry: a 
tetrameric complex composed of dimeric dimers, Rapid Commun. Mass Spectrom. 2009, 23, 
1573-1578. 
62. Allison, T. M.; Yeoman, J. A.; Hutton, R. D.; Cochrane, F. C.; Jameson, G. B.; 
Parker, E. J., Specificity and mutational analysis of the metal-dependent 3-deoxy-D-manno-
octulosonate 8-phosphate synthase from Acidithiobacillus ferrooxidans, Biochim. Biophys. 
Acta, Proteins Proteomics 2010, 1804, 1526-1536. 
63. Xu, X.; Kona, F.; Wang, J.; Lu, J.; Stemmler, T.; Gatti, D. L., The catalytic and 
conformational cycle of Aquifex aeolicus KDO8P synthase: role of the L7 loop, Biochemistry 
2005, 44, 12434-12444. 
64. Li, Y.; Evans, J. N. S., The hard-soft acid-base principle in enzymic catalysis: dual 
reactivity of phosphoenolpyruvate, Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 4612-4616. 
  References 
 
180 
 
65. Wang, J.; Duewel, H. S.; Stuckey, J. A.; Woodard, R. W.; Gatti, D. L., Function of 
His185 in Aquifex aeolicus 3-deoxy-D-manno-octulosonate 8-phosphate synthase, J. Mol. 
Biol. 2002, 324, 205-214. 
66. Vainer, R.; Belakhov, V.; Rabkin, E.; Baasov, T.; Adir, N., Crystal Structures of 
Escherichia coli KDO8P Synthase Complexes Reveal the Source of Catalytic Irreversibility, 
J. Mol. Biol. 2005, 351, 641-652. 
67. Ahn, M.; Pietersma, A. L.; Schofield, L. R.; Parker, E. J., Mechanistic divergence of 
two closely related aldol-like enzyme-catalysed reactions, Org. Biomol. Chem. 2005, 3, 4046-
4049. 
68. Howe, D. L.; Sundaram, A. K.; Wu, J.; Gatti, D. L.; Woodard, R. W., Mechanistic 
insight into 3-Deoxy-D-manno-octulosonate-8-phosphate synthase and 3-deoxy-D-arabino-
heptulosonate-7-phosphate synthase utilizing phosphorylated monosaccharide analogues, 
Biochemistry 2003, 42, 4843-4854. 
69. Williamson, R. M.; Pietersma, A. L.; Jameson, G. B.; Parker, E. J., Stereospecific 
deuteration of 2-deoxyerythrose 4-phosphate using 3-deoxy-D-arabino-heptulosonate 7-
phosphate synthase, Bioorg. Med. Chem. Lett. 2005, 15, 2339-2342. 
70. Ahn, M., Substrate analogues as mechanistic probes for 3-deoxy-D-arabino-
heptulosonate 7-phosphate synthase and 3-deoxy-D-manno-octulosonate 8-phosphate 
synthase.; PhD, Massey University, 2007. 
71. DeLeo, A. B.; Sprinson, D. B., Mechanism of 3-deoxy-D-arabinoheptulosonate-7-
phosphate (DAHP) synthetase, Biochem. Biophys. Res. Commun. 1968, 32, 873-7. 
72. Gunawan, J.; Simard, D.; Gilbert, M.; Lovering, A. L.; Wakarchuk, W. W.; Tanner, 
M. E.; Strynadka, N. C. J., Structural and mechanistic analysis of sialic acid synthase NeuB 
from Neisseria meningitidis in complex with Mn2+, phosphoenolpyruvate, and N-
acetylmannosaminitol, J. Biol. Chem. 2005, 280, 3555-3563. 
73. Bondinell, W. E.; Vnek, J.; Knowles, P. F.; Sprecher, M.; Sprinson, D. B., 
Mechanism of 5-enolpyruvylshikimate 3-phosphate synthetase, J. Biol. Chem. 1971, 246, 
6191-6. 
74. Eschenburg, S.; Kabsch, W.; Healy, M. L.; Schoenbrunn, E., A New View of the 
Mechanisms of UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) and 5-
Enolpyruvylshikimate-3-phosphate Synthase (AroA) Derived from X-ray Structures of Their 
Tetrahedral Reaction Intermediate States, J. Biol. Chem. 2003, 278, 49215-49222. 
75. Bravo, I. G.; Garcia-Vallve, S.; Romeu, A.; Reglero, A., Prokaryotic origin of 
cytidylyltransferases and α-ketoacid synthases, Trends Microbiol. 2004, 12, 120-128. 
  References 
 
181 
 
76. Traving, C.; Schauer, R., Structure, function, and metabolism of sialic acids, Cell. 
Mol. Life Sci. 1998, 54, 1330-1349. 
77. Varki, A., Sialic acids as ligands in recognition phenomena, FASEB J. 1997, 11, 248-
255. 
78. Preston, A.; Mandrell, R. E.; Gibson, B. W.; Apicella, M. A., The 
lipooligosaccharides of pathogenic Gram-negative bacteria, Crit. Rev. Microbiol. 1996, 22, 
139-180. 
79. Angata, T.; Varki, A., Chemical Diversity in the Sialic Acids and Related alpha -Keto 
Acids: An Evolutionary Perspective, Chem. Rev. (Washington, D. C.) 2002, 102, 439-469. 
80. Jia, Z.; DeLuca, C. I.; Chao, H.; Davies, P. L., Structural basis for the binding of a 
globular antifreeze protein to ice, Nature 1996, 384, 285-8. 
81. Sundaram, A. K.; Pitts, L.; Muhammad, K.; Wu, J.; Betenbaugh, M.; Woodard, R. 
W.; Vann, W. F., Characterization of N-acetylneuraminic acid synthase isoenzyme 1 from 
Campylobacter jejuni, Biochem. J. 2004, 383, 83-89. 
82. Onderka, D. K.; Floss, H. G., Steric course of the chorismate synthetase reaction and 
the 3-deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) synthetase reaction, J. Am. Chem. 
Soc. 1969, 91, 5894-6. 
83. Sheffer-Dee-Noor, S.; Belakhov, V.; Baasov, T., Insight into the catalytic mechanism 
of KDO8P synthase. Synthesis and evaluation of the isosteric phosphonate mimic of the 
putative cyclic intermediate, Bioorg. Med. Chem. Lett. 1993, 3, 1583-8. 
84. Xu, X.; Wang, J.; Grison, C.; Petek, S.; Coutrot, P.; Birck, M. R.; Woodard, R. W.; 
Gatti, D. L., Structure-based design of novel inhibitors of 3-deoxy-D-manno-octulosonate 8-
phosphate synthase, Drug Design and Discovery 2003, 18, 91-99. 
85. Belakhov, V.; Dovgolevsky, E.; Rabkin, E.; Shulami, S.; Shoham, Y.; Baasov, T., 
Synthesis and evaluation of a mechanism-based inhibitor of KDO8P synthase, Carbohydr. 
Res. 2004, 339, 385-392. 
86. Walker, S. R., Design, Synthesis and Characterisation of Inhibitors of 3-Deoxy-D-
arabino-Heptulosonate 7-Phosphate Synthase; PhD, University of Canterbury, 2007. 
87. Weichselbaum, A., Ueber die Aetiologie der akuten Meningitis cerebro-spinalis., 
Fortschr Med 1887, 5, 573-83. 
88. Noekleby, H.; Aavitsland, P.; O'Hallahan, J.; Feiring, B.; Tilman, S.; Oster, P., Safety 
review: Two outer membrane vesicle (OMV) vaccines against systemic Neisseria 
meningitidis serogroup B disease, Vaccine 2007, 25, 3080-3084. 
  References 
 
182 
 
89. Rosenstein, N. E.; Perkins, B. A.; Stephens, D. S.; Popovic, T.; Hughes, J. M., 
Meningococcal disease, N. Engl. J. Med. 2001, 344, 1378-1388. 
90. Nikulin, J.; Panzner, U.; Frosch, M.; Schubert-Unkmeir, A., Intracellular survival and 
replication of Neisseria meningitidis in human brain microvascular endothelial cells, Int. J. 
Med. Microbiol. 2006, 296, 553-558. 
91. Colmer, A. R.; Hinkle, M. E., The role of microorganisms in acid mine drainage: a 
preliminary report, Science (Washington, DC, U. S.) 1947, 106, 253-6. 
92. Leduc, L. G.; Ferroni, G. D., The chemolithotropic bacterium Thiobacillus 
ferrooxidans, FEMS Microbiol. Rev. 1994, 14, 103-20. 
93. Gasteiger, E.; Hoogland, C.; Gattiker, A.; Duvaud, S.; Wilkins, M. R.; Appel, R. D.; 
Bairoch, A., Protein identification and analysis tools on the ExPASy server, Proteomics 
Protoc. Handb. 2005, 571-607. 
94. Allison, T. M., Investigations into the role of a lysine residue of 3-deoxy-D-manno-
octulosonate 8-phosphate synthase; BSc(Hons), University of Canterbury, 2007. 
95. Taylor, W. P.; Sheflyan, G. Y.; Woodard, R. W., A single point mutation in 3-deoxy-
D-manno-octulosonate-8-phosphate synthase is responsible for temperature sensitivity in a 
mutant strain of Salmonella typhimurium, J. Biol. Chem. 2000, 275, 32141-6. 
96. Sheflyan, G. Y.; Sundaram, A. K.; Taylor, W. P.; Woodard, R. W., Substrate 
ambiguity of 3-deoxy-D-manno-octulosonate 8-phosphate synthase from Neisseria 
gonorrhoeae revisited, J. Bacteriol. 2000, 182, 5005-5008. 
97. Krosky, D. J.; Alm, R.; Berg, M.; Carmel, G.; Tummino, P. J.; Xu, B.; Yang, W., 
Helicobacter pylori 3-deoxy-D-manno-octulosonate-8-phosphate (KDO-8-P) synthase is a 
zinc-metalloenzyme, Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol. 2002, 1594, 297-
306. 
98. Pauling, L., Nature of forces between large molecules of biological interest, Nature 
1948, 161, 707-9. 
99. Wolfenden, R. V., Transition state analogues for enzyme catalysis, Nature (London) 
1969, 223, 704-5. 
100. Wolfenden, R.; Snider, M. J., The depth of chemical time and the power of enzymes 
as catalysts, Acc. Chem. Res. 2001, 34, 938-945. 
101. Singh, V.; Evans, G. B.; Lenz, D. H.; Mason, J. M.; Clinch, K.; Mee, S.; Painter, G. 
F.; Tyler, P. C.; Furneaux, R. H.; Lee, J. E.; Howell, P. L.; Schramm, V. L., Femtomolar 
Transition State Analogue Inhibitors of 5'-Methylthioadenosine/S-Adenosylhomocysteine 
Nucleosidase from Escherichia coli, J. Biol. Chem. 2005, 280, 18265-18273. 
  References 
 
183 
 
102. Walker, S. R.; Cumming, H.; Parker, E. J., Substrate and reaction intermediate 
mimics as inhibitors of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase, Org. 
Biomol. Chem. 2009, 7, 3031-3035. 
103. Duncan, K.; Lewendon, A.; Coggins, J. R., The purification of 5-
enolpyruvylshikimate 3-phosphate synthase from an overproducing strain of Escherichia coli, 
FEBS Lett. 1984, 165, 121-7. 
104. Anderson, K. S.; Johnson, K. A., Kinetic and structural analysis of enzyme 
intermediates: lessons from EPSP synthase, Chem. Rev. (Washington, D. C.) 1990, 90, 1131-
49. 
105. Kona, F.; Tao, P.; Martin, P.; Xu, X.; Gatti, D. L., Electronic structure of the metal 
center in the Cd2+, Zn2+, and Cu2+ substituted forms of KDO8P synthase: implications for 
catalysis, Biochemistry 2009, 48, 3610-3630. 
106. Romanenko, V. D.; Kukhar, V. P., Fluorinated Phosphonates: Synthesis and 
Biomedical Application, Chem. Rev. (Washington, D. C.) 2006, 106, 3868-3935. 
107. Caplan, N. A.; Pogson, C. I.; Hayes, D. J.; Blackburn, G. M., Novel bisphosphonate 
inhibitors of phosphoglycerate kinase, Bioorg. Med. Chem. Lett. 1998, 8, 515-520. 
108. Jakeman, D. L.; Ivory, A. J.; Williamson, M. P.; Blackburn, G. M., Highly potent 
bisphosphonate ligands for phosphoglycerate kinase, J. Med. Chem. 1998, 41, 4439-4452. 
109. Halazy, S.; Ehrhard, A.; Danzin, C., 9-(Difluorophosphonoalkyl)guanines as a new 
class of multisubstrate analog inhibitors of purine nucleoside phosphorylase, J. Am. Chem. 
Soc. 1991, 113, 315-17. 
110. Nowak, T.; Mildvan, A. S., Stereoselective interactions of phosphoenolpyruvate 
analogs with phosphoenolpyruvate-utilizing enzymes, J. Biol. Chem. 1970, 245, 6057-64. 
111. Rose, I. A., Stereochemistry of pyruvate kinase, pyruvate carboxylase, and malate 
enzyme reactions, J. Biol. Chem. 1970, 245, 6052-6. 
112. Cohn, M.; Pearson, J. E.; O'Connell, E. L.; Rose, I. A., Nuclear magnetic resonance 
assignment of the vinyl hydrogens of phosphoenolpyruvate. Stereochemistry of the enolase 
reaction, J. Am. Chem. Soc. 1970, 92, 4095-8. 
113. Cumming, H., Probing the Substrate Specificity of 3-Deoxy-D-arabino-Heptulosonate 
7-Phosphate Synthase and 3-Deoxy-D-manno-Octulosonate 8-Phosphate Synthase using 
Analogues of Phosphoenolpyruvate; MSc, University of Canterbury, 2007. 
114. Reichau, S., Crystallographic studies of DAH7P synthase from Mycobacterium 
tuberculosis with a tetrahedral intermediate analogue inhibitor., Personal communication. 
  References 
 
184 
 
115. Mammen, M.; Chio, S.-K.; Whitesides, G. M., Polyvalent interactions in biological 
systems: implications for design and use of multivalent ligands and inhibitors, Angew. Chem., 
Int. Ed. 1998, 37, 2755-2794. 
116. Coutrot, P.; Grison, C.; Tabyaoui, M.; Czernecki, S.; Valery, J. M., Novel application 
of alkyl dihaloacetates; chain extension with an alpha -keto ester unit of carbohydrates, J. 
Chem. Soc., Chem. Commun. 1988, 1515-16. 
117. Grison, C.; Coutrot, F.; Comoy, C.; Lemilbeau, C.; Coutrot, P., New efficient 
synthesis of α-hydroxy esters from carbonyl compounds via  α-chloroglycidic esters, 
Tetrahedron Lett. 2000, 41, 6571-6574. 
118. Sobotta, R.; Klingler, F. D.; Schneider, H.; (Boehringer Ingelheim KG, Germany; 
Boehringer Ingelheim International GmbH). Application: EP 
EP, 1995, p 9 pp. 
119. Buchanan, J. G.; Chacón-Fuertes, M. E.; Edgar, A. R.; Moorhouse, S. J.; Rawson, D. 
I.; Wightman, R. H., Assignment of ring size in isopropylidene acetals by 13C N.M.R, 
Tetrahedron Lett. 1980, 21, 1793-1796. 
120. Einhorn, C.; Luche, J. L., Ultrasound in organic synthesis. Part 8. Ready preparation 
of sugar acetals under ultrasonic irradiation, Carbohydr. Res. 1986, 155, 258-61. 
121. Sato, K.-I.; Akai, S.; Hiroshima, T.; Aoki, H.; Sakuma, M.; Suzuki, K.-j., 
Chemoenzymatic synthesis of [3,9-13C]-labeled NeuAc and KDN, Tetrahedron Lett. 2003, 
44, 3513-3516. 
122. Webb, T. H.; Thomasco, L. M.; Schlachter, S. T.; Gaudino, J. J.; Wilcox, C. S., 
Insight into the unusual reactions of stabilized phosphorus ylides with lactols. A specific 
intramolecular hyroxyl group effect leads to high Z-selectivity, Tetrahedron Lett. 1988, 29, 
6823-6. 
123. Yoda, H.; Nakaseko, Y.; Takabe, K., Studies toward a synthesis of trilobatin B, a 
lignan from the liverwort Bazzania trilobata: asymmetric construction of the tetrahydrofuran 
segment, Tetrahedron Lett. 2004, 45, 4217-4220. 
124. Austin Kerrie, A. B.; Banwell Martin, G.; Loong David, T. J.; Rae, A. D.; Willis 
Anthony, C., A chemoenzymatic total synthesis of the undecenolide (-)-cladospolide B via a 
mid-stage ring-closing metathesis and a late-stage photo-rearrangement of the E-isomer, Org. 
Biomol. Chem. 2005, 3, 1081-8. 
  References 
 
185 
 
125. Grison, C.; Petek, S.; Finance, C.; Coutrot, P., Synthesis and antibacterial activity of 
mechanism-based inhibitors of KDO8P synthase and DAH7P synthase, Carbohydr. Res. 
2005, 340, 529-537. 
126. Shen, X.; Wu, Y.-L.; Wu, Y., Enantioselective synthesis of ethyl 4,5,7,8,9-penta-O-
acetyl-2,6-anhydro- 3-deoxy-D-erythro-L-gluca-nononate: a 2-monodeoxygenated derivative 
of `2-keto-3-deoxy-D-glycero-D-galacto-nononic acid', Helv. Chim. Acta 2000, 83, 943-953. 
127. Setoi, H.; Takeno, H.; Hashimoto, M., Total synthesis of (+)-castanospermine from D-
mannose, Tetrahedron Lett. 1985, 26, 4617-20. 
128. Mashimo, K.; Sato, Y., Synthesis of isoajmaline, Tetrahedron 1970, 26, 803-12. 
129. Cunico, R. F.; Bedell, L., The triisopropylsilyl group as a hydroxyl-protecting 
function, J. Org. Chem. 1980, 45, 4797-8. 
130. Davies, J. S.; Higginbotham, C. L.; Tremeer, E. J.; Brown, C.; Treadgold, R. C., 
Protection of hydroxy groups by silylation: use in peptide synthesis and as lipophilicity 
modifiers for peptides, J. Chem. Soc., Perkin Trans. 1 1992, 3043-8. 
131. Schlessinger, R. H.; Lopes, A., A total synthesis of racemic senepoxide: formal 
syntheses of crotepoxide and pipoxide, J. Org. Chem. 1981, 46, 5252-3. 
132. Jarowicki, K.; Kocienski, P., Protecting groups, 2000. 
133. Xiao, X.; Bai, D., An efficient and selective method for hydrolysis of acetonides, 
Synlett 2001, 535-537. 
134. Koelln, O.; Redlich, H.; Frank, H., Trimethylenedithioacetals of carbohydrates; Part 
2. D-Arabinose, D-glucose, and D-mannose propane-1,3-diyldithioacetals and their 
isopropylidene derivatives, Synthesis 1995, 1383-8. 
135. Pedrocchi-Fantoni, G.; Servi, S., Simple synthesis of the two enantiomeric forms of 
erythro-octane-2,3-diol and 2-hydroxyoctan-3-one, proposed pheromones of Xylotrechus 
pyrrhoderus, J. Chem. Res., Synop. 1986, 199. 
136. Anwer, M. K.; Spatola, A. F., An advantageous method for the rapid removal of 
hydrogenolyzable protecting groups under ambient conditions; synthesis of leucine-
enkephalin, Synthesis 1980, 929-32. 
137. Coleman, R. S.; Carpenter, A. J., Synthesis of the aziridino[1,2-α]pyrrolidine 
substructure of the antitumor agents azinomycin A and B, J. Org. Chem. 1992, 57, 5813-15. 
138. Greene, T. W.; Wuts, P. G. M., Protective Groups in Organic Synthesis. 3rd Ed, 
1999. 
  References 
 
186 
 
139. Hoefle, G.; Steglich, W.; Vorbrueggen, H., New synthetic methods. 25. 4-
Dialkylaminopyridines as acylation catalysts. 4. Puridine syntheses. 1. 4-
Dialkylaminopuridines as highly active acylation catalysts, Angew. Chem. 1978, 90, 602-15. 
140. Narayan, R. S.; Borhan, B., Synthesis of the Proposed Structure of Mucoxin via 
Regio- and Stereoselective Tetrahydrofuran Ring-Forming Strategies, J. Org. Chem. 2006, 
71, 1416-1429. 
141. Willson, T. M.; Kocienski, P.; Jarowicki, K.; Isaac, K.; Hitchcock, P. M.; Faller, A.; 
Campbell, S. F., Studies related to the synthesis of pederin. Part 2. Synthesis of pederol 
dibenzoate and benzoylpedamide, Tetrahedron 1990, 46, 1767-82. 
142. Bolitt, V.; Mioskowski, C.; Kollah, R. O.; Manna, S.; Rajapaksa, D.; Falck, J. R., 
Total synthesis of vineomycinone B2 methyl ester via double Bradsher cyclization, J. Am. 
Chem. Soc. 1991, 113, 6320-1. 
143. Dess, P. B.; Martin, J. C., A Useful 12-I-4 Triacetoxyperiodinane (the Dess-Martin 
Periodinane) for the Selective Oxidation of Primary of Secondary Alcohols for a Variety of 
Related 12-I-5 Species, J. Am. Chem.  Soc. 1991, 113, 7277-7287. 
144. Omura, K.; Swern, D., Oxidation of alcohols by "activated" dimethyl sulfoxide. A 
preparative steric and mechanistic study, Tetrahedron 1978, 34, 1651-60. 
145. Emerson, W. S., Preparation of amines by reductive alkylation, Org. React. (N.Y.) 
1948, 4, 174-255. 
146. Abdel-Magid, A. F.; Carson, K. G.; Harris, B. D.; Maryanoff, C. A.; Shah, R. D., 
Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies 
on direct and indirect reductive amination procedures, J. Org. Chem. 1996, 61, 3849-3862. 
147. Sato, S.; Sakamoto, T.; Miyazawa, E.; Kikugawa, Y., One-pot reductive amination of 
aldehydes and ketones with α-picoline-borane in methanol, in water, and in neat conditions, 
Tetrahedron 2004, 60, 7899-7906. 
148. Uenishi, J.; Hamada, M.; Aburatani, S.; Matsui, K.; Yonemitsu, O.; Tsukube, H., 
Synthesis of chiral nonracemic 1-(2-pyridinyl)ethylamines: stereospecific introduction of 
amino function onto the 2-pyridinylmethyl carbon center, J. Org. Chem. 2004, 69, 6781-
6789. 
149. Hong, Y.-R.; Gorman, C. B., Synthetic approaches to an isostructural series of redox-
active, metal tris(bipyridine) core dendrimers, J. Org. Chem. 2003, 68, 9019-9025. 
  References 
 
187 
 
150. Micali, E.; Chehade, K. A. H.; Isaacs, R. J.; Andres, D. A.; Spielmann, H. P., Protein 
farnesyltransferase isoprenoid substrate discrimination is dependent on isoprene double 
bonds and branched methyl groups, Biochemistry 2001, 40, 12254-12265. 
151. Rybczynski, P., J.; Zeck, R., E.; Dudash, J., Jr.; Combs, D., W.; Burris, T., P.; Yang, 
M.; Osborne, M., C.; Chen, X.; Demarest, K., T., Benzoxazinones as PPAR-γ agonists. 2. 
SAR of the amide substituent and in vivo results in a type 2 diabetes model, J. Med. Chem. 
2004, 47, 196-209. 
152. Van der Klei, A.; De Jong, R. L. P.; Lugtenburg, J.; Tielens, A. G. M., Synthesis and 
spectroscopic characterization of [1'-14C]ubiquinone-2, [1'-14C]-5-demethoxy-5-
hydroxyubiquinone-2, and [1'-14C]-5-demethoxyubiquinone-2, Eur. J. Org. Chem. 2002, 
3015-3023. 
153. Wiley, G. A.; Hershkowitz, R. L.; Rein, B. M.; Chung, B. C., Organophosphorus 
chemistry. I. Conversion of alcohol and phenols to halides by tertiary phosphine dihalides, J. 
Am. Chem. Soc. 1964, 86, 964-5. 
154. Cossio, F. P.; Ganboa, I.; Palomo, C., Reagents and synthetic methods. 48. 
Triphenylphosphine dibromide and dimethylsulfide dibromide as versatile reagents for β-
lactam synthesis, Tetrahedron Lett. 1985, 26, 3041-4. 
155. Jew, S.-S.; Kim, H.-O.; Jeong, B.-S.; Park, H.-G., Asymmetric synthesis of (R)-(+)-
etomoxir, Tetrahedron: Asymmetry 1997, 8, 1187-1192. 
156. Szardenings, A. K.; Burkoth, T. S.; Look, G. C.; Campbell, D. A., A reductive 
alkylation procedure applicable to both solution- and solid-phase syntheses of secondary 
amines, J. Org. Chem. 1996, 61, 6720-6722. 
157. Salvatore, R. N.; Nagle, A. S.; Schmidt, S. E.; Jung, K. W., Cesium hydroxide 
promoted chemoselective N-alkylation for the generally efficient synthesis of secondary 
amines, Org. Lett. 1999, 1, 1893-1896. 
158. Corey, E. J.; Venkateswarlu, A., Protection of hydroxyl groups as tert-
butyldimethylsilyl derivatives, J. Am. Chem. Soc. 1972, 94, 6190-1. 
159. Nurminen, E. J.; Mattinen, J. K.; Lonnberg, H., Kinetics and mechanism of tetrazole-
catalyzed phosphoramidite alcoholysis, J. Chem. Soc. Perkin Trans. 2 1998, 1621-1628. 
160. Perich, J. W.; Johns, R. B., Di-tert-butyl N,N-diethylphosphoramidite. A new 
phosphitylating agent for the efficient phosphorylation of alcohols, Synthesis 1988, 142-4. 
161. Lindberg, J.; Ekeroth, J.; Konradsson, P., Efficient synthesis of phospholipids from 
glycidyl phosphates, J. Org. Chem. 2002, 67, 194-199. 
  References 
 
188 
 
162. Hartung, W. H.; Simonoff, R., Hydrogenolysis of benzyl groups attached to oxygen, 
nitrogen or sulfur, Org. React. (N.Y.) 1953, VII, 263-326. 
163. Castro, B.; Villieras, J.; Ferracutti, N., Aliphatic aldehydes in the Darzens reaction of 
mono- and dichloroacetic [acid] esters. Specific solvation by hydrogen bonding, C. R. Acad. 
Sci., Paris, Ser. C 1969, 268, 1403-6. 
164. Reichau, S., Two-step conversion of aldehyde functionality to α-hydroxy ester., 
Personal communication. 
165. Gottlieb, H. E.; Kotlyar, V.; Nudelman, A., NMR chemical shifts of common 
laboratory solvents as trace impurities, J. Org. Chem. 1997, 62, 7512-7515. 
166. Lanzetta, P. A.; Alvarez, L. J.; Reinach, P. S.; Candia, O. A., An improved assay for 
nanomole amounts of inorganic phosphate, Anal. Biochem. 1979, 100, 95-7. 
167. Heathcock, C. H.; Ratcliffe, R., Stereoselective total synthesis of the guaiazulenic 
sesquiterpenoids α-bulnesene and bulnesol, J. Am. Chem. Soc. 1971, 93, 1746-57. 
168. Czernecki, S.; Georgoulis, C.; Provelenghiou, C.; Fusey, G., New method of 
benzylation of hindered glucosidic hydroxyl groups, Tetrahedron Lett. 1976, 3535-6. 
169. Kanai, K.; Sakamoto, I.; Ogawa, S.; Suami, T., Synthesis on 1,4-diaminocyclitol 
antibiotics. III. Synthesis of 4-hydroxypurpurosamine B derivatives, Bull. Chem. Soc. Jpn. 
1987, 60, 1529-31. 
170. Kuhn, R.; Low, I.; Trischmann, H., The constitution of lycotetraose, Chem. Ber. 1957, 
90, 203-18. 
171. Tao, P.; Schlegel, H. B.; Gatti, D. L., Common basis for the mechanism of metallo 
and non-metallo KDO8P synthases, J. Inorg. Biochem. 2010, 104, 1267-1275. 
172. Bowman, W. R.; Coghlan, D. R., A facile method for the N-alkylation of alpha -
amino esters, Tetrahedron 1997, 53, 15787-15798. 
173. Coutrot, P.; Legris, C., Convenient synthesis of α-keto-esters and unsymmetrical 1,2-
diketones from carbonyl compounds, Synthesis 1975, 118-20. 
174. Hajipour, A. R.; Khoee, S.; Ruoho, A. E., Regeneration of carbonyl compounds from 
oximes, hydrazones, semicarbazones, acetals, 1,1-diacetates, 1,3-dithiolanes, 1,3-dithianes 
and 1,3-oxathiolanes, Org. Prep. Proced. Int. 2003, 35, 527-581. 
175. Satchell, D. P. N.; Satchell, R. S., Mechanisms of hydrolysis of thioacetals, Chem. 
Soc. Rev. 1990, 19, 55-81. 
176. Wang, P.; Hu, H.; Wang, Y., Novel Photolabile Protecting Group for Carbonyl 
Compounds, Org. Lett. 2007, 9, 1533-1535. 
  References 
 
189 
 
177. Crispino, G. A.; Jeong, K. S.; Kolb, H. C.; Wang, Z. M.; Xu, D.; Sharpless, K. B., 
Improved enantioselectivity in asymmetric dihydroxylations of terminal olefins using 
pyrimidine ligands, J. Org. Chem. 1993, 58, 3785-6. 
178. Takasu, M.; Naruse, Y.; Yamamoto, H., A convenient procedure for the regioselective 
monoprotection of 1,n-diols, Tetrahedron Lett. 1988, 29, 1947-50. 
179. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4, Nature (London, U. K.) 1970, 227, 680-685. 
180. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 1976, 72, 
248-54. 
181. Armarego, W. L. F.; Chai, C., Purification of Laboratory Chemicals, 5th Edition, 
2003. 
182. Frigerio, M.; Santagostino, M.; Sputore, S., A user-friendly entry to 2-iodoxybenzoic 
acid (IBX), J. Org. Chem. 1999, 64, 4537-4538. 
183. Walker, S. R.; Parker, E. J., Synthesis and evaluation of a mechanism-based inhibitor 
of a 3-deoxy-D-arabino heptulosonate 7-phosphate synthase, Bioorg. Med. Chem. Lett. 2006, 
16, 2951-2954. 
 
 
